细胞株Cell Lines 88及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV88
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID OU-AML-3
AC CVCL_8393
DR BioSample; SAMN03151869
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-AML-4
AC CVCL_8394
DR BioSample; SAMN03151870
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-AML-5
AC CVCL_8395
DR BioSample; SAMN03151871
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-AML-6
AC CVCL_8396
DR BioSample; SAMN03151872
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-AML-7
AC CVCL_8397
DR BioSample; SAMN03151873
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-AML-8
AC CVCL_8398
DR BioSample; SAMN03151874
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-LC-A1
AC CVCL_DI01
RX PubMed=10213231;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OU-LC-A2
AC CVCL_DI02
RX PubMed=10213231;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OU-LC-A3
AC CVCL_DI03
RX PubMed=10213231;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OU-LC-A4
AC CVCL_DI04
RX PubMed=10213231;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OU-LC-AS1
AC CVCL_DI05
RX PubMed=10213231;
CC Derived from metastatic site: Supraclavicular lymph node.
DI NCIt; C9133; Adenosquamous lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OU-LC-KI
AC CVCL_DI06
RX PubMed=10213231;
RX PubMed=21048114;
RX PubMed=22109656;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OU-LC-OK
AC CVCL_DI07
RX PubMed=21048114;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OU-LC-ON
AC CVCL_DI08
RX PubMed=21048114;
RX PubMed=22109656;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OU-LC-KM
AC CVCL_DI09
RX PubMed=21048114;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OU-LC-SK
AC CVCL_DI10
RX PubMed=21048114;
RX PubMed=22109656;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OUMS-21
AC CVCL_9131
SY Okayama University Medical School-21
RX DOI=10.1007/978-1-4612-0411-4_32;
RX PubMed=7683277;
CC Characteristics: SV40-transformed but with a finite life span.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9132 ! OUMS-22
CA Finite cell line
//
ID OUMS-22
AC CVCL_9132
SY Okayama University Medical School-22
RX DOI=10.1007/978-1-4612-0411-4_32;
RX PubMed=7683277;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9131 ! OUMS-21
CA Transformed cell line
//
ID OUMS-23
AC CVCL_3088
SY OUMS23; Okayama University Medical School-23
DR EFO; EFO_0006717
DR BioSample; SAMN03470828
DR BioSample; SAMN03472537
DR CCLE; OUMS23_LARGE_INTESTINE
DR Cosmic; 1187312
DR Cosmic-CLP; 1298363
DR GDSC; 1298363
DR GEO; GSM827177
DR GEO; GSM887479
DR GEO; GSM888560
DR GEO; GSM1448077
DR JCRB; JCRB1022
DR JCRB; NIHS0292
RX PubMed=8576285;
RX PubMed=22460905;
RX PubMed=25926053;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0292; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 16
ST D21S11: 28,30
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 10 (JCRB)
ST D7S820: 10,13 (PubMed=25877200)
ST D8S1179: 13,16
ST FGA: 23.2
ST Penta D: 9,12
ST Penta E: 5,9
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OUMS-24
AC CVCL_B369
SY OUMS24; Okayama University Medical School-24
RX PubMed=8985102;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID OUMS-24/P6X
AC CVCL_3089
SY OUMS24/P6X
DR JCRB; JCRB1051
DR JCRB; NIHS0327
RX PubMed=8985102;
CC Transfected with: HGNC; 11998; TP53 (with H-273).
CC Transformant: NCIt; C17262; X-Ray.
CC Discontinued: JCRB; NIHS0327; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 11
ST D7S820: 12
ST TH01: 8,9
ST TPOX: 8,12
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B369 ! OUMS-24
SX Female
CA Transformed cell line
//
ID OUMS-24F
AC CVCL_B370
SY OUMS24F
RX PubMed=8148305;
RX PubMed=8557247;
RX PubMed=9290701;
CC Transformant: ChEBI; CHEBI:16907; 4-nitroquinoline N-oxide (4NQO).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B369 ! OUMS-24
SX Female
CA Transformed cell line
//
ID OUMS-25
AC CVCL_9133
SY Okayama University Medical School-25
RX PubMed=8168158;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID OUMS-27
AC CVCL_3090
SY OUMS27; Okayama University Medical School-27
DR BioSample; SAMN03472799
DR CCLE; OUMS27_BONE
DR Cosmic; 1602478
DR Cosmic; 1992325
DR GEO; GSM887480
DR GEO; GSM888561
DR IFO; IFO50488
RX PubMed=9714054;
RX PubMed=22057234;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 14
ST D5S818: 10,11
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 11
ST vWA: 14
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OUMS-29
AC CVCL_9130
SY Okayama University Medical School-29
RX PubMed=11513080;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID OUMS-31
AC CVCL_9129
SY Okayama University Medical School-31
RX PubMed=10476912;
CC Breed/subspecies: C3H/AnLCsb-Csb.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9134 ! OUMS-32
OI CVCL_9135 ! OUMS-33
SX Female
CA Spontaneously immortalized cell line
//
ID OUMS-32
AC CVCL_9134
SY Okayama University Medical School-32
RX PubMed=10476912;
CC Breed/subspecies: C3H/AnLCsb-Csb.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9129 ! OUMS-31
OI CVCL_9135 ! OUMS-33
SX Female
CA Spontaneously immortalized cell line
//
ID OUMS-33
AC CVCL_9135
SY Okayama University Medical School-33
RX PubMed=10476912;
CC Breed/subspecies: C3H/AnLCsb-Csb.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9129 ! OUMS-31
OI CVCL_9134 ! OUMS-32
SX Female
CA Spontaneously immortalized cell line
//
ID OUMS-34
AC CVCL_9136
SY Okayama University Medical School-34
RX PubMed=10476912;
CC Breed/subspecies: C3H/AnLCsa-Csa.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9137 ! OUMS-35
CA Spontaneously immortalized cell line
//
ID OUMS-35
AC CVCL_9137
SY Okayama University Medical School-35
RX PubMed=10476912;
CC Breed/subspecies: C3H/AnLCsa-Csa.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9136 ! OUMS-34
CA Spontaneously immortalized cell line
//
ID OUMS-36
AC CVCL_3091
SY Okayama University Medical School-36
DR BioSample; SAMN03472528
DR JCRB; JCRB1006.0
DR JCRB; NIHS0291.0
CC Discontinued: JCRB; NIHS0291.0; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID OUMS-36T-1
AC CVCL_3092
DR JCRB; JCRB1006.1
DR JCRB; NIHS0291.1
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.1; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-1F
AC CVCL_3093
DR JCRB; JCRB1006.1F
DR JCRB; NIHS0291.1S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.1S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-2
AC CVCL_3094
DR JCRB; JCRB1006.2
DR JCRB; NIHS0291.2
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.2; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-2F
AC CVCL_3095
DR JCRB; JCRB1006.2F
DR JCRB; NIHS0291.2S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.2S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-3
AC CVCL_3096
DR JCRB; JCRB1006.3
DR JCRB; NIHS0291.3
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.3; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-3F
AC CVCL_3097
DR JCRB; JCRB1006.3F
DR JCRB; NIHS0291.3S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.3S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-4
AC CVCL_3098
DR JCRB; JCRB1006.4
DR JCRB; NIHS0291.4
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.4; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-4F
AC CVCL_3099
DR JCRB; JCRB1006.4F
DR JCRB; NIHS0291.4S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.4S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-5
AC CVCL_3100
DR JCRB; JCRB1006.5
DR JCRB; NIHS0291.5
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.5; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-5F
AC CVCL_3101
DR BioSample; SAMN03472529
DR JCRB; JCRB1006.5F
DR JCRB; NIHS0291.5S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.5S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,21
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-6
AC CVCL_3102
DR JCRB; JCRB1006.6
DR JCRB; NIHS0291.6
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.6; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-6F
AC CVCL_3103
DR JCRB; JCRB1006.6F
DR JCRB; NIHS0291.6S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.6S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-7
AC CVCL_3104
DR JCRB; JCRB1006.7
DR JCRB; NIHS0291.7
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.7; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-7F
AC CVCL_3105
DR JCRB; JCRB1006.7F
DR JCRB; NIHS0291.7S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.7S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-8
AC CVCL_3106
DR JCRB; JCRB1006.8
DR JCRB; NIHS0291.8
RX DOI=10.11418/jtca1981.19.4_203;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.8; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-36T-8F
AC CVCL_3107
DR JCRB; JCRB1006.8F
DR JCRB; NIHS0291.8S
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0291.8S; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,20
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3091 ! OUMS-36
CA Telomerase immortalized cell line
//
ID OUMS-37
AC CVCL_9128
SY OUMS37; Okayama University Medical School-37
RX PubMed=10548428;
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID OUR-10
AC CVCL_A416
SY OUR10
DR Cosmic; 849376
DR TKG; TKG 0694
RX PubMed=40693;
RX PubMed=11146448;
CC Doubling time: ~32 hours, at 50th passage (PubMed=40693).
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 13
ST D5S818: 9,13
ST D7S820: 10,11
ST TH01: 6,7,9.3
ST TPOX: 11,12
ST vWA: 14,17,18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OUR-20
AC CVCL_A417
SY OUR20
DR Cosmic; 849367
RX PubMed=1958632;
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OUR-20P
AC CVCL_A418
RX PubMed=1958632;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A417 ! OUR-20
CA Cancer cell line
//
ID OUR-20S
AC CVCL_A419
RX PubMed=1958632;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A417 ! OUR-20
CA Cancer cell line
//
ID OUR-30
AC CVCL_A420
RX PubMed=1958632;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OUS-11
AC CVCL_3108
SY OUS11
DR BTO; BTO:0003968
DR BioSample; SAMN03472481
DR JCRB; JCRB1034
DR JCRB; NIHS0313
CC Discontinued: JCRB; NIHS0313; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID OV-1063
AC CVCL_4366
SY OV1063; 0V-1063
DR ATCC; CRL-2183
DR BioSample; SAMN03152024
DR BioSample; SAMN03472561
DR CCRID; 3111C0001CCC000361
DR ChEMBL-Cells; CHEMBL3308411
DR ChEMBL-Targets; CHEMBL614211
DR Cosmic; 844352
DR Cosmic; 849609
DR Cosmic; 897432
DR Cosmic; 948286
DR Cosmic; 1044238
DR Cosmic; 2582808
RX PubMed=2412195;
RX PubMed=20143388;
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).
CC Discontinued: ATCC; CRL-2183; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 10,11,13
ST D5S818: 10,13
ST D7S820: 7,9,11
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Undefined cell line type
//
ID OV-1369(R2)
AC CVCL_9T12
SY OV1369(R2)
RX PubMed=22931248;
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T17 ! TOV-1369
SX Female
CA Cancer cell line
//
ID OV-1847
AC CVCL_D703
SY Ovary 1847; Ovary1847; OVARY1847
DR BioSample; SAMN03151864
DR Cosmic; 1709260
DR GEO; GSM851927
RX PubMed=22328975;
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OVCAR-8 derivative (PubMed=22710073).
CC Omics: Transcriptome analysis.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1629 ! OVCAR-8
SX Female
CA Cancer cell line
//
ID OV-2295
AC CVCL_9T13
SY OV2295
RX PubMed=22931248;
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T14 ! OV-2295(R2)
OI CVCL_9T18 ! TOV-2295(R)
SX Female
CA Cancer cell line
//
ID OV-1946
AC CVCL_4375
SY OV1946
DR Cosmic; 1122315
RX PubMed=18507860;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OV-1946
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4062 ! TOV-1946
SX Female
CA Cancer cell line
//
ID OV-2008
AC CVCL_0473
AS CVCL_4066
SY OV2008; Ov2008; OV 2008; 2008; A2008
DR BTO; BTO:0003792
DR MCCL; MCC:0000371
DR BioSample; SAMN03151841
DR BioSample; SAMN03151843
DR ChEMBL-Cells; CHEMBL3308015
DR ChEMBL-Targets; CHEMBL612818
DR Cosmic; 849613
DR Cosmic; 948293
DR Cosmic; 988874
DR Cosmic; 1102825
DR Cosmic; 1524359
DR Cosmic; 1707563
DR Cosmic; 2582806
DR GEO; GSM184384
DR GEO; GSM184385
DR GEO; GSM659387
DR GEO; GSM851907
DR GEO; GSM851925
RX PubMed=4118903;
RX PubMed=9234707;
RX PubMed=11314036;
RX PubMed=22710073;
RX PubMed=24023729;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-62.html
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
CC Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=22710073
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 12
ST D19S433: 13,15.2
ST D21S11: 30,31
ST D2S1338: 18
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 14
ST FGA: 23
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1401 ! ME-180
SX Female
CA Cancer cell line
//
ID OV-2295(R2)
AC CVCL_9T14
SY OV2295(R2)
RX PubMed=22931248;
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T13 ! OV-2295
OI CVCL_9T18 ! TOV-2295(R)
SX Female
CA Cancer cell line
//
ID OV-3133(R)
AC CVCL_9T15
SY OV3133(R)
RX PubMed=22931248;
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T16 ! OV-3133(R2)
OI CVCL_9T19 ! TOV-3133D
OI CVCL_4064 ! TOV-3133G
SX Female
CA Cancer cell line
//
ID OV-3133(R2)
AC CVCL_9T16
SY OV3133(R2)
RX PubMed=22931248;
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9T15 ! OV-3133(R)
OI CVCL_9T19 ! TOV-3133D
OI CVCL_4064 ! TOV-3133G
SX Female
CA Cancer cell line
//
ID OV-4453
AC CVCL_9T20
SY OV4453
RX PubMed=26622941;
CC Doubling time: 2.44 +- 0.03 days (PubMed=26622941).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C36101; BRCA2 syndrome
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-4485
AC CVCL_9T21
SY OV4485
RX PubMed=26622941;
CC Doubling time: 1.85 +- 0.29 days (PubMed=26622941).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C36100; BRCA1 syndrome
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-866(2)
AC CVCL_9T22
SY OV866(2)
RX PubMed=26622941;
CC Doubling time: 1.77 +- 0.32 days (PubMed=26622941).
CC Omics: Deep exome analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-90
AC CVCL_3768
SY OV90
DR BTO; BTO:0004852
DR CLO; CLO_0008276
DR EFO; EFO_0002311
DR ATCC; CRL-11732
DR BioSample; SAMN03471308
DR CCLE; OV90_OVARY
DR Cosmic; 1102815
DR Cosmic; 1113283
DR Cosmic; 1139219
DR Cosmic; 1305311
DR Cosmic; 1709257
DR Cosmic; 2186586
DR Cosmic-CLP; 1240197
DR GDSC; 1240197
DR GEO; GSM659389
DR GEO; GSM784576
DR GEO; GSM851926
DR GEO; GSM887483
DR GEO; GSM888564
DR GEO; GSM1001427
DR GEO; GSM1001428
DR GEO; GSM1001492
DR GEO; GSM1374800
DR GEO; GSM1670314
DR IGRhCellID; OV90
RX Patent=US5710038;
RX PubMed=10949993;
RX PubMed=11641787;
RX PubMed=22328975;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OV-90
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 40 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'TOV-90' in Cosmic 1139219.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 12
ST D21S11: 30,30.2
ST D3S1358: 18
ST D5S818: 11,15
ST D7S820: 10,10.1 (ATCC; PubMed=25230021; PubMed=25877200)
ST D7S820: 10 (Cosmic-CLP)
ST D8S1179: 12,14
ST FGA: 21,22
ST Penta D: 12,13
ST Penta E: 11,13
ST TH01: 9.3
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-1
AC CVCL_X950
RX PubMed=1500230;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-10
AC CVCL_4003
DR BTO; BTO:0004485
RX PubMed=7510115;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-12
AC CVCL_X965
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-14
AC CVCL_X966
SY OVMZ-14
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-15
AC CVCL_4004
DR BTO; BTO:0004486
DR GEO; GSM313678
RX PubMed=7510115;
RX PubMed=11242531;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-16
AC CVCL_X959
SY OVMZ-16
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-19
AC CVCL_6863
RX PubMed=9735390;
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-1a
AC CVCL_X962
SY OVMZ-1a
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X950 ! OV-MZ-1
SX Female
CA Cancer cell line
//
ID OV-MZ-2
AC CVCL_X951
RX PubMed=1500230;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-20
AC CVCL_X967
SY OVMZ-20
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-21
AC CVCL_X968
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-22
AC CVCL_E117
RX PubMed=11242531;
RX PubMed=11733966;
RX PubMed=15153938;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-26
AC CVCL_X969
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-27
AC CVCL_X970
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-2a
AC CVCL_X955
RX PubMed=10741907;
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X951 ! OV-MZ-2
SX Female
CA Cancer cell line
//
ID OV-MZ-3
AC CVCL_X952
RX PubMed=1500230;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-30
AC CVCL_X971
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-31
AC CVCL_X972
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-32
AC CVCL_X956
SY OVMZ32
RX PubMed=10741907;
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-33
AC CVCL_X973
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-35
AC CVCL_X957
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-36
AC CVCL_X987
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-37
AC CVCL_X960
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-38
AC CVCL_X961
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-4
AC CVCL_X953
SY OVMZ-4
RX PubMed=1500230;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-5
AC CVCL_X954
RX PubMed=1500230;
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-6
AC CVCL_4005
SY OVMZ-6
DR BTO; BTO:0004487
RX PubMed=1500230;
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-6#8
AC CVCL_X988
RX PubMed=12297307;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4005 ! OV-MZ-6
SX Female
CA Cancer cell line
//
ID OV-MZ-7a
AC CVCL_X974
SY OVMZ-7a
RX PubMed=11242531;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-8
AC CVCL_X958
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-MZ-9
AC CVCL_X964
SY OVMZ-9
RX PubMed=11242531;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-TRL-12B
AC CVCL_DH78
SY OV-TRL 12B; OV-TRL12B; TRL-12B
DR GEO; GSM313705
RX PubMed=19222485;
DI NCIt; C40093; Ovarian squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-TRL-90T
AC CVCL_DH79
SY TRL-90T; TRL90T
DR GEO; GSM313687
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV-UL-2
AC CVCL_X963
RX PubMed=11242531;
RX PubMed=15153938;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV(hyg)CAR3
AC CVCL_Y033
SY Ov(hyg)CAR3
RX PubMed=8824553;
CC Selected for resistance to: ChEBI; CHEBI:16976; Hygromycin B.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OV1/ADR
AC CVCL_8744
SY OV1/DXR
RX PubMed=2731146;
RX PubMed=17934650;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID OV1/CDDP
AC CVCL_8745
RX PubMed=2731146;
RX PubMed=17934650;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID OV1/VCR
AC CVCL_8746
RX PubMed=2731146;
RX PubMed=2925277;
RX PubMed=17934650;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1304 ! IGROV-1
SX Female
CA Cancer cell line
//
ID OV167
AC CVCL_A402
SY Ov167; OV-167; OV 167
DR Cosmic; 1523766
DR GEO; GSM659385
RX PubMed=9473353;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV176
AC CVCL_6E73
SY ov176
DR Cosmic; 845143
RX PubMed=9625810;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV177
AC CVCL_A403
SY Ov177; ov177; OV 177
DR Cosmic; 845144
DR Cosmic; 1523767
DR GEO; GSM659386
RX PubMed=9473353;
RX PubMed=9625810;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV17R
AC CVCL_2672
SY OV-17R
DR Cosmic-CLP; 1480361
DR ECACC; 96020763
DR GDSC; 1480361
DR GEO; GSM1670311
RX PubMed=7707437;
RX PubMed=25230021;
RX PubMed=27397505;
CC Part of: OCCP ovarian cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 11,13
ST D16S539: 9,13
ST D18S51: 13,18
ST D19S433: 14,16
ST D21S11: 30
ST D2S1338: 24,25
ST D3S1358: 14,17
ST D5S818: 11
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 21,22
ST Penta D: 10,13
ST Penta E: 14
ST TH01: 9 (Cosmic-CLP; ECACC)
ST TH01: 9,9.3 (PubMed=25230021)
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV202
AC CVCL_4067
SY Ov202; ov202; OV-202; OV 202
DR BTO; BTO:0003504
DR Cosmic; 845145
DR Cosmic; 1523768
RX PubMed=9473353;
RX PubMed=9625810;
RX PubMed=10690552;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV202 hp
AC CVCL_4068
SY OV-202 hp; OV202 high passage
RX PubMed=10690552;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4067 ! OV202
SX Female
CA Cancer cell line
//
ID OV207
AC CVCL_A404
SY Ov207; ov207; OV 207
DR Cosmic; 845146
DR Cosmic; 1223314
DR Cosmic; 1328063
DR Cosmic; 1434892
DR Cosmic; 1523769
DR Cosmic; 1708376
DR Cosmic; 2074244
DR GEO; GSM659388
RX PubMed=9473353;
RX PubMed=9625810;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV25R
AC CVCL_X502
RX PubMed=7707437;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV266
AC CVCL_A405
SY Ov266; ov266; OV 266
DR Cosmic; 845147
RX PubMed=9473353;
RX PubMed=9625810;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV2944
AC CVCL_E953
SY OV 2944
CC Breed/subspecies: C57BL/6N x C3H/He.
DI NCIt; C30037; Mouse malignant ovarian neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID OV2944-HM-1
AC CVCL_E954
SY HM-1
DR CLO; CLO_0051455
DR RCB; RCB1483
RX PubMed=2502522;
CC Breed/subspecies: C57BL/6N x C3H/He.
DI NCIt; C30037; Mouse malignant ovarian neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E953 ! OV2944
SX Female
CA Cancer cell line
//
ID OV2944-LM-1
AC CVCL_E955
SY LM-1
RX PubMed=2502522;
CC Breed/subspecies: C57BL/6N x C3H/He.
DI NCIt; C30037; Mouse malignant ovarian neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E953 ! OV2944
SX Female
CA Cancer cell line
//
ID OV2944-LM-3
AC CVCL_E956
SY LM-3
RX PubMed=2502522;
CC Breed/subspecies: C57BL/6N x C3H/He.
DI NCIt; C30037; Mouse malignant ovarian neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_E953 ! OV2944
SX Female
CA Cancer cell line
//
ID OV3121
AC CVCL_6547
DR JCRB; JCRB1026
DR JCRB; NIHS0255
RX PubMed=7775256;
RX PubMed=15541573;
CC Discontinued: JCRB; NIHS0255; true.
CC Breed/subspecies: C57BL/6N x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID OV3121-1
AC CVCL_0474
DR MCCL; MCC:0000372
RX PubMed=7775256;
CC Breed/subspecies: C57BL/6N x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6547 ! OV3121
SX Female
CA Cancer cell line
//
ID OV3121-ras4
AC CVCL_6548
SY OV312ras4; OV-ras4
DR JCRB; JCRB0186
RX PubMed=7775256;
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Breed/subspecies: C57BL/6N x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0474 ! OV3121-1
SX Female
CA Cancer cell line
//
ID OV3121-ras7
AC CVCL_6549
SY OV312ras7; OV-ras7
DR JCRB; JCRB0187
RX PubMed=7775256;
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Breed/subspecies: C57BL/6N x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0474 ! OV3121-1
SX Female
CA Cancer cell line
//
ID OV56
AC CVCL_2673
SY OV-56
DR EFO; EFO_0006458
DR BioSample; SAMN03472428
DR CCLE; OV56_OVARY
DR Cosmic-CLP; 1480362
DR ECACC; 96020759
DR GDSC; 1480362
DR GEO; GSM887481
DR GEO; GSM888562
DR GEO; GSM1670312
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,9
ST D16S539: 10,13
ST D18S51: 14
ST D19S433: 13,15
ST D21S11: 28
ST D2S1338: 20,24
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 8,14
ST FGA: 21
ST Penta D: 13,15
ST Penta E: 12,20
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 15,19
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV58
AC CVCL_2674
SY OV-58
DR ECACC; 96020760
CC Discontinued: ECACC; 96020760; probable.
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV7
AC CVCL_2675
SY OV-7
DR EFO; EFO_0006459
DR BioSample; SAMN03473061
DR CCLE; OV7_OVARY
DR ECACC; 96020764
DR Cosmic-CLP; 1480360
DR GDSC; 1480360
DR GEO; GSM887482
DR GEO; GSM888563
DR GEO; GSM1670313
RX PubMed=7707437;
RX PubMed=22460905;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 110 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: shRNA library screening.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 13
ST D18S51: 12,14
ST D19S433: 14
ST D21S11: 30,31.2
ST D2S1338: 20,24
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 10,14
ST FGA: 23
ST Penta D: 12,14
ST Penta E: 10,12
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 15
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OV90C-A
AC CVCL_4Z23
RX PubMed=22141344;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3768 ! OV-90
SX Female
CA Cancer cell line
//
ID OV90C-D
AC CVCL_4Z24
RX PubMed=22141344;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3768 ! OV-90
SX Female
CA Cancer cell line
//
ID OV90D-6
AC CVCL_4Z25
RX PubMed=22141344;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3768 ! OV-90
SX Female
CA Cancer cell line
//
ID OV90D-7
AC CVCL_4Z26
RX PubMed=22141344;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3768 ! OV-90
SX Female
CA Cancer cell line
//
ID OV90P-3
AC CVCL_4Z27
RX PubMed=22141344;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3768 ! OV-90
SX Female
CA Cancer cell line
//
ID OV90P-7
AC CVCL_4Z28
RX PubMed=22141344;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3768 ! OV-90
SX Female
CA Cancer cell line
//
ID OVAS
AC CVCL_0V12
DR Cosmic; 1889264
DR BioSample; SAMN03472381
DR JCRB; NIHS0403
DR PRIDE; PXD000901
RX PubMed=23430509;
CC From: Minaguchi H.; Yokohama City University; Yokohama; Japan.
CC Discontinued: JCRB; NIHS0403; true.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12,13
ST D13S317: 11,13
ST D16S539: 9,12
ST D5S818: 6,9,10,12
ST D7S820: 10,11,12
ST TH01: 6,7
ST TPOX: 10,11
ST vWA: 16,17,18,19
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVAS-21
AC CVCL_A768
SY OVAS21
DR Cosmic; 945376
RX CelloPub=CLPUB00096;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVB-3
AC CVCL_3109
SY OVB3
DR CLO; CLO_0008277
DR ATCC; HB-9147
RX Patent=US4806494;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OVC1-PI 32
AC CVCL_9U97
DR NCBI_Iran; C442
RX PubMed=24936210;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA-X
AC CVCL_DH80
SY OVCA X; OV-CAX
DR Cosmic; 1609528
DR GEO; GSM313716
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA400
AC CVCL_IQ31
SY OVCA 400
RX PubMed=7028788;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA420
AC CVCL_3935
SY OVCA 420; OvCa 420; OVCA-420; OVCAR-420; OVCAR 420; OVCAR420
DR BTO; BTO:0002563
DR EFO; EFO_0006720
DR BioSample; SAMN03471874
DR Cosmic; 924145
DR Cosmic; 927566
DR Cosmic-CLP; 1480364
DR GDSC; 1480364
DR GEO; GSM659390
DR GEO; GSM851928
DR GEO; GSM1670315
RX PubMed=1536252;
RX PubMed=6346879;
RX PubMed=7028788;
RX PubMed=10972993;
RX PubMed=11793438;
RX PubMed=12960427;
RX PubMed=22115851;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=22115851; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8
ST D13S317: 12,13
ST D16S539: 9,12 (Cosmic-CLP; PubMed=25877200)
ST D16S539: 9 (PubMed=22115851)
ST D18S51: 14,17
ST D21S11: 30.2
ST D3S1358: 16,17
ST D5S818: 13
ST D7S820: 11 (Cosmic-CLP; PubMed=22115851)
ST D7S820: 8,11 (PubMed=25877200)
ST D8S1179: 14,15
ST FGA: 22 (PubMed=22115851)
ST FGA: 21,22 (PubMed=25877200)
ST Penta D: 12
ST Penta E: 5,8
ST TH01: 6,9 (Cosmic-CLP)
ST TH01: 6 (PubMed=25877200)
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA424
AC CVCL_IQ30
SY OVCA 424; OvCa 424
RX PubMed=6346879;
RX PubMed=7028788;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA429
AC CVCL_3936
SY OVCA 429; OvCA 429; OVCA-429; OVCAR-429; OVCAR 429; OVCAR429; OV429
DR BTO; BTO:0002564
DR EFO; EFO_0006721
DR BioSample; SAMN03470937
DR Cosmic; 924146
DR Cosmic; 927567
DR Cosmic; 1223315
DR Cosmic; 1328064
DR Cosmic; 1434898
DR Cosmic; 2074245
DR GEO; GSM95439
DR GEO; GSM659391
DR GEO; GSM851929
RX PubMed=1536252;
RX PubMed=6346879;
RX PubMed=7028788;
RX PubMed=10972993;
RX PubMed=12080474;
RX PubMed=12960427;
RX PubMed=16382445;
RX PubMed=22710073;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 7,12
ST D16S539: 12
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 14,15
ST FGA: 24
ST Penta D: 13,14
ST Penta E: 12
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA429/T40
AC CVCL_CZ99
SY OVCA429T40
DR GEO; GSM95441
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3936 ! OVCA429
SX Female
CA Cancer cell line
//
ID OVCA429/TxT50
AC CVCL_CZ98
SY OVCA429TxT50; OV429 TxT50
DR GEO; GSM95430
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3936 ! OVCA429
SX Female
CA Cancer cell line
//
ID OVCA432
AC CVCL_3769
SY OV-CA 432; OVCA 432; OvCA 432; OVCA-432; OVCAR-432; OVCAR 432; OVCAR432
DR BTO; BTO:0002565
DR CLO; CLO_0008278
DR EFO; EFO_0006722
DR CLDB; cl3778
DR BioSample; SAMN03470830
DR Cosmic; 924147
DR Cosmic; 991322
DR Cosmic; 1524354
DR GDSC; 1480366
DR GEO; GSM659392
DR GEO; GSM851930
RX PubMed=1536252;
RX PubMed=6346879;
RX PubMed=7028788;
RX PubMed=7836420;
RX PubMed=10972993;
RX PubMed=11793438;
RX PubMed=12960427;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 15,16
ST D21S11: 29,31.2
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 8,10
ST D8S1179: 10,14
ST FGA: 20,24
ST Penta D: 10,14
ST Penta E: 13,19
ST TH01: 10
ST TPOX: 11
ST vWA: 15,19
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IQ28 ! LAZ-446
SX Female
CA Cancer cell line
//
ID OVCA433
AC CVCL_0475
SY OVCA 433; OvCa 433; OVCA-433; OVCAR-433; OVCAR 433; OVCAR433; SKOV-433; SK-OV-433; OV433
DR BTO; BTO:0002566
DR EFO; EFO_0006723
DR MCCL; MCC:0000373
DR BioSample; SAMN03473291
DR Cosmic; 924148
DR Cosmic; 927568
DR Cosmic; 1175882
DR Cosmic; 1524355
DR Cosmic; 1709258
DR Cosmic-CLP; 1480367
DR GDSC; 1480367
DR GEO; GSM95433
DR GEO; GSM851931
DR GEO; GSM1670316
RX PubMed=1536252;
RX PubMed=6346879;
RX PubMed=7028788;
RX PubMed=10972993;
RX PubMed=11793438;
RX PubMed=16382445;
RX PubMed=22328975;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=24434149;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27561551;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCA433_Bast
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Exosome proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 7,12
ST D16S539: 12
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 11,12
ST D8S1179: 14,15
ST FGA: 24
ST Penta D: 13,14
ST Penta E: 7,12
ST TH01: 9
ST TPOX: 9,11
ST vWA: 16,18
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IQ32 ! LAZ-444
SX Female
CA Cancer cell line
//
ID OVCA433/T40
AC CVCL_DA01
SY OVCA433T40; 433T40
DR GEO; GSM95451
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0475 ! OVCA433
SX Female
CA Cancer cell line
//
ID OVCA433/TxT50
AC CVCL_DA00
SY OVCA433TxT50; OV433TxT50
DR GEO; GSM95432
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0475 ! OVCA433
SX Female
CA Cancer cell line
//
ID OVCA633
AC CVCL_W776
RX PubMed=11793438;
RX PubMed=15571795;
CC Omics: Transcriptome analysis.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA680
AC CVCL_W781
RX PubMed=12492109;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA702
AC CVCL_W782
RX PubMed=12492109;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCA810
AC CVCL_W783
RX PubMed=12492109;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-10
AC CVCL_4377
SY NIH:OVCAR-10; OVCAR10
DR Cosmic; 1102813
DR GEO; GSM185131
DR GEO; GSM185132
DR GEO; GSM313703
DR GEO; GSM851932
RX PubMed=2307530;
RX PubMed=9041185;
RX PubMed=22710073;
RX PubMed=23415752;
CC Omics: Transcriptome analysis.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-2
AC CVCL_3941
SY NIH:OVCAR-2; OVCAR2; OVCAR 2
DR BTO; BTO:0002560
DR GEO; GSM185133
DR GEO; GSM185134
DR GEO; GSM851933
RX PubMed=2307530;
RX PubMed=9041185;
RX PubMed=22710073;
CC Omics: Transcriptome analysis.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-3
AC CVCL_0465
SY Ovcar-3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR.3; OVCAR3; Ovcar3
DR BTO; BTO:0000812
DR CLO; CLO_0008171
DR CLO; CLO_0008279
DR CLO; CLO_0051451
DR EFO; EFO_0003061
DR MCCL; MCC:0000363
DR CLDB; cl3712
DR CLDB; cl3780
DR CLDB; cl5237
DR ATCC; HTB-161
DR BCRC; 60551
DR BCRJ; 0317
DR BioSample; SAMN01821585
DR BioSample; SAMN03471390
DR CCLE; NIHOVCAR3_OVARY
DR CCRID; 3111C0001CCC000362
DR CCRID; 3131C0001000700108
DR CCRID; 3142C0001000000122
DR ChEMBL-Cells; CHEMBL3307564
DR ChEMBL-Targets; CHEMBL614213
DR CLS; 300307/p690_NIH:Ovcar-3
DR Cosmic; 687926
DR Cosmic; 688104
DR Cosmic; 755845
DR Cosmic; 809113
DR Cosmic; 844347
DR Cosmic; 845142
DR Cosmic; 875859
DR Cosmic; 897433
DR Cosmic; 905933
DR Cosmic; 906577
DR Cosmic; 920357
DR Cosmic; 924144
DR Cosmic; 927564
DR Cosmic; 949227
DR Cosmic; 974296
DR Cosmic; 991321
DR Cosmic; 1044239
DR Cosmic; 1092623
DR Cosmic; 1102816
DR Cosmic; 1139222
DR Cosmic; 1175883
DR Cosmic; 1218877
DR Cosmic; 1305312
DR Cosmic; 1312192
DR Cosmic; 1312354
DR Cosmic; 1436033
DR Cosmic; 1482525
DR Cosmic; 1524357
DR Cosmic; 1709250
DR Cosmic; 1998465
DR Cosmic; 2186584
DR Cosmic-CLP; 905933
DR ENCODE; ENCBS419ENC
DR GDSC; 905933
DR GEO; GSM50219
DR GEO; GSM50282
DR GEO; GSM95463
DR GEO; GSM185135
DR GEO; GSM185136
DR GEO; GSM313683
DR GEO; GSM459733
DR GEO; GSM459741
DR GEO; GSM645843
DR GEO; GSM659393
DR GEO; GSM750817
DR GEO; GSM784564
DR GEO; GSM799362
DR GEO; GSM799363
DR GEO; GSM799425
DR GEO; GSM799426
DR GEO; GSM847106
DR GEO; GSM844668
DR GEO; GSM851934
DR GEO; GSM887456
DR GEO; GSM888536
DR GEO; GSM1001493
DR GEO; GSM1153434
DR GEO; GSM1153435
DR GEO; GSM1181276
DR GEO; GSM1181278
DR GEO; GSM1186813
DR GEO; GSM1186814
DR GEO; GSM1186815
DR GEO; GSM1186816
DR GEO; GSM1186827
DR GEO; GSM1374771
DR GEO; GSM1374772
DR GEO; GSM1374773
DR GEO; GSM1670317
DR ICLC; HTL97004
DR IGRhCellID; OVCAR3
DR IZSLER; BS TCL 131
DR KCB; KCB 2006106YJ
DR KCLB; 30161
DR NCBI_Iran; C430
DR PRIDE; PXD003105
DR RCB; RCB2135
DR SKY/M-FISH/CGH; 2742
DR TKG; TKG 0602
DR TOKU-E; 2754
RX PubMed=1892748;
RX PubMed=2041050;
RX PubMed=2307530;
RX PubMed=2653399;
RX PubMed=9041185;
RX PubMed=11414198;
RX PubMed=11793438;
RX PubMed=12417041;
RX PubMed=12960427;
RX PubMed=16382445;
RX PubMed=17088437;
RX PubMed=18560578;
RX PubMed=19372543;
RX PubMed=22328975;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23172893;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24023729;
RX PubMed=24434149;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=22
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCAR-3
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-239.html
WW http://tcpaportal.org/mclp/
CC Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 64 hours (PubMed=25984343); 34.7 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Exosome proteome analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Secretome proteome analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: Occasionally 'OVCA3'.
CC Misspelling: Occasionally 'OVOCAR3'.
CC Misspelling: 'OVCAK3' in GEO GSM459741.
CC Discontinued: ICLC; HTL97004; true.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; COG; Cosmic-CLP; KCLB; PubMed=19372543; PubMed=25230021; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D18S51: 13
ST D19S433: 16.2
ST D21S11: 29,31.2
ST D2S1338: 17,21
ST D3S1358: 17,18
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10,15
ST FGA: 21
ST Penta D: 12,13
ST Penta E: 7,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-3 SimpleCell O-GalNAc
AC CVCL_S033
SY OVCAR-3 SimpleCell; OVCAR-3 SC
RX PubMed=23584533;
CC Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC Knockout cell: Method=ZFN; HGNC; 24338; C1GALT1C1.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR-3/CMV-Luc
AC CVCL_4Y18
DR JCRB; NIHS0732
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR-3/T40
AC CVCL_DA03
SY OVCAR-3T40
DR GEO; GSM95435
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR-3/TxT5
AC CVCL_DA02
SY OVCAR-3TxT5
DR GEO; GSM95456
RX PubMed=16382445;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Ascites.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR-4
AC CVCL_1627
SY NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4
DR BTO; BTO:0002561
DR EFO; EFO_0005442
DR BioSample; SAMN03472889
DR CCLE; OVCAR4_OVARY
DR ChEMBL-Cells; CHEMBL3307517
DR ChEMBL-Targets; CHEMBL614051
DR Cosmic; 688105
DR Cosmic; 875860
DR Cosmic; 897434
DR Cosmic; 905990
DR Cosmic; 974295
DR Cosmic; 1044240
DR Cosmic; 1092624
DR Cosmic; 1175884
DR Cosmic; 1305313
DR Cosmic; 1312355
DR Cosmic; 1436034
DR Cosmic; 1998466
DR Cosmic-CLP; 905990
DR GDSC; 905990
DR GEO; GSM50220
DR GEO; GSM50284
DR GEO; GSM185137
DR GEO; GSM185138
DR GEO; GSM186442
DR GEO; GSM186443
DR GEO; GSM750829
DR GEO; GSM784572
DR GEO; GSM799364
DR GEO; GSM799427
DR GEO; GSM847107
DR GEO; GSM844669
DR GEO; GSM844670
DR GEO; GSM851935
DR GEO; GSM887484
DR GEO; GSM888565
DR GEO; GSM1153436
DR GEO; GSM1181279
DR GEO; GSM1181286
DR GEO; GSM1374801
DR GEO; GSM1670318
DR SKY/M-FISH/CGH; 2817
RX PubMed=2041050;
RX PubMed=2307530;
RX PubMed=9041185;
RX PubMed=12080474;
RX PubMed=12960427;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24023729;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=23
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 43 hours (PubMed=25984343); 41.4 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 11
ST D18S51: 15
ST D19S433: 13,15
ST D21S11: 28,31
ST D2S1338: 23
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 21
ST Penta D: 12,14
ST Penta E: 11
ST TH01: 9
ST TPOX: 8
ST vWA: 14,18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-5
AC CVCL_1628
SY NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5
DR BTO; BTO:0001870
DR CLO; CLO_0008280
DR EFO; EFO_0005443
DR CLDB; cl3781
DR BioSample; SAMN03472888
DR ChEMBL-Cells; CHEMBL3307565
DR ChEMBL-Targets; CHEMBL614214
DR Cosmic; 875861
DR Cosmic; 897435
DR Cosmic; 905969
DR Cosmic; 974297
DR Cosmic; 1044241
DR Cosmic; 1092625
DR Cosmic; 1102824
DR Cosmic; 1175885
DR Cosmic; 1305314
DR Cosmic; 1312356
DR Cosmic; 1436035
DR Cosmic; 1523763
DR Cosmic; 1707573
DR Cosmic; 1709255
DR Cosmic; 1995605
DR Cosmic; 1998467
DR Cosmic; 2186583
DR Cosmic-CLP; 905969
DR GDSC; 905969
DR GEO; GSM50221
DR GEO; GSM50285
DR GEO; GSM185139
DR GEO; GSM185140
DR GEO; GSM659394
DR GEO; GSM750830
DR GEO; GSM784573
DR GEO; GSM799365
DR GEO; GSM799428
DR GEO; GSM847108
DR GEO; GSM844671
DR GEO; GSM851936
DR GEO; GSM1153437
DR GEO; GSM1181280
DR GEO; GSM1181287
DR GEO; GSM1374802
DR GEO; GSM1670319
DR SKY/M-FISH/CGH; 2818
RX PubMed=2041050;
RX PubMed=2307530;
RX PubMed=9041185;
RX PubMed=12417041;
RX PubMed=12960427;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22328975;
RX PubMed=22336246;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24023729;
RX PubMed=24434149;
RX PubMed=25485619;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=24
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCA5
WW http://tcpaportal.org/mclp/
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 48.8 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Exosome proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,13
ST D16S539: 11
ST D18S51: 12
ST D19S433: 13,14
ST D21S11: 31
ST D2S1338: 17,23
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 12
ST Penta E: 9,16
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-7
AC CVCL_DG79
SY OVCAR7
DR GEO; GSM185141
DR GEO; GSM185142
RX PubMed=2307530;
RX PubMed=9041185;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-8
AC CVCL_1629
SY NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8
DR BTO; BTO:0003054
DR EFO; EFO_0005444
DR BioSample; SAMN03472794
DR CCLE; OVCAR8_OVARY
DR ChEMBL-Cells; CHEMBL3307975
DR ChEMBL-Targets; CHEMBL612555
DR Cosmic; 688106
DR Cosmic; 875862
DR Cosmic; 905991
DR Cosmic; 974298
DR Cosmic; 1044242
DR Cosmic; 1092626
DR Cosmic; 1312357
DR Cosmic; 1305315
DR Cosmic; 1436036
DR Cosmic; 1523764
DR Cosmic; 1526923
DR Cosmic; 1998468
DR Cosmic; 2186582
DR Cosmic-CLP; 905991
DR GDSC; 905991
DR GEO; GSM50222
DR GEO; GSM50286
DR GEO; GSM185143
DR GEO; GSM185144
DR GEO; GSM322534
DR GEO; GSM322535
DR GEO; GSM322536
DR GEO; GSM459646
DR GEO; GSM459647
DR GEO; GSM750819
DR GEO; GSM750831
DR GEO; GSM784574
DR GEO; GSM799366
DR GEO; GSM799429
DR GEO; GSM847109
DR GEO; GSM844672
DR GEO; GSM844673
DR GEO; GSM851937
DR GEO; GSM887485
DR GEO; GSM888566
DR GEO; GSM1153438
DR GEO; GSM1181299
DR GEO; GSM1181339
DR GEO; GSM1374803
DR GEO; GSM1670320
DR SKY/M-FISH/CGH; 1437
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=2041050;
RX PubMed=2307530;
RX PubMed=9041185;
RX PubMed=12417041;
RX PubMed=12960427;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24023729;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=25
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=OVCA8
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 25 hours (PubMed=25984343); 26.1 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'OVACAR8' in Cosmic 1526923.
CC Misspelling: Occasionally 'OVOCAR-8'.
CC Misspelling: Occasionally 'OVOCAR8'.
ST Source(s): Cosmic-CLP; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13
ST D18S51: 14
ST D19S433: 14,16
ST D21S11: 28
ST D2S1338: 19,23
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 10
ST FGA: 20
ST Penta D: 12
ST Penta E: 10
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVCAR-8 RIA
AC CVCL_IM65
DR GEO; GSM322537
DR GEO; GSM322538
DR GEO; GSM322539
RX PubMed=18822129;
CC Transfected with: HGNC; 9388; PRKAR1A.
CC Omics: Transcriptome analysis.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1629 ! OVCAR-8
SX Female
CA Cancer cell line
//
ID OVCAR-8 RIIB
AC CVCL_IM66
DR GEO; GSM322540
DR GEO; GSM322541
DR GEO; GSM322542
RX PubMed=18822129;
CC Transfected with: HGNC; 9392; PRKAR2B.
CC Omics: Transcriptome analysis.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1629 ! OVCAR-8
SX Female
CA Cancer cell line
//
ID OVCAR3-533533-R1
AC CVCL_DH37
SY 533533-R1
DR GEO; GSM1186817
DR GEO; GSM1186822
DR GEO; GSM1186828
RX PubMed=24004674;
CC Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR3-533533-R3
AC CVCL_DH38
DR GEO; GSM1186818
DR GEO; GSM1186823
DR GEO; GSM1186829
RX PubMed=24004674;
CC Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR3-533533-R5
AC CVCL_DH39
DR GEO; GSM1186819
DR GEO; GSM1186824
DR GEO; GSM1186830
RX PubMed=24004674;
CC Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR3-533533-R6
AC CVCL_DH40
SY 533533-R6
DR GEO; GSM1186820
DR GEO; GSM1186825
DR GEO; GSM1186831
RX PubMed=24004674;
CC Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVCAR3-533533-R7
AC CVCL_DH41
DR GEO; GSM1186821
DR GEO; GSM1186826
DR GEO; GSM1186832
RX PubMed=24004674;
CC Selected for resistance to: ChEBI; CHEBI:132239; PHA-533533.
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID OVHS-1
AC CVCL_A769
SY OVHS1
DR Cosmic; 991319
DR Cosmic; 1524356
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVI-P
AC CVCL_W129
SY OVI/p; OVIP; OV1-P; OV1/p
DR Cosmic; 688107
DR Cosmic; 1609527
RX PubMed=15677628;
CC Microsatellite instability: Instable (MSI) (PubMed=15677628).
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVISE
AC CVCL_3116
DR BTO; BTO:0003498
DR EFO; EFO_0006724
DR BioSample; SAMN03472858
DR CCLE; OVISE_OVARY
DR CGH-DB; 330-2
DR Cosmic; 1223316
DR Cosmic; 1328065
DR Cosmic; 1434893
DR Cosmic; 1708377
DR Cosmic; 1995606
DR Cosmic; 2074246
DR Cosmic-CLP; 1240198
DR GDSC; 1240198
DR GEO; GSM659395
DR GEO; GSM827222
DR GEO; GSM888567
DR GEO; GSM1176280
DR GEO; GSM1670321
DR JCRB; JCRB1043
DR JCRB; NIHS0296
DR JCRB; NIHS0338
DR PRIDE; PXD000901
DR PRIDE; PXD003105
RX DOI=10.5795/jjscc.31.966;
RX PubMed=9328139;
RX PubMed=15677628;
RX PubMed=17671176;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 48 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Discontinued: JCRB; NIHS0296; true.
CC Discontinued: JCRB; NIHS0338; true.
CC Derived from metastatic site: Innominate bone.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 19
ST D21S11: 28,30
ST D3S1358: 14,15
ST D5S818: 10
ST D7S820: 11,12
ST D8S1179: 15,16
ST FGA: 19,23
ST Penta D: 9,11
ST Penta E: 14
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVISE-3
AC CVCL_U211
RX PubMed=7882618;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3116 ! OVISE
SX Female
CA Cancer cell line
//
ID OVK18
AC CVCL_3770
SY OVK-18; OVK#18
DR CLO; CLO_0051452
DR BioSample; SAMN03472087
DR CCLE; OVK18_OVARY
DR Cosmic; 1066216
DR Cosmic; 1708385
DR Cosmic-CLP; 1480371
DR GDSC; 1480371
DR GEO; GSM887486
DR GEO; GSM888568
DR GEO; GSM1670322
DR RCB; RCB1903
DR TKG; TKG 0323
RX PubMed=6584390;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 8,13
ST D7S820: 8 (RCB)
ST D7S820: 8,13,14 (Cosmic-CLP; TKG)
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVK18#102
AC CVCL_7171
DR CLO; CLO_0051453
DR BioSample; SAMN03471921
DR Cosmic; 1066217
DR RCB; RCB2535
DR TKG; TKG 0357
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12 (RCB)
ST CSF1PO: 10 (TKG)
ST D13S317: 9,12
ST D16S539: 9,11
ST D5S818: 8,11 (RCB)
ST D5S818: 8,11,12 (TKG)
ST D7S820: 8 (RCB)
ST D7S820: 8,13 (TKG)
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3770 ! OVK18
SX Female
CA Cancer cell line
//
ID OVKATE
AC CVCL_3110
DR BTO; BTO:0003503
DR EFO; EFO_0006725
DR BioSample; SAMN03472859
DR CCLE; OVKATE_OVARY
DR CGH-DB; 338-2
DR Cosmic; 1995607
DR Cosmic-CLP; 1240199
DR GDSC; 1240199
DR GEO; GSM659396
DR GEO; GSM887487
DR GEO; GSM888569
DR GEO; GSM1670323
DR JCRB; JCRB1044
DR JCRB; NIHS0297
DR JCRB; NIHS0339
RX PubMed=9328139;
RX PubMed=15677628;
RX PubMed=17671176;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27561551;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0297; true.
CC Discontinued: JCRB; NIHS0339; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D18S51: 12
ST D19S433: 14,15.2
ST D21S11: 30,33.2
ST D2S1338: 18,23
ST D3S1358: 18
ST D5S818: 9,13
ST D7S820: 11,12
ST D8S1179: 11
ST FGA: 19
ST Penta D: 9,13
ST Penta E: 5,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVMANA
AC CVCL_3111
DR BTO; BTO:0003500
DR EFO; EFO_0006726
DR BioSample; SAMN03472488
DR CCLE; OVMANA_OVARY
DR CGH-DB; 337-2
DR Cosmic; 1223317
DR Cosmic; 1305330
DR Cosmic; 1328066
DR Cosmic; 1434894
DR Cosmic; 1708384
DR Cosmic; 2074247
DR GEO; GSM459731
DR GEO; GSM659397
DR GEO; GSM887488
DR GEO; GSM888570
DR GEO; GSM1176281
DR JCRB; JCRB1045
DR JCRB; NIHS0298
DR JCRB; NIHS0340
DR PRIDE; PXD003105
RX PubMed=9328139;
RX PubMed=15677628;
RX PubMed=17671176;
RX PubMed=22460905;
RX PubMed=22710073;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 70 hours (PubMed=25984343).
CC Omics: Deep RNAseq analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0298; true.
CC Discontinued: JCRB; NIHS0340; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,9
ST D16S539: 10
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVMIU
AC CVCL_3112
DR BioSample; SAMN03151882
DR BioSample; SAMN03472489
DR Cosmic; 1995608
DR Cosmic-CLP; 1240200
DR GDSC; 1240200
DR GEO; GSM827252
DR GEO; GSM1670324
DR JCRB; JCRB1049
DR JCRB; NIHS0302
DR JCRB; NIHS0344
RX PubMed=20143388;
RX PubMed=27397505;
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OVSAYO derivative (PubMed=20143388).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0302; true.
CC Discontinued: JCRB; NIHS0344; true.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3115 ! OVSAYO
SX Female
CA Cancer cell line
//
ID OVMIU-II
AC CVCL_3113
DR BioSample; SAMN03472490
DR JCRB; JCRB1050
DR JCRB; NIHS0303
DR JCRB; NIHS0345
CC Discontinued: JCRB; NIHS0303; true.
CC Discontinued: JCRB; NIHS0345; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 14
ST D16S539: 11
ST D5S818: 13
ST D7S820: 13,14
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVNIS
AC CVCL_3409
DR CLO; CLO_0008281
DR CLDB; cl3782
DR ECACC; 93122324
CC Discontinued: ECACC; 93122324; probable.
OX NCBI_TaxID=9940; ! Ovis aries
CA Undefined cell line type
//
ID OVSAHO
AC CVCL_3114
DR BTO; BTO:0003502
DR EFO; EFO_0006727
DR BioSample; SAMN03472860
DR CCLE; OVSAHO_OVARY
DR CGH-DB; 334-2
DR GEO; GSM459648
DR GEO; GSM659398
DR GEO; GSM887489
DR GEO; GSM888571
DR JCRB; JCRB1046
DR JCRB; NIHS0299
DR JCRB; NIHS0341
DR PRIDE; PXD003105
RX PubMed=9328139;
RX PubMed=15677628;
RX PubMed=17671176;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25485619;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27561551;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0299; true.
CC Discontinued: JCRB; NIHS0341; true.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9
ST D18S51: 16,20
ST D21S11: 31
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 8,10
ST D8S1179: 14
ST FGA: 24
ST Penta D: 9
ST Penta E: 15
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVSAYO
AC CVCL_3115
DR BTO; BTO:0003501
DR JCRB; JCRB1047
DR JCRB; NIHS0300
DR JCRB; NIHS0342
DR PRIDE; PXD003105
RX PubMed=9328139;
RX PubMed=15677628;
RX PubMed=24023729;
RX PubMed=26972028;
RX PubMed=27141528;
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Discontinued: JCRB; NIHS0300; true.
CC Discontinued: JCRB; NIHS0342; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 9,11
ST vWA: 17,18
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVT2
AC CVCL_W292
RX PubMed=12080474;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVTOKO
AC CVCL_3117
DR BTO; BTO:0003499
DR EFO; EFO_0006728
DR BioSample; SAMN03472861
DR CCLE; OVTOKO_OVARY
DR CGH-DB; 331-2
DR Cosmic; 1223318
DR Cosmic; 1328067
DR Cosmic; 1434895
DR Cosmic; 1708379
DR Cosmic; 1889263
DR Cosmic; 2074248
DR Cosmic-CLP; 1298365
DR GDSC; 1298365
DR GEO; GSM459732
DR GEO; GSM659399
DR GEO; GSM827253
DR GEO; GSM887490
DR GEO; GSM888572
DR GEO; GSM1176282
DR GEO; GSM1670325
DR JCRB; JCRB1048
DR JCRB; NIHS0301
DR JCRB; NIHS0343
RX PubMed=9328139;
RX PubMed=15677628;
RX PubMed=17671176;
RX PubMed=22460905;
RX PubMed=23430509;
RX PubMed=23839242;
RX PubMed=24023729;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0301; true.
CC Discontinued: JCRB; NIHS0343; true.
CC Derived from metastatic site: Spleen.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 11,12
ST D18S51: 19
ST D21S11: 29,31
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 10,14
ST FGA: 21,23
ST Penta D: 9,10
ST Penta E: 14
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 14,17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVXF 1023
AC CVCL_D166
SY OVXF1023
DR ChEMBL-Cells; CHEMBL3308696
DR ChEMBL-Targets; CHEMBL615008
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVXF 1353
AC CVCL_D167
SY OVXF1353
DR ChEMBL-Cells; CHEMBL3307799
DR ChEMBL-Targets; CHEMBL612271
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVXF 1544
AC CVCL_D168
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVXF 1619L
AC CVCL_D169
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OVXF 899L
AC CVCL_D170
SY OVXF 899
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OX-1
AC CVCL_G677
SY OX1
DR ECACC; 84112004
CC Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-101
AC CVCL_U017
SY OX101
DR ECACC; 03062503
CC Monoclonal antibody target: UniProtKB; P97829; Rat Cd47.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-102
AC CVCL_U018
SY OX102
DR ECACC; 03062504
CC Monoclonal antibody target: UniProtKB; Q9ES58; Rat Cd200r1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-104
AC CVCL_U019
SY OX104
DR ECACC; 03062505
CC Monoclonal antibody target: UniProtKB; P41217; Human CD200.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-106
AC CVCL_X517
SY OX106
DR ECACC; 13082220
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-108
AC CVCL_X518
SY OX108
DR ECACC; 13082222
CC Monoclonal antibody target: UniProtKB; Q8TD46; Human CD200R1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-109
AC CVCL_U020
SY OX109
DR ECACC; 13082223
CC Monoclonal antibody target: UniProtKB; Q8TD46; Human CD200R1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-110
AC CVCL_X519
SY OX110
DR ECACC; 13082225
RX PubMed=23691022;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-114
AC CVCL_U021
SY OX114
DR ECACC; 13082227
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-115
AC CVCL_X520
SY OX115
DR ECACC; 13082229
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-116
AC CVCL_X521
SY OX116
DR ECACC; 13082231
RX PubMed=15294972;
CC Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-117
AC CVCL_X522
SY OX117
DR ECACC; 13082233
RX PubMed=15294972;
CC Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-118
AC CVCL_X523
SY OX118
DR ECACC; 13082235
RX PubMed=15294972;
CC Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-119
AC CVCL_X524
SY OX119
DR ECACC; 13082237
RX PubMed=15294972;
CC Monoclonal antibody target: UniProtKB; Q9P1W8; Human SIRPG.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-12
AC CVCL_G678
SY OX12
DR ECACC; 88051301
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-129
AC CVCL_X525
SY OX129
DR ECACC; 13082239
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-131
AC CVCL_X526
SY OX131
DR ECACC; 13082241
RX PubMed=23691022;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-132
AC CVCL_U022
SY OX132
DR ECACC; 13082243
RX PubMed=23691022;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-14
AC CVCL_G679
SY OX14
DR ECACC; 87112401
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-17
AC CVCL_J180
SY MRC-OX17; OX17
DR ECACC; 84112010
RX PubMed=6178598;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-18
AC CVCL_G680
SY MRC-OX18; OX18
DR ECACC; 84112011
RX PubMed=6178598;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-19
AC CVCL_G681
SY OX19
DR ECACC; 84112012
CC Monoclonal antibody target: UniProtKB; P51882; Rat Cd5.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-2
AC CVCL_G682
SY OX2
DR ECACC; 84112005
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-20
AC CVCL_G683
SY OX20
DR ECACC; 88070801
CC Discontinued: ECACC; 88070801; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-21
AC CVCL_G684
SY OX21
DR ECACC; 91060417
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-22
AC CVCL_G685
SY OX22
DR ECACC; 84112013
CC Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-23
AC CVCL_U023
SY MRC OX-23; MRC-OX23; OX23
DR ECACC; 00010402
RX PubMed=6199050;
CC Monoclonal antibody target: UniProtKB; P08603; Human CFH.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-24
AC CVCL_U024
SY MRC OX-24; MRC-OX24; OX24
DR ECACC; 00010403
RX PubMed=6199050;
CC Monoclonal antibody target: UniProtKB; P08603; Human CFH.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-26
AC CVCL_J181
SY OX26
DR ECACC; 84112014
CC Monoclonal antibody target: UniProtKB; Q99376; Rat Tfrc/Cd71.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-27
AC CVCL_J182
SY OX27
DR ECACC; 84112015
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-29
AC CVCL_J183
SY OX29
DR ECACC; 88070802
CC Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-3
AC CVCL_J184
SY MRC-OX3; OX3
DR ECACC; 84112006
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-30
AC CVCL_J185
SY OX30
DR ECACC; 86100901
CC Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-32
AC CVCL_G686
SY OX32
DR ECACC; 88051302
CC Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-33
AC CVCL_J186
SY OX33
DR ECACC; 86100902
CC Monoclonal antibody target: UniProtKB; P04157; Rat Ptprc/Cd45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-34
AC CVCL_J187
SY OX34
DR ECACC; 86100903
CC Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-35 clone 5
AC CVCL_J188
DR ECACC; 89041184
CC Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-36 clone 3
AC CVCL_J189
DR ECACC; 91051422
CC Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-38
AC CVCL_J190
SY OX38
DR ECACC; 88051303
CC Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID OX-39
AC CVCL_J191
SY OX39
DR ECACC; 86100905
RX PubMed=2828930;
CC Monoclonal antibody target: UniProtKB; P26897; Rat Il2ra/Cd25.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-40
AC CVCL_J192
SY OX40
DR ECACC; 86100906
RX PubMed=2828930;
CC Monoclonal antibody target: UniProtKB; P15725; Rat Tnfrsf4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-41
AC CVCL_J193
SY OX41
DR ECACC; 88051304
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-42
AC CVCL_J194
SY OX42
DR ECACC; 87081803
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-43
AC CVCL_J195
SY OX43
DR ECACC; 87081804
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-44
AC CVCL_J196
SY OX44
DR ECACC; 92102355
CC Monoclonal antibody target: UniProtKB; P24485; Rat Cd53.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-45
AC CVCL_J197
SY OX45
DR ECACC; 86100910
RX PubMed=2942461;
CC Monoclonal antibody target: UniProtKB; P10252; Rat Cd48.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-46
AC CVCL_U025
SY OX46
DR ECACC; 13082205
RX PubMed=2942461;
CC Monoclonal antibody target: UniProtKB; P10252; Rat Cd48.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-47
AC CVCL_J198
SY OX47
DR ECACC; 90071611
RX PubMed=2828930;
CC Discontinued: ECACC; 90071611; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-48
AC CVCL_X512
SY OX48
DR ECACC; 13082207
RX PubMed=2828930;
RX PubMed=14734622;
CC Monoclonal antibody target: UniProtKB; O35531; Rat Cd86.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-49
AC CVCL_J199
SY OX49
DR ECACC; 91062501
RX PubMed=2828930;
CC Monoclonal antibody target: UniProtKB; P26051; Rat Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-50
AC CVCL_J200
SY OX50
DR ECACC; 91062502
RX PubMed=2828930;
CC Monoclonal antibody target: UniProtKB; P26051; Rat Cd44.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-52
AC CVCL_J201
SY OX52
DR ECACC; 87081805
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-53
AC CVCL_J202
SY OX53
DR ECACC; 89081707
CC Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-54
AC CVCL_J203
SY OX54
DR ECACC; 88070803
CC Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-55
AC CVCL_J204
SY OX55
DR ECACC; 88070804
CC Monoclonal antibody target: UniProtKB; P08921; Rat Cd2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-57
AC CVCL_J205
SY OX57
DR ECACC; 91051424
CC Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-58
AC CVCL_J206
SY OX58
DR ECACC; 91051425
CC Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-59
AC CVCL_J207
SY OX59
DR ECACC; 92102356
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-6
AC CVCL_J208
SY MRC-OX6; OX6
DR ECACC; 84112007
RX PubMed=6178598;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-60
AC CVCL_J209
SY OX60
DR ECACC; 92102357
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-61
AC CVCL_J210
SY OX61
DR ECACC; 91100409
CC Monoclonal antibody target: UniProtKB; P14740; Rat Dpp4/Cd26.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-62
AC CVCL_J211
SY OX62
DR ECACC; 91061805
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-68
AC CVCL_J212
SY OX68
DR ECACC; 94011007
CC Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID OX-7
AC CVCL_J213
SY OX7
DR ECACC; 84112008
CC Monoclonal antibody target: UniProtKB; P01830; Rat Thy1/Cd90.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-74
AC CVCL_J214
SY OX74
DR ECACC; 91051426
CC Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-75
AC CVCL_J215
SY OX75
DR ECACC; 91051427
CC Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-76
AC CVCL_U026
SY OX76
DR ECACC; 13082209
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-78
AC CVCL_J216
SY OX78
DR ECACC; 92102358
CC Monoclonal antibody target: UniProtKB; P18181; Mouse Cd48.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-8
AC CVCL_J217
SY OX8
DR ECACC; 84112009
CC Monoclonal antibody target: UniProtKB; P07725; Rat Cd8a.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-80
AC CVCL_U027
SY OX80
DR ECACC; 13082211
CC Monoclonal antibody target: UniProtKB; Q61451; Mouse Cd53.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID OX-81
AC CVCL_J218
SY OX81
DR ECACC; 95040518
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-82
AC CVCL_X513
SY OX82
DR ECACC; 13082213
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-83
AC CVCL_X514
SY OX83
DR ECACC; 13082214
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-85
AC CVCL_J219
SY OX85
DR ECACC; 95111405
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-86
AC CVCL_J220
SY OX86
DR ECACC; 96110601
CC Monoclonal antibody target: UniProtKB; P47741; Mouse Tnfrsf4.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-87
AC CVCL_J221
SY OX87
DR ECACC; 95102516
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-89
AC CVCL_U028
SY OX89
DR ECACC; 03062501
RX PubMed=11359859;
CC Monoclonal antibody target: UniProtKB; P43488; Mouse Tnfsf4/Cd252.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-90
AC CVCL_U029
SY OX90
DR ECACC; 03062502
CC Monoclonal antibody target: UniProtKB; O54901; Mouse Cd200.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-96
AC CVCL_X515
SY OX96
DR ECACC; 13082216
CC Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-97
AC CVCL_X516
SY OX97
DR ECACC; 13082218
CC Monoclonal antibody target: UniProtKB; P35329; Mouse Cd22.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OX-CO-1
AC CVCL_B451
SY OXCO-1; OXCO1
DR GEO; GSM1448134
RX PubMed=17312135;
RX PubMed=20606684;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OX-CO-2
AC CVCL_2H53
SY OXCO-2; OXCO2
DR GEO; GSM1448146
RX PubMed=20606684;
RX PubMed=25926053;
CC Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OX-CO-3
AC CVCL_B452
SY OXCO-3; OXCO3
DR GEO; GSM1448147
RX PubMed=17312135;
RX PubMed=20606684;
RX PubMed=25926053;
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OxF1
AC CVCL_B021
SY OXF1
DR ISCR; 1652
RX PubMed=20333479;
RX PubMed=22528356;
CC From: University of Oxford; Oxford; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-11-001, Steering comm. appl. SCSC10-40.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OxF2
AC CVCL_L185
SY OXF2
DR ISCR; 2230
RX PubMed=22528356;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/oxf2.aspx
CC From: University of Oxford; Oxford; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-11-002, Steering comm. appl. SCSC10-38.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OxF3
AC CVCL_L186
SY OXF3
DR ISCR; 2231
RX PubMed=22528356;
CC From: University of Oxford; Oxford; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-11-003, Steering comm. appl. SCSC10-39.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID OxF4
AC CVCL_L187
SY OXF4
DR ISCR; 2232
RX PubMed=22528356;
CC From: University of Oxford; Oxford; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-11-004, Steering comm. appl. SCSC10-41.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID oxMMNK1-L
AC CVCL_AE16
RX PubMed=26100205;
CC Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M266 ! MMNK-1
CA Telomerase immortalized cell line
//
ID OZ [Human cholangiocarcinoma]
AC CVCL_3118
DR BioSample; SAMN03472539
DR Cosmic; 1122353
DR Cosmic; 1373552
DR JCRB; JCRB1032
DR JCRB; NIHS0282
RX CelloPub=CLPUB00275;
RX PubMed=2889643;
CC Discontinued: JCRB; NIHS0282; true.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 10
ST D5S818: 13,14
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 14,16
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OZ [Human ESC]
AC CVCL_B022
SY IMHe008-A
DR hPSCreg; IMHe008-A
DR ISCR; 1143
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ [Human diffuse large B-cell lymphoma]
AC CVCL_M710
SY Oz
DR Cosmic; 929818
DR Cosmic; 2297001
DR GEO; GSM115816
DR GEO; GSM201347
RX PubMed=9600110;
RX PubMed=16960149;
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OZ-1
AC CVCL_B023
SY IMHe009-A
DR hPSCreg; IMHe009-A
DR ISCR; 1144
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ-2
AC CVCL_B024
SY IMHe010-A
DR hPSCreg; IMHe010-A
DR ISCR; 1145
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ-3
AC CVCL_B025
SY IMHe014-A
DR hPSCreg; IMHe014-A
DR ISCR; 1146
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID OZ-4
AC CVCL_B026
SY IMHe015-A
DR hPSCreg; IMHe015-A
DR ISCR; 1147
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ-5
AC CVCL_B027
SY IMHe016-A
DR hPSCreg; IMHe016-A
DR ISCR; 1148
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ-6
AC CVCL_B028
SY IMHe017-A
DR hPSCreg; IMHe017-A
DR ISCR; 1149
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ-7
AC CVCL_B029
SY IMHe018-A
DR hPSCreg; IMHe018-A
DR ISCR; 1150
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID OZ-8
AC CVCL_B030
SY IMHe011-A
DR hPSCreg; IMHe011-A
DR ISCR; 1151
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID OzA
AC CVCL_W200
SY OZA
RX PubMed=3164747;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OZB
AC CVCL_E799
SY TER205; TER306
DR dbMHC; 48994
DR ECACC; 94022545
DR IHW; IHW9216
DR IMGT/HLA; 11224
WW http://bioinformatics.hsanmartino.it/ecbr/cl216.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID P-1
AC CVCL_G239
SY P1
DR CLO; CLO_0008286
DR ATCC; CRL-2588
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6971 ! FOX-NY
CA Hybridoma
//
ID P-16(2)
AC CVCL_6G32
RX PubMed=3879567;
RX PubMed=7951345;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID P-6
AC CVCL_G242
DR CLO; CLO_0008339
DR ATCC; CRL-2589
RX PubMed=1426051;
CC Monoclonal antibody target: UniProtKB; P07384; Human CAPN1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID P-9
AC CVCL_G243
DR CLO; CLO_0008343
DR ATCC; CRL-2590
CC Monoclonal antibody target: UniProtKB; P07384; Human CAPN1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID p-hiPS01
AC CVCL_C959
DR ISCR; 1839
RX PubMed=19481515;
CC From: Harvard Medical School; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2435 ! Detroit 573
SX Female
CA Induced pluripotent stem cell
//
ID p-hiPS02
AC CVCL_C960
DR ISCR; 1840
RX PubMed=19481515;
CC From: Harvard Medical School; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2435 ! Detroit 573
SX Female
CA Induced pluripotent stem cell
//
ID P-SC(1)
AC CVCL_6G33
SY P-SC
RX PubMed=3879567;
RX PubMed=7951345;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID P-STS
AC CVCL_L298
DR GEO; GSM966945
RX PubMed=19528452;
RX PubMed=22538498;
DI NCIt; C6422; Midgut carcinoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L296 ! H-STS
OI CVCL_L297 ! L-STS
SX Male
CA Cancer cell line
//
ID P-tyr-1
AC CVCL_G188
DR CLO; CLO_0008521
DR ATCC; CRL-1955
DR BCRC; 60342
DR ECACC; 95092903
CC Monoclonal antibody target: ChEBI; CHEBI:74956; O(4)-phosphotyrosine.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID P.H.
AC CVCL_S460
DR ATCC; CRL-6177
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6177; true.
OX NCBI_TaxID=71117; ! Paradoxurus hermaphroditus
SX Female
CA Finite cell line
//
ID P0318
AC CVCL_W189
RX PubMed=20418894;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID P1
AC CVCL_Z996
DR CLO; CLO_0008285
DR CLDB; cl3802
DR ECACC; 90070556
CC Group: Insect cell line.
CC Discontinued: ECACC; 90070556; probable.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID P1-iPSC
AC CVCL_DD57
SY P01-iPSC
RX PubMed=25843045;
RX PubMed=27191603;
ST Source(s): PubMed=27191603
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 10,11
ST D21S11: 28,32.2
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DD47 ! ND30171
SX Male
CA Induced pluripotent stem cell
//
ID P1.17
AC CVCL_3564
DR CLO; CLO_0008288
DR ATCC; TIB-10
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID P1.1A3
AC CVCL_A042
SY P1-1A3
DR BioSample; SAMN03151919
RX PubMed=7514905;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494, PubMed=20143388).
CC Characteristics: Has lost chromosome Y.
CC Derived from metastatic site: Ascites.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0525 ! SK-HEP-1
SX Male
CA Cancer cell line
//
ID P1.1C3
AC CVCL_A043
RX PubMed=7514905;
CC Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A037 ! PEC.1
CA Finite cell line
//
ID P1.2C8
AC CVCL_A044
RX PubMed=7514905;
CC Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A037 ! PEC.1
CA Finite cell line
//
ID P1.3F6
AC CVCL_A045
RX PubMed=7514905;
CC Problematic cell line: Possibly contaminated. May originate from SK-HEP-1 as 4 other cell lines from the same paper (PubMed=7514905) have been shown to be contaminated.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A037 ! PEC.1
CA Finite cell line
//
ID P1.4D6
AC CVCL_A046
SY P1-4D6
DR BioSample; SAMN03151920
RX PubMed=7514905;
RX PubMed=10508494;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SK-HEP-1 derivative (PubMed=10508494, PubMed=20143388).
CC Characteristics: Has lost chromosome Y.
CC Derived from metastatic site: Ascites.
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0525 ! SK-HEP-1
SX Male
CA Cancer cell line
//
ID P1.HTR
AC CVCL_4265
SY P1.HTR1; P1.B5.4.8.12.16.2
DR CLO; CLO_0008289
DR CLDB; cl3803
DR ECACC; 87121104
RX PubMed=3929396;
RX PubMed=18432777;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: UniProtKB; Q9QNF7; HHV-1 TK.
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F735 ! P815-X2
SX Male
CA Cancer cell line
//
ID P1.HTR.TK-
AC CVCL_4266
SY P1.HTR.tk-; P1.HTR1.tk-; P1.B5.4.8.12.16.2.1
DR CLO; CLO_0008290
DR CLDB; cl3804
DR ECACC; 87121103
RX PubMed=3929396;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Transfected with: UniProtKB; Q9QNF7; HHV-1 TK.
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4265 ! P1.HTR
SX Male
CA Cancer cell line
//
ID P11-90
AC CVCL_9U43
RX PubMed=7586804;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: Kunming.
DI NCIt; C24068; Mouse cervical carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9U22 ! L10-90
OI CVCL_9U56 ! U14
SX Female
CA Cancer cell line
//
ID P114
AC CVCL_L410
DR GEO; GSM724827
DR GEO; GSM724828
DR GEO; GSM724841
DR GEO; GSM724842
DR GEO; GSM1075090
DR GEO; GSM1075094
DR GEO; GSM1075099
DR GEO; GSM1290248
DR GEO; GSM1290249
DR GEO; GSM1889007
DR GEO; GSM1889008
RX PubMed=9042250;
RX PubMed=20453304;
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID P116
AC CVCL_6429
DR CLO; CLO_0008292
DR ATCC; CRL-2676
DR BioSample; SAMN03471760
DR GDSC; 1330986
DR GEO; GSM827152
DR TOKU-E; 2820
RX PubMed=9488454;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,11.3
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0367 ! Jurkat E6.1
SX Male
CA Cancer cell line
//
ID P116.cl39
AC CVCL_6430
SY P116.c39
DR CLO; CLO_0008293
DR ATCC; CRL-2677
DR BioSample; SAMN03471762
RX PubMed=9488454;
CC Transfected with: HGNC; 12858; ZAP70.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,11.3
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6429 ! P116
SX Male
CA Cancer cell line
//
ID P12
AC CVCL_CW37
SY P 12
DR ATCC; HB-8551
DR NCBI_Iran; H133
RX Patent=US4762800;
RX Patent=US5168043;
CC Discontinued: ATCC; HB-8551; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID P12-Ichikawa
AC CVCL_1630
SY P12-ICHIKAWA; P12/ICHIKAWA; P12/Ichikawa; P12ichikawa; P12/ICH; P12/ICh; P12-ICH; P-12; P12
DR BTO; BTO:0002839
DR CLO; CLO_0008298
DR CLDB; cl3807
DR BioSample; SAMN03473354
DR CCLE; P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3307676
DR ChEMBL-Targets; CHEMBL614660
DR Cosmic; 721706
DR Cosmic; 909251
DR Cosmic; 913422
DR Cosmic; 933543
DR Cosmic; 1118465
DR Cosmic; 1151789
DR Cosmic; 1224371
DR Cosmic; 1281381
DR Cosmic; 1330492
DR Cosmic; 1375582
DR Cosmic; 1524812
DR Cosmic; 1641387
DR Cosmic; 1664526
DR Cosmic; 1760529
DR Cosmic; 2165715
DR Cosmic-CLP; 909251
DR DSMZ; ACC-34
DR GDSC; 909251
DR GEO; GSM887491
DR GEO; GSM888573
DR GEO; GSM1670326
RX PubMed=6582512;
RX PubMed=9933131;
RX PubMed=10071127;
RX PubMed=22460905;
RX PubMed=22675565;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 10,11
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID P153SV40T
AC CVCL_4874
SY P153SV40-T
RX PubMed=21544329;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID P1798
AC CVCL_B453
SY P-1798
DR BTO; BTO:0000796
RX PubMed=6892700;
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID P19
AC CVCL_2153
SY P-19
DR BTO; BTO:0000596
DR CLO; CLO_0008301
DR CLO; CLO_0008302
DR CLDB; cl3813
DR CLDB; cl4980
DR ATCC; CRL-1825
DR BCRC; 60052
DR CCRID; 3111C0001CCC000020
DR CCRID; 3131C0001000800027
DR CLS; 400416/p533_P19
DR ChEMBL-Cells; CHEMBL3307297
DR ChEMBL-Targets; CHEMBL614064
DR DSMZ; ACC-316
DR ECACC; 95102107
DR ICLC; ATL99013
DR IZSLER; BS TCL 206
DR KCB; KCB 200844YJ
DR NCBI_Iran; C422
DR RSCB; RSCB0346
DR TOKU-E; 2822
DR Wikidata; Q7117837
RX PubMed=7056443;
RX PubMed=8507558;
RX PubMed=12757864;
WW https://en.wikipedia.org/wiki/P19_cell
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/p19/p19cells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-229.html
CC Doubling time: ~2-3 days (DSMZ).
CC Caution: There seems to be 3 distinct cell lines which were assigned NCBI_Iran catalog number C422.
CC Breed/subspecies: C3H/He.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID P19C6
AC CVCL_L988
DR RCB; RCB1790
RX PubMed=11414696;
CC Breed/subspecies: C3H/He.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2153 ! P19
SX Male
CA Cancer cell line
//
ID P19CL6
AC CVCL_L981
SY P19Cl6; P19.CL6; CL6
DR CLO; CLO_0050544
DR CLO; CLO_0050545
DR RCB; RCB1539
DR RCB; RCB2318
DR Wikidata; Q28473091
RX PubMed=8790939;
RX PubMed=12757864;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-475.html
CC Breed/subspecies: C3H/He.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2153 ! P19
SX Male
CA Cancer cell line
//
ID P1Bb1.1 (DBA/2)
AC CVCL_7693
DR CLO; CLO_0008306
DR CLDB; cl3816
DR ECACC; 87121102
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_F735 ! P815-X2
SX Male
CA Cancer cell line
//
ID P2
AC CVCL_Z997
DR CLO; CLO_0008307
DR CLDB; cl3817
DR ECACC; 90070558
CC Group: Insect cell line.
CC Discontinued: ECACC; 90070558; probable.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID P2 50D8
AC CVCL_L684
DR ATCC; HB-9506
RX Patent=US5126258;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID P2 57G4
AC CVCL_L685
DR ATCC; HB-9505
RX Patent=US5126258;
CC Discontinued: ATCC; HB-9505; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID P20.1
AC CVCL_K262
DR CLO; CLO_0050392
DR RCB; RCB2815
RX PubMed=18787202;
RX PubMed=18847346;
WW http://www.wako-chem.co.jp/english/labchem/product/life/TARGET_Tag/
CC Monoclonal antibody target: UniProtKB; Q96RI0; Human F2RL3/PAR4 (binds to the hexapeptide GYPGQV used in the TARGET tag system).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID P25.15
AC CVCL_N084
DR ATCC; HB-9140
RX Patent=US4970299;
RX Patent=US5177000;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID P25.48
AC CVCL_G240
DR CLO; CLO_0008312
DR ATCC; HB-9119
RX Patent=US4970299;
RX Patent=US5177000;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID P25.91
AC CVCL_N085
DR ATCC; HB-9120
RX Patent=US4970299;
RX Patent=US5177000;
CC Discontinued: ATCC; HB-9120; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID P2UR/K-562
AC CVCL_L434
DR CLO; CLO_0050120
DR RCB; RCB1197
CC Transfected with: HGNC; 8541; P2RY2.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
SX Female
CA Cancer cell line
//
ID P3 6D4
AC CVCL_L683
SY P3 6D4 (SCRF 43.1)
DR CLO; CLO_0008314
DR ATCC; HB-9168
RX Patent=US5126258;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID P3 8D2
AC CVCL_G687
SY P3 8D2 (SCRF 43.1)
DR CLO; CLO_0008316
DR ATCC; HB-9169
RX Patent=US5126258;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID P3.6.2.8.1
AC CVCL_3565
DR CLO; CLO_0008318
DR ATCC; TIB-8
DR JCRB; JCRB9109
RX PubMed=4758896;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_T278 ! P3K
SX Female
CA Cancer cell line
//
ID P3/NS1/1-Ag4.1
AC CVCL_2155
SY P3/NSI/1-AG4-1; P3/NS1/1-Ag4-1; P3/NS1/1-AG4-1; P3/NS1/Ag4-1; P3 NS1 Ag4/1; P3 NS1 Ag4; P3.NS-1/1.Ag4.1; P3-NS1/1-Ag4-1; P3-NS1/1Ag 4.1; P3/NS-1; NS1/1-Ag4.1; NS1-1 Ag4.1; NS-1-Ag4-1; NS1-Ag4/1; NS1-Ag 4/1; P3X63NS1; NS-I/1; NS-1; NS1; GM03573
DR BTO; BTO:0001907
DR CLO; CLO_0008317
DR CLO; CLO_0008319
DR CLO; CLO_0008320
DR CLO; CLO_0017234
DR CLO; CLO_0050176
DR CLDB; cl3823
DR CLDB; cl3824
DR CLDB; cl3825
DR CLDB; cl3826
DR CLDB; cl3827
DR CLDB; cl3828
DR ATCC; TIB-18
DR BCRC; 60036
DR CCRID; 3111C0001CCC000384
DR CCRID; 3111C0002000000041
DR CCRID; 3131C0001000800025
DR CCRID; 3142C0001000000011
DR CLS; 400108/p2759_NS-1_(P3-NS1-Ag4-1)
DR Coriell; GM03573
DR DSMZ; ACC-145
DR ECACC; 85011427
DR IZSLER; BS TCL 50
DR JCRB; JCRB0009
DR JCRB; JCRB9107
DR KCLB; 40018
DR KCLB; 60059
DR NCBI_Iran; C522
DR RCB; RCB0095
DR TKG; TKG 0233
CC Group: Hybridoma fusion partner cell line.
CC Doubling time: ~24 hours (DSMZ).
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C522.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
SX Female
CA Cancer cell line
//
ID P30/OHK
AC CVCL_1631
SY P30-OHK; P30 OHK; P30OHK; P30/Ohkubo; P30-OHKUBO; P30/0HK
DR CLO; CLO_0051011
DR BioSample; SAMN01821712
DR BioSample; SAMN03471069
DR ChEMBL-Cells; CHEMBL3308275
DR ChEMBL-Targets; CHEMBL2366165
DR Cosmic; 909252
DR Cosmic; 919141
DR Cosmic; 998703
DR Cosmic; 1037718
DR Cosmic-CLP; 909252
DR DSMZ; ACC-727
DR GDSC; 909252
DR GEO; GSM827254
DR GEO; GSM1670327
DR JCRB; JCRB0094
DR RCB; RCB1938
DR TKG; TKG 0463
RX PubMed=6983990;
RX PubMed=27397505;
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 10
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 10,11
ST vWA: 14,21
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID P31/FUJ
AC CVCL_1632
SY P31-FUJ; P31 FUJ; P31FUJ; P31/Fujioka
DR BioSample; SAMN03471067
DR CCLE; P31FUJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308276
DR ChEMBL-Targets; CHEMBL2366370
DR Cosmic; 717683
DR Cosmic; 909253
DR Cosmic; 996318
DR Cosmic; 998749
DR Cosmic; 1037670
DR Cosmic; 2089656
DR Cosmic; 2131555
DR Cosmic-CLP; 909253
DR GDSC; 909253
DR GEO; GSM827226
DR GEO; GSM887492
DR GEO; GSM888574
DR GEO; GSM1670328
DR JCRB; JCRB0091
DR PRIDE; PXD000185
RX PubMed=6962783;
RX PubMed=22460905;
RX PubMed=23955599;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'P31-FUF' in Cosmic 717683.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 9,12,13
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 10
ST TH01: 9
ST TPOX: 7,11
ST vWA: 19,21
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID P32/ISH
AC CVCL_3119
SY P32/ish; P32-ISH; P32 ISH; P32/Ishishida; P32
DR BioSample; SAMN03471070
DR Cosmic; 1995609
DR Cosmic; 2297027
DR Cosmic-CLP; 1330987
DR GDSC; 1330987
DR GEO; GSM115814
DR GEO; GSM827227
DR GEO; GSM1670329
DR JCRB; JCRB0095
RX PubMed=6667834;
RX PubMed=16960149;
RX PubMed=27397505;
CC Characteristics: EBV-negative.
CC Doubling time: 40 hours (JCRB).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9,12
ST D5S818: 9,10
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID P388
AC CVCL_7222
SY P-388
DR BTO; BTO:0000748
DR CLO; CLO_0008321
DR CLO; CLO_0050216
DR CLDB; cl3829
DR BCRJ; 0198
DR CCRID; 3111C0002000000073
DR ChEMBL-Cells; CHEMBL3308401
DR ChEMBL-Targets; CHEMBL389
DR JCRB; JCRB0017
DR RCB; RCB2776
DR TKG; TKG 0326
RX PubMed=10516761;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID P388/A20
AC CVCL_D642
RX PubMed=2824504;
CC Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D641 ! P388/amsacrine
SX Female
CA Cancer cell line
//
ID P388/amsacrine
AC CVCL_D641
RX PubMed=3037302;
CC Selected for resistance to: ChEBI; CHEBI:2687; Amsacrine.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/BR/A
AC CVCL_4Y67
SY BR/A
RX PubMed=7917900;
CC Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/BR/B
AC CVCL_4Y68
SY BR/B
RX PubMed=7917900;
CC Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/BR/C
AC CVCL_4Y69
SY BR/C
RX PubMed=7917900;
CC Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/BR/D
AC CVCL_4Y70
SY BR/D
RX PubMed=7917900;
CC Selected for resistance to: ChEBI; CHEBI:88353; Bryostatin-1.
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/CPA
AC CVCL_4Y58
DR ChEMBL-Cells; CHEMBL3307336
DR ChEMBL-Targets; CHEMBL614219
RX PubMed=6354439;
CC Selected for resistance to: ChEBI; CHEBI:4027; Cyclophosphamide (CP; Endoxan).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/CPT45
AC CVCL_D638
SY P388CPT45; P388/CPT; CPT45
DR ChEMBL-Cells; CHEMBL3307567
DR ChEMBL-Targets; CHEMBL614223
RX PubMed=2172765;
RX PubMed=14679002;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D640 ! P388/S
SX Female
CA Cancer cell line
//
ID P388/DDP
AC CVCL_1B39
DR ChEMBL-Cells; CHEMBL3307305
DR ChEMBL-Targets; CHEMBL614138
RX PubMed=1556003;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/Dx
AC CVCL_9123
SY P388/DX; P388/dx
DR CLO; CLO_0008324
DR CLDB; cl3832
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/NVB-0.63
AC CVCL_4W03
SY P388-N.63; N.63
RX PubMed=11488526;
RX PubMed=18071633;
CC Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D640 ! P388/S
SX Female
CA Cancer cell line
//
ID P388/NVB-2.5
AC CVCL_4W04
SY P388-N2.5; N2.5
RX PubMed=11488526;
RX PubMed=18071633;
CC Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D640 ! P388/S
SX Female
CA Cancer cell line
//
ID P388/PtR4
AC CVCL_4V15
SY P388PtR4
DR ChEMBL-Cells; CHEMBL3307340
DR ChEMBL-Targets; CHEMBL614225
RX PubMed=3335002;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/S
AC CVCL_D640
SY p388/s; P388S; P388 sensitive; P388 leukemia-sensitive
DR ChEMBL-Cells; CHEMBL3307337
DR ChEMBL-Targets; CHEMBL614220
RX PubMed=3037302;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/VCR-20
AC CVCL_1B38
SY P388/VCR20
DR ChEMBL-Cells; CHEMBL3307484
DR ChEMBL-Targets; CHEMBL614221
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388/VFL-10
AC CVCL_4W05
RX PubMed=11488526;
CC Selected for resistance to: ChEBI; CHEBI:90241; Vinflunine (VFL; Javlor).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D640 ! P388/S
SX Female
CA Cancer cell line
//
ID P388/VFL-2.5
AC CVCL_4W06
RX PubMed=11488526;
CC Selected for resistance to: ChEBI; CHEBI:90241; Vinflunine (VFL; Javlor).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D640 ! P388/S
SX Female
CA Cancer cell line
//
ID P388/WT20
AC CVCL_D643
RX PubMed=2824504;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D640 ! P388/S
SX Female
CA Cancer cell line
//
ID P388D1
AC CVCL_0477
SY P-388D1; P388-D1; P388.D1; P3 88 D1
DR BTO; BTO:0000984
DR CLO; CLO_0008315
DR CLO; CLO_0008326
DR CLO; CLO_0008327
DR MCCL; MCC:0000375
DR CLDB; cl3833
DR CLDB; cl3834
DR ATCC; CCL-46
DR BCRC; 60222
DR CLS; 400308/p665_P388-D1
DR IFO; IFO50036
DR IZSLER; BS TCL 51
DR JCRB; JCRB0016
DR KCB; KCB 200775YJ
DR KCLB; 10046
RX PubMed=3792703;
RX PubMed=10516761;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-231.html
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7222 ! P388
SX Female
CA Cancer cell line
//
ID P388D1 (IL-1)
AC CVCL_0625
SY P388D1(IL-1); P388 D1 IL-1
DR CLO; CLO_0008325
DR CLO; CLO_0008328
DR CLDB; cl3835
DR ATCC; TIB-63
DR BCRC; 60341
DR BCRJ; 0199
DR CCRID; 3111C0001CCC000235
DR CCRID; 3131C0001000800011
DR DSMZ; ACC-288
CC Doubling time: ~30-60 hours, depending on cell density (DSMZ).
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0477 ! P388D1
SX Female
CA Cancer cell line
//
ID P388D1 clone 3124
AC CVCL_3410
SY P388.D1 clone 3124; P388.D1 (clone 3124); P388.D1(cl3124)
DR CLO; CLO_0008322
DR CLO; CLO_0008323
DR CLDB; cl3831
DR CLDB; cl4921
DR ECACC; 85011439
DR ICLC; ATL97013
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0477 ! P388D1
SX Female
CA Cancer cell line
//
ID P39
AC CVCL_0478
SY P39/TSU; P39-TSU; P39 TSU; P39TSU; P39/Tsugane; P39/TSUGANE; TSUGANE
DR MCCL; MCC:0000376
DR BioSample; SAMN03151775
DR BioSample; SAMN03471068
DR Cosmic; 717681
DR Cosmic; 998740
DR Cosmic; 2089663
DR JCRB; JCRB0092
RX PubMed=6597119;
RX PubMed=12592342;
RX PubMed=20143388;
RX PubMed=20421273;
RX PubMed=23955599;
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342, PubMed=20143388, PubMed=20421273).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID P3D
AC CVCL_G241
DR CLO; CLO_0008329
DR ATCC; HB-11129
RX Patent=WO1994010201A1;
CC Monoclonal antibody target: UniProtKB; Q66T51; Brugia malayi beta-tubulin (also reacts with other nematods).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID P3H3
AC CVCL_B066
DR CLO; CLO_0008330
DR CLDB; cl3836
DR Cosmic; 931108
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2676 ! P3HR-1
SX Male
CA Cancer cell line
//
ID P3HR-1
AC CVCL_2676
SY P 3 HR 1; P3HR1; P3HRI; P3HR1-BL; P3J HR-1; P3J-HR-1; P3JHR-1; P3JHR1; P3J HR1-K; P3J.HR1K; HR-1; HR1K
DR CLO; CLO_0008282
DR CLO; CLO_0008331
DR EFO; EFO_0002312
DR CLDB; cl3837
DR CLDB; cl5159
DR CLDB; cl5242
DR ATCC; HTB-62
DR BCRJ; 0338
DR CCLE; P3HR1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 9199-4
DR ChEMBL-Cells; CHEMBL3307242
DR ChEMBL-Targets; CHEMBL612705
DR Cosmic; 724830
DR Cosmic; 1517661
DR ECACC; 86010701
DR GDSC; 1330988
DR GEO; GSM887493
DR GEO; GSM888575
DR IGRhCellID; P3HR1
DR IZSLER; BS TCL 99
RX PubMed=170370;
RX PubMed=327080;
RX PubMed=1915267;
RX PubMed=2052620;
RX PubMed=4115493;
RX PubMed=4122458;
RX PubMed=4321974;
RX PubMed=4364259;
RX PubMed=4912237;
RX PubMed=4932228;
RX PubMed=6265077;
RX PubMed=6286763;
RX PubMed=8344493;
RX PubMed=12967475;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=28196595;
WW http://www.rccc.cytspb.rssi.ru/RussianCellBank/CellLinePerson/clP3HR-1%28P3J-HR1K%29.htm
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; ECACC
ST Amelogenin: X,Y (ATCC)
ST Amelogenin: X (ECACC)
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 6,8
ST vWA: 15,19
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1317 ! Jiyoye
SX Male
CA Cancer cell line
//
ID P3K
AC CVCL_T278
RX PubMed=5439579;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_T277 ! MOPC-21
SX Female
CA Cancer cell line
//
ID P3NP
AC CVCL_D018
CC Group: Hybridoma fusion partner cell line.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID P3NP/PFn
AC CVCL_4549
SY P3NP/PFN
DR CLO; CLO_0008283
DR CLO; CLO_0008332
DR CLDB; cl5243
DR ATCC; HB-91
DR IZSLER; BS Hy 18
CC Monoclonal antibody target: UniProtKB; P02751; Human FN.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D018 ! P3NP
CA Hybridoma
//
ID P3X63Ag8
AC CVCL_3411
SY P3-X63-Ag8; P3/X63-Ag8; P3/X63/Ag8; P3-X63Ag8; P3X63 Ag8; X63-Ag8; x63-Ag8; X63; GM03571
DR BTO; BTO:0001118
DR CLO; CLO_0008334
DR CLO; CLO_0017237
DR CLDB; cl3840
DR CLDB; cl3841
DR CLDB; cl7165
DR ATCC; TIB-9
DR BCRC; 60340
DR CCRID; 3131C0001000800009
DR Coriell; GM03571
DR ECACC; 85011401
DR ICLC; ATL05001
DR JCRB; JCRB9105
CC Group: Hybridoma fusion partner cell line.
CC Doubling time: 16-26 hours (ECACC).
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_T278 ! P3K
SX Female
CA Cancer cell line
//
ID P3X63Ag8.653
AC CVCL_4032
AS CVCL_2243
SY P3-X63-Ag8.653; P3-X63-Ag8-653; P3-x63-Ag8 653; P3-X63-Ag 8.653; P3-X63Ag8.653; P3-X63.Ag8.653; P3/X63/Ag8.653; P3X63 Ag8.653; P3X63 AG8-653; P3X63-Ag8.653; P3x63-Ag8.653; P3X63 AG 8.653; P3X63Ag8653; P3-X63-Ag8-6-5-3; P3X63Ag8-6-5-3; P3.times.63 Ag8.653; P3.653; X63-Ag8-653; X63-Ag8.653; X63.Ag8.653; X63Ag8-653; X63Ag8.653; X63AG8.653; GM03570; GM3570; NS653
DR CLO; CLO_0008335
DR CLO; CLO_0009643
DR CLO; CLO_0017240
DR CLO; CLO_0050177
DR CLDB; cl3842
DR CLDB; cl3843
DR CLDB; cl3844
DR CLDB; cl3845
DR CLDB; cl3846
DR ATCC; CRL-1580
DR ATCC; CRL-8008
DR CCRID; 3111C0002000000042
DR CCRID; 3131C0001000800010
DR CCRID; 3142C0001000000014
DR CLS; 400118/p8830_P3X63Ag8653
DR Coriell; GM03570
DR DSMZ; ACC-43
DR ECACC; 85011420
DR JCRB; JCRB9030
DR KCLB; 21580
DR NCBI_Iran; C109
DR RCB; RCB0146
DR TOKU-E; 4144
RX PubMed=113458;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-230.html
CC Group: Hybridoma fusion partner cell line.
CC Doubling time: ~30-60 hours (DSMZ).
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Misspelling: Occasionally 'P3-X63-Ag8-635'.
CC Misspelling: Occasionally 'P3X63-A68.653'.
CC Discontinued: ATCC; CRL-8008; probable.
CC Discontinued: KCLB; 21580; probable.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
SX Female
CA Cancer cell line
//
ID P3X63Ag8.653-Turbodoma
AC CVCL_Z937
DR ECACC; 03092502
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
SX Female
CA Cancer cell line
//
ID P3X63Ag8U.1
AC CVCL_3412
AS CVCL_4268
SY P3-X63-Ag8-U1; P3-X63-Ag8.U1; P3X63-Ag8-U1; P3X63Ag8-U1; P3X63Ag8.U1; P3.x63.Ag8.U1; P3U1; P3UI; P3U-1
DR CLO; CLO_0008333
DR CLO; CLO_0008336
DR CLDB; cl3839
DR CLDB; cl3847
DR CLDB; cl3848
DR CLDB; cl3849
DR CLDB; cl3850
DR ATCC; CRL-1597
DR ECACC; 85011417
DR ECACC; 94120802
DR ICLC; ATL96012
DR JCRB; JCRB0708
DR JCRB; JCRB9085
DR NCBI_Iran; C579
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
SX Female
CA Cancer cell line
//
ID P4
AC CVCL_Z998
DR CLO; CLO_0008337
DR CLDB; cl3851
DR ECACC; 90070557
CC Group: Insect cell line.
CC Discontinued: ECACC; 90070557; probable.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID P4 MAGI CCR5+
AC CVCL_1H21
SY P4.R5 MAGI; P4-R5 MAGI
DR NIH-ARP; 3580-31
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID P404
AC CVCL_L411
RX PubMed=21801068;
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID P43D09
AC CVCL_J590
DR ATCC; HB-8594
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8594; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID P44E11
AC CVCL_J542
DR ATCC; HB-8593
RX Patent=US5015571;
RX Patent=US5733738;
CC Discontinued: ATCC; HB-8593; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID P493-6
AC CVCL_6783
SY P-493-6; p493-6
DR BTO; BTO:0003291
DR PRIDE; PXD000589
RX PubMed=10956386;
RX PubMed=25894527;
CC Transfected with: HGNC; 7553; MYC.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Cell surface proteome.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W845 ! EREB2-5
CA Transformed cell line
//
ID P4E6
AC CVCL_2677
DR BTO; BTO:0003540
DR ECACC; 10112301
RX PubMed=11121225;
RX PubMed=17163777;
WW http://capcelllines.ca/details.asp?id=111
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 7,8
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID p53-def-MOSE
AC CVCL_C563
DR JCRB; JCRB0151.1
DR JCRB; NIHS0215
RX PubMed=9820870;
CC Discontinued: JCRB; NIHS0215; true.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID p53-RE-luc/A549
AC CVCL_5J44
SY P53-RE-luc/A549
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119274.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Cancer cell line
//
ID p53HCT116
AC CVCL_S744
SY P53HCT116; p53-/- HCT116; p53(-/-) HCT-116; HCT116-p53-/-; HCT116-p53
DR Cosmic; 1132690
DR SKY/M-FISH/CGH; 1688
DR SKY/M-FISH/CGH; 2781
RX PubMed=9822382;
RX PubMed=19927377;
CC Knockout cell: Method=Gamma radiation; HGNC; 11998; TP53.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0291 ! HCT 116
SX Male
CA Cancer cell line
//
ID P53LMACO1
AC CVCL_U220
DR JCRB; JCRB0150
DR JCRB; NIHS0213
RX PubMed=9299470;
CC Discontinued: JCRB; NIHS0213; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID p53NiS1
AC CVCL_8902
SY P53N1S1
DR CLO; CLO_0008338
DR ATCC; CRL-2619
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID p53R
AC CVCL_J916
DR ATCC; CRL-2781
DR ATCC; JHU-56
DR BioSample; SAMN03471788
RX PubMed=12082016;
CC Problematic cell line: Misidentified. Originally thought to derive from Hs 766T but was later (erratum) shown to be derived from RKO (PubMed=12082016).
CC Discontinued: ATCC; CRL-2781; true.
CC Discontinued: ATCC; JHU-56; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 6,10
ST TPOX: 11
ST vWA: 16,22
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0504 ! RKO
CA Cancer cell line
//
ID P59M8
AC CVCL_T837
SY 59M8; P59-M08
DR RCB; HPS0061
DR SKIP; SKIP000143
RX Patent=US20130224156;
RX PubMed=21347327;
DI NCIt; C85045; Retinitis pigmentosa
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID P69SV40T
AC CVCL_4875
SY P69SV40-T; P69SV40 T; P69SV40; P69
DR BTO; BTO:0005982
DR Cosmic; 1172630
RX PubMed=9018337;
RX PubMed=12725112;
RX PubMed=21544329;
WW http://capcelllines.ca/details.asp?id=145
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID P6C
AC CVCL_T056
RX PubMed=23736004;
CC Group: Cancer stem cell line.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID P72-9
AC CVCL_Y455
DR ATCC; CRL-6525
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6525; true.
OX NCBI_TaxID=34884; ! Callorhinus ursinus
SX Male
CA Finite cell line
//
ID P815
AC CVCL_2154
SY P-815; P 815
DR BTO; BTO:0000985
DR CLO; CLO_0008340
DR CLO; CLO_0008341
DR CLO; CLO_0050217
DR CLDB; cl3784
DR CLDB; cl3785
DR CLDB; cl5244
DR ATCC; TIB-64
DR BCRC; 60178
DR BCRJ; 0200
DR CCRID; 3111C0001CCC000114
DR CCRID; 3131C0001000800012
DR CCRID; 3142C0001000000084
DR ChEMBL-Cells; CHEMBL3307568
DR ChEMBL-Targets; CHEMBL614226
DR CLS; 400242/p600_P-815
DR DSMZ; ACC-1
DR IZSLER; BS TCL 118
DR JCRB; JCRB0078
DR KCB; KCB 93032YJ
DR NCBI_Iran; C550
DR RCB; RCB1167
DR TKG; TKG 0168
RX PubMed=3792703;
RX PubMed=18432777;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-232.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-233.html
CC Doubling time: ~18-22 hours (DSMZ).
CC Misspelling: Occasionally 'P825'.
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID P815 MB
AC CVCL_4Z63
DR ATCC; CRL-6448
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6448; true.
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2154 ! P815
SX Male
CA Cancer cell line
//
ID P815-1-1
AC CVCL_4269
DR CLO; CLO_0008342
DR CLDB; cl3852
DR ECACC; 85011406
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2154 ! P815
SX Male
CA Cancer cell line
//
ID P815-X2
AC CVCL_F735
SY P815.X2; P815X2; P815-(X2); P815 subline X2
CC Breed/subspecies: DBA/2.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2154 ! P815
SX Male
CA Cancer cell line
//
ID PA
AC CVCL_E800
SY PA-PP
DR dbMHC; 48995
DR ECACC; 94050333
DR IHW; IHW9217
DR IMGT/HLA; 11226
WW http://bioinformatics.hsanmartino.it/ecbr/cl217.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID PA #2
AC CVCL_1E44
SY PA 2
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=994214;
CC Doubling time: 106 hours, at 5th passage (PubMed=994214).
CC Derived from metastatic site: Colon.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PA 16/23
AC CVCL_W771
RX PubMed=1320446;
RX PubMed=8198972;
DI NCIt; C4650; Parotid gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PA 3
AC CVCL_AX17
SY PA3
DR Cosmic; 2361387
RX PubMed=8547074;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Pa Coo
AC CVCL_U790
DR ATCC; CRL-1293
CC Discontinued: ATCC; CRL-1293; true.
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Pa Kel-1
AC CVCL_3324
DR CLO; CLO_0008348
DR ATCC; CRL-1341
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3325 ! Pa Kel-2
SX Female
CA Finite cell line
//
ID Pa Kel-2
AC CVCL_3325
DR CLO; CLO_0008349
DR ATCC; CRL-1344
DI NCIt; C125696; Ehlers-Danlos syndrome, type I
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3324 ! Pa Kel-1
SX Female
CA Finite cell line
//
ID Pa Mer
AC CVCL_U684
DR ATCC; CRL-1169
CC Discontinued: ATCC; CRL-1169; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID PA-1
AC CVCL_0479
SY PA1; PA I; PAI
DR BTO; BTO:0001591
DR CLO; CLO_0008350
DR EFO; EFO_0006465
DR MCCL; MCC:0000377
DR CLDB; cl3856
DR CLDB; cl3857
DR CLDB; cl3858
DR CLDB; cl3859
DR ATCC; CRL-1572
DR BCRC; 60063
DR BioSample; SAMN01821586
DR BioSample; SAMN03473209
DR BioSample; SAMN03472415
DR CCRID; 3111C0001CCC000021
DR CGH-DB; 9358-4
DR ChEMBL-Cells; CHEMBL3308812
DR ChEMBL-Targets; CHEMBL614949
DR CLS; 300402/p655_PA-1
DR Cosmic; 688112
DR Cosmic; 801353
DR Cosmic; 809111
DR Cosmic; 844343
DR Cosmic; 909255
DR Cosmic; 931368
DR Cosmic; 1305331
DR Cosmic; 1995610
DR Cosmic-CLP; 909255
DR ECACC; 90013101
DR GDSC; 909255
DR GEO; GSM186444
DR GEO; GSM186445
DR GEO; GSM784566
DR GEO; GSM1374804
DR GEO; GSM1670330
DR ICLC; HTL97002
DR IZSLER; BS TCL 179
DR JCRB; JCRB9061
DR RCB; RCB1946
RX PubMed=2653399;
RX PubMed=6931103;
RX PubMed=9290701;
RX PubMed=11314036;
RX PubMed=11330945;
RX PubMed=10567668;
RX PubMed=15677628;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: KuDOS 95 cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB1946; true.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; COG; Cosmic-CLP; ECACC; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9,10 (ATCC; CLS; COG; Cosmic-CLP; ECACC; PubMed=25877200)
ST D13S317: 9,10,13 (JCRB)
ST D16S539: 9,12 (ATCC; COG; Cosmic-CLP; ECACC; JCRB; PubMed=25877200)
ST D16S539: 9 (CLS)
ST D18S51: 15,18
ST D19S433: 13
ST D21S11: 29,31.2
ST D2S1338: 24
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 14,15
ST FGA: 24
ST Penta D: 9,12
ST Penta E: 14,20
ST TH01: 7,9
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PA-1/6TG-r
AC CVCL_3121
DR JCRB; JCRB1052
DR JCRB; NIHS0328
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Discontinued: JCRB; NIHS0328; true.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9,10
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 9
ST TH01: 7,9
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0479 ! PA-1
SX Female
CA Cancer cell line
//
ID PA-23
AC CVCL_J296
SY PA23
DR BTO; BTO:0004529
RX PubMed=19039943;
DI NCIt; C60504; Rat rhabdomyosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID PA-CLS-52
AC CVCL_5852
SY PA-CLS 52
DR CLS; 300386/NA
CC Discontinued: CLS; 300386; true.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Pa-E-HNU6
AC CVCL_Z571
SY Pa-E-HNU 6
RX CelloPub=CLPUB00177;
CC Group: Insect cell line.
OX NCBI_TaxID=254370; ! Ctenoplusia agnata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PA-GRS1
AC CVCL_6711
SY PAGRS1
RX PubMed=1319328;
RX PubMed=15541573;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID PA-III
AC CVCL_6D67
SY PAIII
RX PubMed=1326342;
RX PubMed=1661415;
CC Breed/subspecies: Lobund-Wistar (L-W).
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID PA018
AC CVCL_1G11
DR Cosmic; 1820268
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA028
AC CVCL_1G12
DR Cosmic; 1820260
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA055
AC CVCL_1G13
DR Cosmic; 1820261
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA086
AC CVCL_1G14
DR Cosmic; 1820265
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA090
AC CVCL_1G15
DR Cosmic; 1820269
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA1
AC CVCL_T887
DR SKIP; SKIP000521
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T885 ! PA9
OI CVCL_T886 ! PA22
SX Female
CA Induced pluripotent stem cell
//
ID PA107
AC CVCL_1G16
DR Cosmic; 1820266
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA12
AC CVCL_0E98
RX PubMed=2985952;
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9116 ! NIH 3T3-TK-
SX Male
CA Transformed cell line
//
ID PA12-Rb
AC CVCL_0E99
SY PA12-RB
DR ATCC; CRL-1916
CC Group: Retrovirus packaging cell line.
CC Transfected with: HGNC; 9884; RB.
CC Discontinued: ATCC; CRL-1916; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0E98 ! PA12
SX Male
CA Transformed cell line
//
ID PA122
AC CVCL_1G17
DR Cosmic; 1820264
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA167
AC CVCL_1G18
DR Cosmic; 1820258
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA182
AC CVCL_1G19
DR Cosmic; 1820263
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA195
AC CVCL_1G20
DR Cosmic; 1820259
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA2.1
AC CVCL_G245
DR CLO; CLO_0008352
DR ATCC; HB-117
RX PubMed=95015;
CC Monoclonal antibody target: UniProtKB; P10316; Human HLA-A Aw69.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PA2.6
AC CVCL_G244
SY PA 2.6
DR CLO; CLO_0008347
DR ATCC; HB-118
RX PubMed=95015;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PA202
AC CVCL_1G21
DR Cosmic; 1820257
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA215
AC CVCL_1G22
DR Cosmic; 1820262
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA22
AC CVCL_T886
DR SKIP; SKIP000207
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T887 ! PA1
OI CVCL_T885 ! PA9
SX Female
CA Induced pluripotent stem cell
//
ID PA254
AC CVCL_1G23
DR Cosmic; 1820270
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA285
AC CVCL_1G24
DR Cosmic; 1820267
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA317
AC CVCL_3920
DR CLO; CLO_0008353
DR CLDB; cl3864
DR CLDB; cl3865
DR CLDB; cl7178
DR ATCC; CRL-9078
DR CCRID; 3111C0001CCC000260
DR CCRID; 3131C0001000300007
DR CCRID; 3142C0001000000097
DR ECACC; 89032007
DR ICLC; HTL06006
DR KCB; KCB 2011112YJ
DR TOKU-E; 2844
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9116 ! NIH 3T3-TK-
SX Male
CA Transformed cell line
//
ID PA317 containing JR-gal
AC CVCL_6505
DR CLO; CLO_0008354
DR ATCC; CRL-9995
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 cyclin E-L
AC CVCL_6506
DR CLO; CLO_0008355
DR ATCC; CRL-2187
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 cyclin E-S
AC CVCL_6507
DR CLO; CLO_0008356
DR ATCC; CRL-2188
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 LXSN
AC CVCL_6508
DR CLO; CLO_0008357
DR ATCC; CRL-2202
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 LXSN 16E6
AC CVCL_6509
DR CLO; CLO_0008358
DR ATCC; CRL-2204
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6].
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 LXSN 16E6E7
AC CVCL_6510
SY PA317/LXSN-16E6E7
DR CLO; CLO_0008359
DR ATCC; CRL-2203
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 LXSN 16E7
AC CVCL_6511
SY PA317LXSN16E7
DR CLO; CLO_0008360
DR ATCC; CRL-2205
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 LXSN 6E6
AC CVCL_6512
DR CLO; CLO_0008361
DR ATCC; CRL-2206
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 10600; Human papillomavirus type 6b (HPV6b) [E6].
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA317 LXSN 6E7
AC CVCL_6513
SY PA317LXSN6E7
DR CLO; CLO_0008362
DR ATCC; CRL-2207
CC Group: Retrovirus packaging cell line.
CC Transformant: NCBI_TaxID; 10600; Human papillomavirus type 6b (HPV6b) [E7].
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3920 ! PA317
SX Male
CA Transformed cell line
//
ID PA333
AC CVCL_1G25
DR Cosmic; 1820271
RX PubMed=22156295;
CC Omics: Deep exome analysis.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PA682 BM1
AC CVCL_IV25
SY PA682BM
RX PubMed=6316501;
RX PubMed=9973220;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C539 ! PA682 PB
OI CVCL_IV26 ! PA682 PE1
SX Male
CA Cancer cell line
//
ID PA682 PB
AC CVCL_C539
SY PA682(PB); PA682PB; Pa682PB; PA682; PA 682; PA-682
DR Cosmic; 850212
DR Cosmic; 931131
DR Cosmic; 1515190
RX PubMed=2052620;
RX PubMed=3927261;
RX PubMed=6316501;
RX PubMed=9473234;
RX PubMed=9973220;
RX PubMed=19358282;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV25 ! PA682 BM1
OI CVCL_IV26 ! PA682 PE1
SX Male
CA Cancer cell line
//
ID PA682 PE1
AC CVCL_IV26
SY PA 682/PE-1; PA682PE
RX PubMed=6316501;
RX PubMed=9973220;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV25 ! PA682 BM1
OI CVCL_C539 ! PA682 PB
SX Male
CA Cancer cell line
//
ID PA9
AC CVCL_T885
DR SKIP; SKIP000206
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T887 ! PA1
OI CVCL_T886 ! PA22
SX Female
CA Induced pluripotent stem cell
//
ID PAb 100
AC CVCL_2156
SY PAB-100; Clone 7
DR CLO; CLO_0008367
DR CLO; CLO_0008371
DR CLDB; cl3870
DR ATCC; TIB-115
DR DSMZ; ACC-188
RX PubMed=6155477;
CC Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PAb 101
AC CVCL_4609
SY Clone 412
DR CLO; CLO_0008368
DR ATCC; TIB-117
RX PubMed=6155477;
CC Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PAb 108
AC CVCL_4610
DR CLO; CLO_0008369
DR ATCC; TIB-230
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID PAb 122
AC CVCL_2157
SY PAB-122; PAb122; Clone 122
DR CLO; CLO_0008370
DR CLO; CLO_0008372
DR CLDB; cl3871
DR ATCC; TIB-116
DR DSMZ; ACC-166
RX PubMed=6155477;
CC Monoclonal antibody target: UniProtKB; P04637; Human TP53 (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PAb 1400
AC CVCL_4562
SY PAb1400
DR CLO; CLO_0050286
DR RCB; RCB0026
CC Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PAb 1620
AC CVCL_2158
SY PAB-1620; PAb1620
DR CLO; CLO_0008373
DR DSMZ; ACC-280
CC Doubling time: ~24 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P04637; Human TP53 (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PAb 419
AC CVCL_B954
SY PAb419
DR CLO; CLO_0050282
DR RCB; RCB0195
CC Monoclonal antibody target: UniProtKB; P03070; SV40 large T antigen.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID PaBrH01
AC CVCL_DR67
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrH02
AC CVCL_DR68
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrH03
AC CVCL_DR69
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrH04
AC CVCL_DR70
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrH05
AC CVCL_DR71
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrH06
AC CVCL_DR72
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrH07
AC CVCL_DR73
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Telomerase immortalized cell line
//
ID PaBrT01
AC CVCL_DR74
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaBrT02
AC CVCL_DR75
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaBrT03
AC CVCL_DR76
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PAC1
AC CVCL_U511
AS CVCL_D258
SY PAC-1; CS-54; CS54
DR BTO; BTO:0003338
RX PubMed=1333373;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-506.html
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID PAC2
AC CVCL_5853
SY PAC-2
DR EFO; EFO_0001224
DR ChEMBL-Cells; CHEMBL3307808
DR ChEMBL-Targets; CHEMBL612709
DR Lonza; 1136
RX CelloPub=CLPUB00276;
RX PubMed=18377224;
RX PubMed=20147193;
CC Group: Fish cell line.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PaCa 5061
AC CVCL_C886
SY PaCa-5061
DR Cosmic; 1352405
RX PubMed=20553613;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PaCa 5072
AC CVCL_C887
SY PaCa-5072
RX PubMed=22490524;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCa-44
AC CVCL_7087
SY PACA 44; PaCa44
DR BTO; BTO:0004848
DR Cosmic; 710863
DR Cosmic; 933533
RX PubMed=11787853;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PaCaDD-119
AC CVCL_1848
SY PACADD-119
DR Cosmic; 1559062
DR DSMZ; ACC-709
RX PubMed=21683373;
CC Doubling time: ~3-4 days (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 9,12
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PaCaDD-135
AC CVCL_1849
SY PACADD-135
DR Cosmic; 1559064
DR DSMZ; ACC-710
RX PubMed=21683373;
CC Doubling time: ~72 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCaDD-137
AC CVCL_1850
SY PACADD-137
DR Cosmic; 1559066
DR DSMZ; ACC-711
RX PubMed=21683373;
CC Doubling time: ~2-3 days (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 9,12
ST D7S820: 9,10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCaDD-141
AC CVCL_M464
SY PACADD-141
RX CelloPub=CLPUB00002;
CC Doubling time: 33.7 hours (CelloPub=CLPUB00002).
CC Derived from metastatic site: Lymph node.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCaDD-159
AC CVCL_M465
SY PACADD-159
DR DSMZ; ACC-745
RX CelloPub=CLPUB00002;
CC Doubling time: 41.3 hours (CelloPub=CLPUB00002); ~1 week (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,14
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9
ST TH01: 7
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PaCaDD-161
AC CVCL_M466
SY PACADD-161
DR DSMZ; ACC-746
RX CelloPub=CLPUB00002;
CC Doubling time: 20.6 hours (CelloPub=CLPUB00002); ~48 hours (DSMZ).
CC Derived from metastatic site: Liver.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,12
ST vWA: 16,19
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCaDD-165
AC CVCL_M467
SY PACADD-165
DR DSMZ; ACC-750
RX CelloPub=CLPUB00002;
CC Doubling time: 26.2 hours (CelloPub=CLPUB00002); ~35-45 hours (DSMZ).
CC Derived from metastatic site: Ascites.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PaCaDD-183
AC CVCL_M468
SY PACADD-183
DR DSMZ; ACC-751
RX CelloPub=CLPUB00002;
CC Doubling time: 43.3 hours (CelloPub=CLPUB00002); ~2-3 days (DSMZ).
CC Derived from metastatic site: Ascites.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 19
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCaDD-188
AC CVCL_M469
SY PACADD-188
DR DSMZ; ACC-753
RX CelloPub=CLPUB00002;
CC Doubling time: 30.8 hours (CelloPub=CLPUB00002); ~2-4 days (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 11,15
ST D16S539: 11,12
ST D5S818: 9,11
ST D7S820: 8,10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaCaDD-43
AC CVCL_8781
SY PACADD-43
DR Cosmic; 1559058
RX PubMed=21683373;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PaCaDD-60
AC CVCL_8782
SY PACADD-60
DR Cosmic; 1559060
RX PubMed=21683373;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PAE-iPS-1
AC CVCL_E019
SY Aries; PL-iPS-01
DR SKIP; SKIP000352
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-10
AC CVCL_E020
SY Capricornus; PL-iPS-10
DR SKIP; SKIP000404
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-11
AC CVCL_E021
SY Aquarius; PL-iPS-11
DR SKIP; SKIP000355
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-12
AC CVCL_E022
SY Pisces; PL-iPS-12
DR SKIP; SKIP000403
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-2
AC CVCL_E023
SY Taurus; PL-iPS-02
DR SKIP; SKIP000397
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-3
AC CVCL_E024
SY Gemini; PL-iPS-03
DR SKIP; SKIP000398
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-4
AC CVCL_E025
SY Cancer; PL-iPS-04
DR SKIP; SKIP000353
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-5
AC CVCL_E026
SY Leo; PL-iPS-05
DR SKIP; SKIP000354
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-6
AC CVCL_E027
SY Virgo; PL-iPS-06
DR SKIP; SKIP000399
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-7
AC CVCL_E028
SY Libra; PL-iPS-07
DR SKIP; SKIP000400
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-8
AC CVCL_E029
SY Scorpio; PL-iPS-08
DR SKIP; SKIP000401
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE-iPS-9
AC CVCL_E030
SY Sagittarius; PL-iPS-09
DR SKIP; SKIP000402
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D692 ! PAE551
SX Male
CA Induced pluripotent stem cell
//
ID PAE551
AC CVCL_D692
SY PL551Ar
DR JCRB; JCRB1543
RX PubMed=21637780;
RX PubMed=23631808;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,12
ST D16S539: 10,13
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6,10
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8532 ! PL551SF
SX Male
CA Finite cell line
//
ID PaFeT01
AC CVCL_DR77
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT02
AC CVCL_DR78
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT03
AC CVCL_DR79
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT04
AC CVCL_DR80
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT05
AC CVCL_DR81
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT06
AC CVCL_DR82
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT07
AC CVCL_DR83
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT08
AC CVCL_DR84
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR85 ! PaFeT09
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT09
AC CVCL_DR85
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR86 ! PaFeT10
CA Transformed cell line
//
ID PaFeT10
AC CVCL_DR86
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
OI CVCL_DR77 ! PaFeT01
OI CVCL_DR78 ! PaFeT02
OI CVCL_DR79 ! PaFeT03
OI CVCL_DR80 ! PaFeT04
OI CVCL_DR81 ! PaFeT05
OI CVCL_DR82 ! PaFeT06
OI CVCL_DR83 ! PaFeT07
OI CVCL_DR84 ! PaFeT08
OI CVCL_DR85 ! PaFeT09
CA Transformed cell line
//
ID PAGRS-21
AC CVCL_6640
SY PA-GRS21; Grs-21
RX PubMed=2171916;
RX PubMed=2845413;
RX PubMed=15541573;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID PAGRS-28
AC CVCL_6641
SY PA-GRS28; Grs-28
RX PubMed=2845413;
RX PubMed=15541573;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID PAGS-6
AC CVCL_W171
SY PA-GS6
RX PubMed=2171916;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID PAI
AC CVCL_J288
DR JCRB; JCRB0113
RX CelloPub=CLPUB00097;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
SX Female
CA Cancer cell line
//
ID PAI-0
AC CVCL_Z070
SY PAI-O
RX CelloPub=CLPUB00097;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
SX Female
CA Cancer cell line
//
ID Paju
AC CVCL_U415
RX PubMed=6436232;
RX PubMed=15218547;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-241.html
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaKiT01
AC CVCL_DR87
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaKiT02
AC CVCL_DR88
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaKiT03
AC CVCL_DR89
DR BioSample; SAMN04335741
DR BioSample; SAMN04335743
DR BioSample; SAMN04335748
DR PRIDE; PXD001165
RX PubMed=20011515;
RX PubMed=25398248;
RX PubMed=26535029;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
CC Omics: Proteome analysis by 2D-DE/MS.
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID Pal Man
AC CVCL_X709
DR ATCC; CRL-1116
CC Discontinued: ATCC; CRL-1116; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Pal-1
AC CVCL_X749
RX PubMed=12028021;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PAL1.K
AC CVCL_S318
DR ATCC; CRL-6292
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6292; true.
OX NCBI_TaxID=9689; ! Panthera leo
OI CVCL_S319 ! PAL1.Ln
OI CVCL_S320 ! PAL1.Ov
SX Female
CA Finite cell line
//
ID PAL1.Ln
AC CVCL_S319
DR ATCC; CRL-6293
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6293; true.
OX NCBI_TaxID=9689; ! Panthera leo
OI CVCL_S318 ! PAL1.K
OI CVCL_S320 ! PAL1.Ov
SX Female
CA Finite cell line
//
ID PAL1.Ov
AC CVCL_S320
DR ATCC; CRL-6294
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6294; true.
OX NCBI_TaxID=9689; ! Panthera leo
OI CVCL_S318 ! PAL1.K
OI CVCL_S319 ! PAL1.Ln
SX Female
CA Finite cell line
//
ID Pala
AC CVCL_9W19
RX PubMed=1373173;
RX PubMed=6160591;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID PALL-1
AC CVCL_D694
RX PubMed=8428799;
DI NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PALL-2
AC CVCL_3122
SY PALL2
DR JCRB; JCRB1345
DR JCRB; NIHS0546
RX PubMed=8428799;
CC Discontinued: JCRB; NIHS0546; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PaLuT01
AC CVCL_DR90
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaLuT02
AC CVCL_DR91
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaLuT03
AC CVCL_DR92
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID PaLuT04
AC CVCL_DR93
RX PubMed=20011515;
CC Group: Bat cell line.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9402; ! Pteropus alecto
CA Transformed cell line
//
ID Pam 212
AC CVCL_7694
SY PAM 212; PAM212; Pam212; PAM 2-12
DR BTO; BTO:0005067
DR ChEMBL-Cells; CHEMBL3307343
DR ChEMBL-Targets; CHEMBL614231
DR TOKU-E; 4030
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-242.html
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Pam LU-1
AC CVCL_Z592
SY PAM LU1; LU-1
RX PubMed=9247255;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7694 ! Pam 212
SX Male
CA Cancer cell line
//
ID Pam LY-1
AC CVCL_Z593
SY PAM LY1
RX PubMed=9247255;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7694 ! Pam 212
SX Male
CA Cancer cell line
//
ID Pam LY-2
AC CVCL_Z594
SY PAM LY2; PAM-LY2; LY-2
RX PubMed=9247255;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7694 ! Pam 212
SX Male
CA Cancer cell line
//
ID PAMC82
AC CVCL_H271
SY PAMC-82
DR Cosmic; 2484975
DR GEO; GSM1374805
RX PubMed=11351862;
CC Omics: Transcriptome analysis.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PAN-03-JCK
AC CVCL_B454
SY PAN03JCK
DR Cosmic; 707258
DR Cosmic; 1066190
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PAN-07-JCK
AC CVCL_B455
SY PAN07JCK
DR Cosmic; 1066191
RX PubMed=19265263;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PAN-08-JCK
AC CVCL_B456
SY PAN08JCK
DR Cosmic; 1066192
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PAN-09-JCK
AC CVCL_B457
SY PAN09JCK
DR Cosmic; 1066193
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Panc 01.28
AC CVCL_7666
SY Panc 1.28; Panc1.28
DR ATCC; CRL-2548
DR BioSample; SAMN03471609
RX PubMed=9612602;
RX PubMed=18000365;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Probably contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Discontinued: ATCC; CRL-2548; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7664 ! Panc 04.21
OI CVCL_7665 ! Panc 06.03
CA Cancer cell line
//
ID Panc 02.02
AC CVCL_U875
SY Panc 2.02
RX PubMed=18000365;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 02.03
AC CVCL_1633
AS CVCL_H597
SY PANC-02-03; Panc_02_03; Panc02.03; Panc 2.03; Panc2.03; Panc2_03; PANC 203; Panc203; PANC203; PANC0203
DR CLO; CLO_0008374
DR EFO; EFO_0006466
DR ATCC; CRL-2553
DR BioSample; SAMN03473181
DR CCLE; PANC0203_PANCREAS
DR ChEMBL-Cells; CHEMBL3307761
DR ChEMBL-Targets; CHEMBL612584
DR Cosmic; 2009528
DR Cosmic; 2434088
DR Cosmic-CLP; 1298475
DR GDSC; 1298475
DR GEO; GSM206527
DR GEO; GSM621891
DR GEO; GSM887494
DR GEO; GSM888576
DR GEO; GSM1024405
DR GEO; GSM1374810
DR GEO; GSM1670331
DR PRIDE; PXD003198
RX PubMed=9612602;
RX PubMed=18000365;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2002.03
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14
ST D21S11: 28,31
ST D3S1358: 14
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 11,12
ST FGA: 20,21
ST Penta D: 9
ST Penta E: 5,7
ST TH01: 6
ST TPOX: 9,12
ST vWA: 17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 02.05
AC CVCL_E278
AS CVCL_U876
SY Panc 2.05; PANC 2.5; Panc2.5; Pa21C
DR Cosmic; 1473043
DR Cosmic; 1509862
RX PubMed=18000365;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 02.08
AC CVCL_E277
AS CVCL_U877
SY Panc 2.08; PANC 2.8; Panc2.8; Panc2_8; Pa104C
DR Cosmic; 949523
DR Cosmic; 1509880
RX PubMed=18000365;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Panc 02.13
AC CVCL_1634
SY Panc 2.13; Panc-02.13; Panc2.13; PANC0213; PL1; PL-1
DR CLO; CLO_0008375
DR ATCC; CRL-2554
DR BioSample; SAMN03472905
DR CCLE; PANC0213_PANCREAS
DR GEO; GSM887495
DR GEO; GSM888577
DR GEO; GSM1024406
RX PubMed=9612602;
RX PubMed=14695172;
RX PubMed=18000365;
RX PubMed=22460905;
RX PubMed=25167228;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9,12
ST D18S51: 11
ST D21S11: 29
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 7,11
ST D8S1179: 12,13
ST FGA: 21,23
ST Penta D: 12
ST Penta E: 8,13
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 02.43
AC CVCL_E282
SY PANC 2.43; Panc2.43; Pa113C
DR Cosmic; 1473018
DR Cosmic; 1509882
RX PubMed=18000365;
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Panc 03.27
AC CVCL_1635
AS CVCL_H601
SY Panc 3.27; Panc-03.27; PANC-03-27; Panc_03_27; Panc-3_27; PANC3.27; Panc3.27; Panc3_27; PANC 327; Panc327; Panc-327; PANC0327; PL11; PL-11
DR CLO; CLO_0008376
DR EFO; EFO_0006467
DR ATCC; CRL-2549
DR BioSample; SAMN03473169
DR CCLE; PANC0327_PANCREAS
DR ChEMBL-Cells; CHEMBL3308124
DR ChEMBL-Targets; CHEMBL1075557
DR Cosmic; 925346
DR Cosmic; 949522
DR Cosmic; 1198222
DR Cosmic; 2434102
DR Cosmic-CLP; 925346
DR GDSC; 925346
DR GEO; GSM206528
DR GEO; GSM621904
DR GEO; GSM784705
DR GEO; GSM887496
DR GEO; GSM888578
DR GEO; GSM1024407
DR GEO; GSM1374811
DR GEO; GSM1670332
DR PRIDE; PXD003198
RX PubMed=9612602;
RX PubMed=14695172;
RX PubMed=18000365;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2003.27
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Doubling time: 51 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 18
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 8,13
ST D8S1179: 13,14
ST FGA: 22,26
ST Penta D: 10,15
ST Penta E: 7,11
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 04.03
AC CVCL_1636
SY PANC-04-03; Panc_04_03; Panc04.03; Panc 4.03; PANC 4.03; Panc4.03; PANC0403; PANC403; Pa17C; Pa017C; PL5; PL-5; PL 5
DR CLO; CLO_0008377
DR EFO; EFO_0006468
DR ATCC; CRL-2555
DR BioSample; SAMN03473168
DR CCLE; PANC0403_PANCREAS
DR Cosmic; 1198213
DR Cosmic; 1509872
DR Cosmic; 2434101
DR Cosmic-CLP; 1298476
DR GDSC; 1298476
DR GEO; GSM206529
DR GEO; GSM621892
DR GEO; GSM887497
DR GEO; GSM888579
DR GEO; GSM1024408
DR GEO; GSM1374812
DR GEO; GSM1670333
DR PRIDE; PXD003198
RX PubMed=9612602;
RX PubMed=18000365;
RX PubMed=22460905;
RX PubMed=22753594;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2004.03
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 16
ST D21S11: 28
ST D3S1358: 15,17
ST D5S818: 11
ST D7S820: 8,12
ST D8S1179: 10,15
ST FGA: 22,23
ST Penta D: 10,13
ST Penta E: 13,14
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 14,16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Panc 04.03 MAP2K4(-/-)
AC CVCL_HE14
SY MAP2K4 (-/-) Panc 04.03; MKK4-/- cells
RX PubMed=16740690;
WW https://www.horizondiscovery.com/human-map2k4-panc-04-03-cell-lines-hd-109-002
CC Knockout cell: Method=Homologous recombination; HGNC; 6844; MAP2K4.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1636 ! Panc 04.03
SX Male
CA Cancer cell line
//
ID Panc 04.14
AC CVCL_U872
SY Panc 4.14; PL3; PL-3
RX PubMed=14695172;
RX PubMed=18000365;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 04.21
AC CVCL_7664
SY Panc 4.21; Panc-04.21; Panc4.21
DR ATCC; CRL-2556
RX PubMed=9612602;
RX PubMed=18000365;
CC Problematic cell line: Probably contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Discontinued: ATCC; CRL-2556; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7666 ! Panc 01.28
OI CVCL_7665 ! Panc 06.03
CA Cancer cell line
//
ID Panc 05.04
AC CVCL_1637
SY Panc-05.04; Panc_05_04; Panc05.04; Panc 5.04; Panc5.04; PANC0504; Pa18C
DR CLO; CLO_0008378
DR EFO; EFO_0006469
DR ATCC; CRL-2557
DR BioSample; SAMN03473170
DR CCLE; PANC0504_PANCREAS
DR Cosmic; 1473038
DR Cosmic; 1509860
DR Cosmic; 2434083
DR GEO; GSM206530
DR GEO; GSM621931
DR GEO; GSM887498
DR GEO; GSM888580
DR GEO; GSM1024409
DR PRIDE; PXD003198
RX PubMed=9612602;
RX PubMed=22460905;
RX PubMed=22753594;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2005.04
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 10,12
ST D16S539: 9,11
ST D18S51: 14
ST D21S11: 28,33.2
ST D3S1358: 14,16
ST D5S818: 12,13
ST D7S820: 9,12
ST D8S1179: 11,13
ST FGA: 19,23
ST Penta D: 7,9
ST Penta E: 5,18
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 15,20
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 06.03
AC CVCL_7665
SY Panc-06.03; Panc 6.03; PANC 6.03; Panc6.03; Pa19C; Pa019C
DR ATCC; CRL-2550
DR Cosmic; 1473096
DR Cosmic; 1509873
RX PubMed=9612602;
RX PubMed=14695172;
RX PubMed=18000365;
RX PubMed=22753594;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Probably contaminated. Panc 01.28, Panc 04.21 and Panc 06.03 have been shown to be identical (on the basis of STR profile).
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2550; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7666 ! Panc 01.28
OI CVCL_7664 ! Panc 04.21
CA Cancer cell line
//
ID Panc 08.13
AC CVCL_1638
AS CVCL_H599
SY Panc 8.13; Panc-08.13; PANC-08-13; Panc_08_13; Panc08.13; Panc8.13; Panc-8_13; Panc-813; PANC 813; Panc813; PANC813; PANC0813; Pa14C; PL9; PL-9
DR CLO; CLO_0008379
DR EFO; EFO_0006470
DR ATCC; CRL-2551
DR BioSample; SAMN03472947
DR CCLE; PANC0813_PANCREAS
DR ChEMBL-Cells; CHEMBL3308777
DR ChEMBL-Targets; CHEMBL1075558
DR Cosmic; 925347
DR Cosmic; 949526
DR Cosmic; 1198215
DR Cosmic; 1198221
DR Cosmic; 1473126
DR Cosmic; 1509858
DR Cosmic; 2434104
DR Cosmic-CLP; 925347
DR GDSC; 925347
DR GEO; GSM206531
DR GEO; GSM621905
DR GEO; GSM784709
DR GEO; GSM827278
DR GEO; GSM887499
DR GEO; GSM888581
DR GEO; GSM1024410
DR GEO; GSM1374813
DR GEO; GSM1670334
DR PRIDE; PXD003198
RX PubMed=9612602;
RX PubMed=14695172;
RX PubMed=18000365;
RX PubMed=22460905;
RX PubMed=22753594;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2008.13
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Doubling time: 117 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 13
ST D18S51: 19
ST D21S11: 32.2
ST D3S1358: 16
ST D5S818: 13,14
ST D7S820: 11
ST D8S1179: 10,14
ST FGA: 21,23
ST Penta D: 10
ST Penta E: 5,16,17
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 18
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Panc 09.06
AC CVCL_U873
SY Panc 9.06; Panc9.06; Panc9_06; PL13; PL-13
DR ATCC; CRL-2552
DR BioSample; SAMN03471670
DR Cosmic; 949520
DR Cosmic; 1198217
RX PubMed=9612602;
RX PubMed=18000365;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Discontinued: ATCC; CRL-2552; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,12
ST D16S539: 11,14
ST D5S818: 9,11
ST D7S820: 8,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Panc 09.06.94
AC CVCL_E297
SY PANC 9.6.94; Panc9.6.94; Pa221C
DR Cosmic; 1473044
DR Cosmic; 1509959
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U873 ! Panc 09.06
SX Female
CA Cancer cell line
//
ID Panc 10.05
AC CVCL_1639
AS CVCL_H600
SY Panc-10.05; Panc10.05; PANC-10-05; PANC 1005; Panc1005; PANC1005; Pa16C; PL12; PL-12
DR CLO; CLO_0008380
DR ATCC; CRL-2547
DR CCLE; PANC1005_PANCREAS
DR ChEMBL-Cells; CHEMBL3307991
DR ChEMBL-Targets; CHEMBL612583
DR Cosmic; 925348
DR Cosmic; 1198216
DR Cosmic; 1473147
DR Cosmic; 1509859
DR Cosmic; 2046532
DR Cosmic; 2434097
DR Cosmic-CLP; 925348
DR GDSC; 925348
DR GEO; GSM206533
DR GEO; GSM784707
DR GEO; GSM887500
DR GEO; GSM888582
DR GEO; GSM1024412
DR GEO; GSM1374809
DR GEO; GSM1670335
DR PRIDE; PXD003198
RX PubMed=9612602;
RX PubMed=18000365;
RX PubMed=22460905;
RX PubMed=22753594;
RX PubMed=25167228;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=Panc%2010.05
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC Doubling time: 30 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 8,9
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3567 ! PL45
SX Male
CA Cancer cell line
//
ID Panc 12.01
AC CVCL_Y004
RX PubMed=9612602;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PANC 1002
AC CVCL_E283
SY Panc1002; Pa231C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PANC 185
AC CVCL_E284
SY Panc185; Pa37C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PANC 198
AC CVCL_E285
SY Panc198; Pa20C
DR Cosmic; 1473061
DR Cosmic; 1509861
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PANC 215
AC CVCL_E286
SY Panc215; Pa09C
DR Cosmic; 1473090
DR Cosmic; 1509855
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PANC 233
AC CVCL_E300
SY Panc233; Pa223C
DR Cosmic; 1477298
DR Cosmic; 1509961
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PANC 247
AC CVCL_E287
SY Panc247; Pa34C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PANC 253
AC CVCL_E288
SY Panc253; Pa39C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PANC 3.014
AC CVCL_E298
SY Panc 3.014; 3.014; Pa28C
DR Cosmic; 1473074
DR Cosmic; 1509863
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PANC 430
AC CVCL_H598
SY Panc430; Panc-4_30
DR ChEMBL-Cells; CHEMBL3307680
DR ChEMBL-Targets; CHEMBL614673
DR Cosmic; 1198223
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PANC 480
AC CVCL_E289
SY Panc480; Pa102C
DR Cosmic; 1509879
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PANC 486
AC CVCL_E290
SY Panc486; Pa222C
DR Cosmic; 1473045
DR Cosmic; 1509960
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PANC 502
AC CVCL_E291
SY Panc502; Pa227C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PANC 503
AC CVCL_E292
SY Panc503; Pa228C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PANC 504
AC CVCL_E293
SY Panc504; Pa229C
RX PubMed=22753594;
CC From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PANC-1
AC CVCL_0480
SY Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1
DR BCGO; BCGO_0000122
DR BTO; BTO:0000304
DR CLO; CLO_0008381
DR CLO; CLO_0050102
DR EFO; EFO_0002713
DR MCCL; MCC:0000378
DR CLDB; cl3872
DR CLDB; cl3873
DR CLDB; cl3874
DR ATCC; CRL-1469
DR BCRC; 60284
DR BCRJ; 0201
DR BioSample; SAMN01821587
DR BioSample; SAMN03472068
DR CCLE; PANC1_PANCREAS
DR CCRID; 3111C0001CCC000023
DR CCRID; 3131C0001000700098
DR CGH-DB; 180-1
DR CGH-DB; 9267-4
DR ChEMBL-Cells; CHEMBL3307545
DR ChEMBL-Targets; CHEMBL614139
DR CLS; 300228/p635_Panc-1
DR Cosmic; 707250
DR Cosmic; 710864
DR Cosmic; 724643
DR Cosmic; 730533
DR Cosmic; 753625
DR Cosmic; 808171
DR Cosmic; 868242
DR Cosmic; 873000
DR Cosmic; 913307
DR Cosmic; 918054
DR Cosmic; 922248
DR Cosmic; 923171
DR Cosmic; 932521
DR Cosmic; 947397
DR Cosmic; 948377
DR Cosmic; 949235
DR Cosmic; 968106
DR Cosmic; 1006367
DR Cosmic; 1108335
DR Cosmic; 1122348
DR Cosmic; 1198204
DR Cosmic; 1299304
DR Cosmic; 1320459
DR Cosmic; 1366282
DR Cosmic; 1477432
DR Cosmic; 1518236
DR Cosmic; 1534320
DR Cosmic; 1571781
DR Cosmic; 1644316
DR Cosmic; 1609544
DR Cosmic; 1768264
DR Cosmic; 2434107
DR Cosmic; 2546060
DR DSMZ; ACC-783
DR ECACC; 87092802
DR ENCODE; ENCBS397PLZ
DR ENCODE; ENCBS399ENC
DR ENCODE; ENCBS425ENC
DR ENCODE; ENCBS465AAA
DR ENCODE; ENCBS466AAA
DR ENCODE; ENCBS467AAA
DR ENCODE; ENCBS470AAA
DR ENCODE; ENCBS492WPY
DR ENCODE; ENCBS556WYR
DR ENCODE; ENCBS761TKL
DR ENCODE; ENCBS729QZR
DR ENCODE; ENCBS945URM
DR GEO; GSM206532
DR GEO; GSM244423
DR GEO; GSM472938
DR GEO; GSM472939
DR GEO; GSM621900
DR GEO; GSM784698
DR GEO; GSM887501
DR GEO; GSM888583
DR GEO; GSM923421
DR GEO; GSM945246
DR GEO; GSM945261
DR GEO; GSM1024411
DR GEO; GSM1374806
DR GEO; GSM1374807
DR GEO; GSM1374808
DR GEO; GSM1588613
DR IZSLER; BS TCL 49
DR KCB; KCB 200809YJ
DR KCLB; 21469
DR NCBI_Iran; C556
DR PRIDE; PXD002192
DR PRIDE; PXD003198
DR RCB; RCB2095
DR SKY/M-FISH/CGH; 2001
DR TKG; TKG 0606
DR TOKU-E; 2865
RX DOI=10.4172/jpb.1000057;
RX PubMed=1140870;
RX PubMed=6435863;
RX PubMed=10027410;
RX PubMed=11169957;
RX PubMed=11169959;
RX PubMed=11787853;
RX PubMed=12692724;
RX PubMed=12800145;
RX PubMed=14695172;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=23325432;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PANC-1.html
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PANC-1
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/PANC-1_Myers_protocol.pdf
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=65
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-179.html
WW http://tcpaportal.org/mclp/
CC Part of: AKT genetic alteration cell panel (ATCC TCP-1029).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Has lost chromosome Y.
CC Doubling time: ~42 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11
ST D18S51: 12
ST D21S11: 28
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 14,15
ST FGA: 21
ST Penta D: 14
ST Penta E: 7,14
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Panc-4
AC CVCL_IU72
RX PubMed=21475719;
CC Derived from metastatic site: Lymph node.
DI NCIt; C7977; Pancreatic acinar cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Panc02
AC CVCL_D627
SY Panc-02; Panc 02; Pan02; Panc02-H0
DR BTO; BTO:0005175
RX PubMed=6692374;
RX PubMed=12754403;
RX PubMed=20805420;
RX PubMed=21720167;
RX PubMed=22208613;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Panc02-H7
AC CVCL_D628
DR BTO; BTO:0005175
RX PubMed=12754403;
RX PubMed=22208613;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D627 ! Panc02
SX Male
CA Cancer cell line
//
ID Panc03
AC CVCL_1U10
SY Panc-03; Panc 03
RX PubMed=6692374;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: C57BL/6.
DI NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Panc1-bC2GnT-M
AC CVCL_0Q69
DR BTO; BTO:0005502
RX PubMed=10455130;
RX PubMed=22525330;
CC Transfected with: HGNC; 7508; MUC1.
CC Transfected with: UniProtKB; Q92180; Bovine GCNT1.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0Q68 ! Panc1-MUC1
SX Male
CA Cancer cell line
//
ID Panc1-MUC1
AC CVCL_0Q68
SY Panc1/MUC1
CC Transfected with: HGNC; 7508; MUC1.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0480 ! PANC-1
SX Male
CA Cancer cell line
//
ID PANC3
AC CVCL_3921
SY PANC-3
DR BTO; BTO:0000979
RX PubMed=11332991;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PancTu-I
AC CVCL_4012
SY PancTu-1; PancTu 1; Panc-TU-I; Panc-Tu1; Panc-TuI; Panc TUI; PancTuI; PancTUI; PaTu-I; PaTu I; PaTu1
DR EFO; EFO_0002715
DR Cosmic; 710865
DR Cosmic; 736275
DR Cosmic; 933530
DR Cosmic; 1534321
DR GEO; GSM244424
RX PubMed=11169959;
RX PubMed=11787853;
RX PubMed=12692724;
RX PubMed=12800145;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PaTu%201.html
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4013 ! PancTu-II
SX Female
CA Cancer cell line
//
ID PancTu-II
AC CVCL_4013
SY PaTu II; PaTu-II; Pa Tu-II; Patu-2; PATU2; PancTuII; Panc-TU-II; Panc-Tu2
DR Cosmic; 736276
DR Cosmic; 808162
DR Cosmic; 933531
RX PubMed=11169959;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PaTu%20II.html
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4012 ! PancTu-I
SX Female
CA Cancer cell line
//
ID PandPush
AC CVCL_9W24
SY PANDPUSH
DR IMGT/HLA; 11279
RX PubMed=10372548;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PanG 12.1
AC CVCL_X926
SY PanG 12-1
RX PubMed=2247455;
CC Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PAP 7
AC CVCL_J770
SY PAP7
DR ECACC; 86080701
RX PubMed=3545314;
CC Monoclonal antibody target: UniProtKB; P05994; Papaya proteinase 4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PAP 8
AC CVCL_J771
SY PAP8
DR ECACC; 86080702
RX PubMed=3545314;
CC Monoclonal antibody target: UniProtKB; P10056; Papaya proteinase 3 (omega).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PAP-HT25
AC CVCL_4678
DR BTO; BTO:0001527
RX PubMed=3303963;
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_9702 ! GRB-PAP1
CA Spontaneously immortalized cell line
//
ID PAR
AC CVCL_E801
DR dbMHC; 48996
DR ECACC; 94050315
DR IHW; IHW9266
DR IMGT/HLA; 11231
WW http://bioinformatics.hsanmartino.it/ecbr/cl266.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Par Bel
AC CVCL_U680
DR ATCC; CRL-1191
RX PubMed=3860870;
CC Discontinued: ATCC; CRL-1191; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Par-C10
AC CVCL_8903
SY PAR-C10; ParC10; Parotid C10; C10; Pa-3
RX PubMed=9112124;
RX PubMed=9542637;
RX PubMed=9688590;
RX PubMed=20121592;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID Par-C5
AC CVCL_D695
SY PAR-C5; ParC5; Parotid C5; C5; Pa-4
RX PubMed=9112124;
RX PubMed=9542637;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID PARK4-14
AC CVCL_T869
DR SKIP; SKIP000195
RX PubMed=22848530;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F204 ! ND27760
SX Female
CA Induced pluripotent stem cell
//
ID PARK4-4
AC CVCL_T870
DR SKIP; SKIP000194
RX PubMed=22848530;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F204 ! ND27760
SX Female
CA Induced pluripotent stem cell
//
ID Parks
AC CVCL_DN32
SY PARKS
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
DI NCIt; C120298; Canine melanoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID PAS
AC CVCL_R914
SY Purplish Amberjack Skin
RX DOI=10.1577/1548-8667(1993)005<0127:COTCCL>2.3.CO;2;
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=41447; ! Seriola dumerili
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Pat Bru
AC CVCL_X708
SY PatBru
DR ATCC; CRL-1121
RX PubMed=865488;
CC Discontinued: ATCC; CRL-1121; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Pat5
AC CVCL_0J19
SY Pat 5
RX PubMed=17828574;
WW http://inventions.umich.edu/technologies/1862_pluripotent-mouse-embryonic-stem-cell-line-pat-5
CC Breed/subspecies: 129X1/SvJ.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Patas-BARF1
AC CVCL_4T88
SY P-BA
RX PubMed=9223671;
RX PubMed=19724690;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV) [BARF1].
CC Transformant: EBV BARF1.
OX NCBI_TaxID=9538; ! Erythrocebus patas
CA Transformed cell line
//
ID PATH.1
AC CVCL_9W29
SY Peripheral Adrenergic TH-expressing 1
RX Patent=US5591626;
RX PubMed=7680068;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9W30 ! PATH.2
SX Female
CA Transformed cell line
//
ID PATH.2
AC CVCL_9W30
SY Peripheral Adrenergic TH-expressing 2
RX Patent=US5591626;
RX PubMed=7680068;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_9W29 ! PATH.1
SX Female
CA Transformed cell line
//
ID Patrick
AC CVCL_IU34
SY NK-45
RX PubMed=4320167;
RX PubMed=5021706;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Patscl-52
AC CVCL_8400
SY PatScl 52; Patscl52
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Patski
AC CVCL_Y494
SY PATSKI
DR EFO; EFO_0005481
DR ENCODE; ENCBS171ENC
DR ENCODE; ENCBS172ENC
DR ENCODE; ENCBS463JXY
DR GEO; GSM1014171
RX PubMed=9500539;
RX PubMed=20363980;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/Patski_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=186842; ! Mus musculus x Mus spretus
SX Female
CA Spontaneously immortalized cell line
//
ID PaTu 8902
AC CVCL_1845
SY PA-TU-8902; PATU-8902; PaTu8902; PATU8902; 8902
DR CLO; CLO_0008382
DR EFO; EFO_0006729
DR CLDB; cl3860
DR BioSample; SAMN03473078
DR CCLE; PATU8902_PANCREAS
DR Cosmic; 873004
DR Cosmic; 948381
DR Cosmic; 2434100
DR Cosmic-CLP; 1298526
DR DSMZ; ACC-179
DR GDSC; 1298526
DR GEO; GSM206534
DR GEO; GSM887502
DR GEO; GSM888584
DR GEO; GSM1670336
DR NCBI_Iran; C557
RX PubMed=8287116;
RX PubMed=11787853;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~25-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 23
ST Penta D: 11
ST Penta E: 12,15
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PaTu 8988s
AC CVCL_1846
SY PA-TU-8988S; PaTu8988s; PaTu8988S; PATU8988S; PaTu 8988 S; PaTu-8988s; PATU-8988S; PATU-S
DR BTO; BTO:0005879
DR CLO; CLO_0008383
DR EFO; EFO_0006730
DR CLDB; cl3861
DR CCLE; PATU8988S_PANCREAS
DR Cosmic; 873007
DR Cosmic; 2046530
DR Cosmic; 2434103
DR DSMZ; ACC-204
DR GEO; GSM887503
DR GEO; GSM888585
RX PubMed=1348891;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PaTu_8988S
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40-60 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 26
ST D5S818: 11,13
ST D7S820: 7,8
ST D8S1179: 13,16
ST FGA: 23
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1847 ! PaTu 8988t
SX Female
CA Cancer cell line
//
ID PaTu 8988t
AC CVCL_1847
SY PA-TU-8988T; PaTu8988t; PaTu8988T; PATU8988T; PaTu 8988 T; PaTu-8988t; PATU-8988T; PATU-T; 8988T
DR BTO; BTO:0005878
DR CLO; CLO_0008384
DR EFO; EFO_0005713
DR CLDB; cl3862
DR BioSample; SAMN03473157
DR CCLE; PATU8988T_PANCREAS
DR Cosmic; 873006
DR Cosmic; 948382
DR Cosmic; 1524020
DR Cosmic; 1995611
DR Cosmic; 2046531
DR Cosmic; 2434111
DR Cosmic-CLP; 1240201
DR DSMZ; ACC-162
DR ENCODE; ENCBS158AAA
DR GDSC; 1240201
DR GEO; GSM206535
DR GEO; GSM385524
DR GEO; GSM385535
DR GEO; GSM816667
DR GEO; GSM827178
DR GEO; GSM887504
DR GEO; GSM888586
DR GEO; GSM16703371
DR IGRhCellID; PA-TU-8988T%20GEO
RX PubMed=1348891;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PaTu_8988T
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/8988T_Crawford_protocol.pdf
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~22-30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 12
ST D21S11: 26
ST D3S1358: 15,17
ST D5S818: 11,13
ST D7S820: 7,8
ST D8S1179: 13,16
ST FGA: 23
ST Penta D: 8
ST Penta E: 14
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1846 ! PaTu 8988s
SX Female
CA Cancer cell line
//
ID PaTuO2
AC CVCL_L218
SY PaTuO-2
DR BTO; BTO:0005398
CC Miscellaneous: Only mentioned as a pancreatic adenocarcinoma cell line in PubMed=20709028.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PAV-1
AC CVCL_7995
DR BTO; BTO:0003523
RX PubMed=12007639;
RX PubMed=17760834;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID PAZ6
AC CVCL_GS29
SY PAZ-6
DR GEO; GSM1543670
DR GEO; GSM1543671
RX Patent=US6071747;
RX PubMed=9133667;
RX PubMed=18283285;
RX PubMed=22649407;
RX PubMed=25925588;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1531.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID PB-1 [Human]
AC CVCL_8443
SY PB1
RX PubMed=11021758;
RX PubMed=11737246;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PB-1 [Mouse mast cell]
AC CVCL_Y654
RX PubMed=3493490;
RX PubMed=6873525;
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID PB-1 [Mouse pre-B cell]
AC CVCL_2159
DR CLO; CLO_0008385
DR CLDB; cl836
DR DSMZ; ACC-241
RX PubMed=10699580;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=PB-1
CC Characteristics: IL7 dependent.
CC Doubling time: ~50 hours (DSMZ).
CC Breed/subspecies: C57BL/6 x CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID PB-3c
AC CVCL_5346
SY PB-3C; PB-3
DR IFO; IFO50267
RX PubMed=3079807;
RX PubMed=3493490;
RX PubMed=6873525;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID PB03
AC CVCL_C345
SY PB3; UPS-FRi004-A; UPSFRi001-A
DR hPSCreg; UPSFRi001-A
RX PubMed=22425713;
RX PubMed=22514597;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PB04
AC CVCL_C346
SY PB4; UPS-FRi005-A; UPSFRi002-A
DR hPSCreg; UPSFRi002-A
RX PubMed=22425713;
RX PubMed=22514597;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB05
AC CVCL_C347
SY PB5; UPS-FRi007-A; UPSFRi004-A
DR hPSCreg; UPSFRi004-A
RX PubMed=22425713;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB05-1
AC CVCL_C348
SY PB05.1; UPS-FRi006-A; UPSFRi003-A
DR hPSCreg; UPSFRi003-A
RX PubMed=22425713;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C34375; Thalassemia major
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C347 ! PB05
SX Male
CA Induced pluripotent stem cell
//
ID PB06
AC CVCL_C349
SY UPS-FRi008-A; UPSFRi005-A
DR hPSCreg; UPSFRi005-A
RX PubMed=22425713;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB06-1
AC CVCL_C350
SY UPS-FRi008-A-1; UPSFRi005-A-1
DR hPSCreg; UPSFRi005-A-1
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C349 ! PB06
SX Male
CA Induced pluripotent stem cell
//
ID PB07
AC CVCL_C351
SY PB7; UPS-FRi009-A; UPSFRi006-A
DR hPSCreg; UPSFRi006-A
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB08
AC CVCL_C352
SY PB8; UPS-FRi010-A; UPSFRi007-A
DR hPSCreg; UPSFRi007-A
RX PubMed=22514597;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB09
AC CVCL_C353
SY PB9; UPS-FRi011-A; UPSFRi008-A
DR hPSCreg; UPSFRi008-A
RX PubMed=22425713;
RX PubMed=22514597;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB1
AC CVCL_T881
DR SKIP; SKIP000202
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T882 ! PB2
OI CVCL_T883 ! PB18
OI CVCL_T884 ! PB20
SX Male
CA Induced pluripotent stem cell
//
ID PB10
AC CVCL_C354
SY UPS-FRi012-A; UPSFRi009-A
DR hPSCreg; UPSFRi009-A
RX PubMed=22425713;
RX PubMed=22514597;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB11
AC CVCL_GR17
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PB13
AC CVCL_Y593
RX PubMed=22514597;
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PB150.18
AC CVCL_2H73
SY BALB/cByJ-PB150.18
WW http://jaxmice.jax.org/strain/012488.html
CC From: Predictive Biology, Inc.
CC Breed/subspecies: BALB/cByJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PB151.24
AC CVCL_2H74
SY C3H/HeJ-PB151.24
WW http://jaxmice.jax.org/strain/012490.html
CC From: Predictive Biology, Inc.
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PB17
AC CVCL_GR18
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PB18
AC CVCL_T883
DR SKIP; SKIP000204
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T881 ! PB1
OI CVCL_T882 ! PB2
OI CVCL_T884 ! PB20
SX Male
CA Induced pluripotent stem cell
//
ID PB2
AC CVCL_T882
DR SKIP; SKIP000203
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T881 ! PB1
OI CVCL_T883 ! PB18
OI CVCL_T884 ! PB20
SX Male
CA Induced pluripotent stem cell
//
ID PB20
AC CVCL_T884
DR SKIP; SKIP000205
RX PubMed=23039195;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T881 ! PB1
OI CVCL_T882 ! PB2
OI CVCL_T883 ! PB18
SX Male
CA Induced pluripotent stem cell
//
ID PB30
AC CVCL_GR19
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PB32
AC CVCL_GR24
RX PubMed=27879209;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB32-1
AC CVCL_GR25
RX PubMed=27879209;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_GR24 ! PB32
SX Male
CA Induced pluripotent stem cell
//
ID PB32-4
AC CVCL_GR26
RX PubMed=27879209;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_GR24 ! PB32
SX Male
CA Induced pluripotent stem cell
//
ID PB32-5
AC CVCL_GR27
RX PubMed=27879209;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_GR24 ! PB32
SX Male
CA Induced pluripotent stem cell
//
ID PB33
AC CVCL_GR20
RX PubMed=26938212;
CC From: Universite Paris-Sud 11; Paris; France.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PB35.17
AC CVCL_2H75
SY NZW/LacJ-PB35.17
WW http://jaxmice.jax.org/strain/012489.html
CC From: Predictive Biology, Inc.
CC Breed/subspecies: NZW/LacJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PB48
AC CVCL_GQ02
RX PubMed=27558615;
CC From: Universite Paris-Sud 11; Paris; France.
DI NCIt; C123329; Multiple endocrine neoplasia type 2
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PB60.6
AC CVCL_2H76
SY BTBR T+ Itpr3tf/J-PB60.6
WW http://jaxmice.jax.org/strain/012486.html
CC From: Predictive Biology, Inc.
CC Breed/subspecies: BTBR T+ Itpr3tf/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PB61.11
AC CVCL_2H77
SY MRL/MpJ-PB61.11
WW http://jaxmice.jax.org/strain/012485.html
CC From: Predictive Biology, Inc.
CC Breed/subspecies: MRL/MpJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PB84.3
AC CVCL_2H78
SY FVB/NJ-PB84.3
WW http://jaxmice.jax.org/strain/012487.html
CC From: Predictive Biology, Inc.
CC Breed/subspecies: FVB/NJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PBEI
AC CVCL_8270
DR BioSample; SAMN03151852
RX PubMed=10508494;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a NALM-6 derivative (PubMed=10508494, PubMed=12592342, PubMed=20143388).
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID PBL-Om
AC CVCL_G007
RX PubMed=6088403;
RX PubMed=6189906;
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_F912 ! ILT-Om
SX Male
CA Transformed cell line
//
ID PBLE
AC CVCL_R845
SY Peripheral Blood Leukocyte Eel
RX PubMed=17163780;
CC Group: Fish cell line.
OX NCBI_TaxID=7938; ! Anguilla rostrata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PBMC1-iPS4F1
AC CVCL_9U44
RX PubMed=26987924;
RX PubMed=27346199;
ST Source(s): PubMed=27346199
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,13
ST D18S51: 10,16
ST D19S433: 12,14
ST D21S11: 30,34
ST D2S1338: 17
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13,16
ST FGA: 18,22
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PBMC1-iPS4F1 shDLL4
AC CVCL_DQ81
RX PubMed=27346199;
CC Knockout cell: Method=shRNA knockdown; HGNC; 2910; DLL4.
ST Source(s): PubMed=27346199
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,13
ST D18S51: 10,16
ST D19S433: 12,14
ST D21S11: 30,34
ST D2S1338: 17
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13,16
ST FGA: 18,22
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U44 ! PBMC1-iPS4F1
SX Female
CA Induced pluripotent stem cell
//
ID PBMC1-iPS4F1 shSCR
AC CVCL_DQ82
RX PubMed=27346199;
ST Source(s): PubMed=27346199
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,13
ST D18S51: 10,16
ST D19S433: 12,14
ST D21S11: 30,34
ST D2S1338: 17
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13,16
ST FGA: 18,22
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 15,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9U44 ! PBMC1-iPS4F1
SX Female
CA Induced pluripotent stem cell
//
ID PBS-1
AC CVCL_1K16
RX DOI=10.4172/2157-7560.1000345;
RX PubMed=18524432;
RX PubMed=25903999;
CC Group: Bird cell line.
CC Group: Vaccine production cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_Y589 ! CHCC-OU2
CA Transformed cell line
//
ID PBS-12SF
AC CVCL_1K17
SY PBS-12 SF; PBS12SF
DR ATCC; PTA-8565
RX DOI=10.4172/2157-7560.1000345;
RX Patent=US8716016;
RX PubMed=18524432;
RX PubMed=21911025;
RX PubMed=25903999;
CC Group: Bird cell line.
CC Group: Vaccine production cell line.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Discontinued: ATCC; PTA-8565; probable.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_1K16 ! PBS-1
CA Transformed cell line
//
ID PC 61-5-3
AC CVCL_4550
SY PC 61 5.3; PC 61.5.3; PC615.3; PC 61
DR CLO; CLO_0008390
DR CLO; CLO_0008391
DR CLDB; cl5246
DR ATCC; TIB-222
DR BCRC; 60492
DR CCRID; 3131C0001000600052
DR ECACC; 88041902
DR IZSLER; BS Hy 23
CC Monoclonal antibody target: UniProtKB; P01590; Mouse Il2ra/Cd25.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PC-0199-BR
AC CVCL_Z242
RX PubMed=11562717;
CC Group: Insect cell line.
OX NCBI_TaxID=869071; ! Psorophora confinnis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PC-1 [Hamster]
AC CVCL_L900
SY PC1
DR BTO; BTO:0002747
RX PubMed=2000935;
RX PubMed=2539915;
RX PubMed=8382114;
RX PubMed=8863680;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
SX Male
CA Cancer cell line
//
ID PC-1 [Human lung carcinoma]
AC CVCL_S978
SY PC1
DR EFO; EFO_0002842
DR Cosmic; 1089227
DR Cosmic; 1571733
RX PubMed=3731100;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-1 [Human pancreatic carcinoma]
AC CVCL_S969
DR Cosmic; 965556
RX PubMed=2118052;
RX PubMed=14640107;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PC-1 [Plagionotus]
AC CVCL_Z274
SY Plagionotus Christophi-1
RX PubMed=18946707;
CC Group: Insect cell line.
CC Doubling time: 3.79 days (PubMed=18946707).
OX NCBI_TaxID=157322; ! Plagionotus christophi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PC-1.0
AC CVCL_L901
SY PC1.0
DR BTO; BTO:0002746
RX PubMed=1530768;
RX PubMed=8382114;
RX PubMed=8863680;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_L900 ! PC-1 [Hamster]
SX Male
CA Cancer cell line
//
ID PC-1.2
AC CVCL_L902
SY PC1.2
RX PubMed=1530768;
RX PubMed=8863680;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_L900 ! PC-1 [Hamster]
SX Male
CA Cancer cell line
//
ID PC-10
AC CVCL_7088
SY PC10
DR BTO; BTO:0004886
DR EFO; EFO_0002843
DR CGH-DB; 190-1
DR CGH-DB; 9175-4
DR ChEMBL-Cells; CHEMBL3307345
DR ChEMBL-Targets; CHEMBL614234
DR Cosmic; 713859
DR Cosmic; 801575
DR Cosmic; 844813
DR Cosmic; 876168
DR Cosmic; 917999
DR Cosmic; 929155
DR Cosmic; 1089228
DR Cosmic; 1219087
DR Cosmic; 1239915
DR Cosmic; 1571736
DR Cosmic; 2125280
RX PubMed=3731100;
RX PubMed=11005564;
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=23381221;
RX PubMed=25120651;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PC-12
AC CVCL_S979
SY PC12
RX PubMed=3731100;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-12 Adh
AC CVCL_F659
SY PC-12 ADH; PC-12Adh; PC-12 Adherent
DR ATCC; CRL-1721.1
DR BCRJ; 0202
WW http://www.atcc.org/support/faqs/2ef3f/PC12%20Cells%20%20ATCC%20CRL1721%20vs%20ATCC%20CRL17211-783.aspx
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC-12 HD-Q23 cell 14
AC CVCL_AU97
DR Ximbio; 152416
RX PubMed=11532992;
CC Transfected with: HGNC; 4851; HTT (1st exon with 23-Q run).
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC-12 HD-Q23 cell 7
AC CVCL_AU98
DR Ximbio; 152416
RX PubMed=11532992;
CC Transfected with: HGNC; 4851; HTT (1st exon with 23-Q run).
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC-12 HD-Q74 cell 10
AC CVCL_AU99
DR Ximbio; 152417
RX PubMed=11532992;
CC Transfected with: HGNC; 4851; HTT (1st exon with 74-Q run).
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC-12 HD-Q74 cell 1b
AC CVCL_AV00
DR Ximbio; 152417
RX PubMed=11532992;
CC Transfected with: HGNC; 4851; HTT (1st exon with 74-Q run).
CC Transfected with: UniProtKB; P42212; GFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC-12TG
AC CVCL_5574
SY PC12TG
DR IFO; IFO50496
RX PubMed=7763725;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC-13
AC CVCL_B259
SY PC13
DR CGH-DB; 9184-4
DR ChEMBL-Cells; CHEMBL3307865
DR ChEMBL-Targets; CHEMBL614100
DR Cosmic; 801576
DR Cosmic; 809128
DR Cosmic; 844835
DR Cosmic; 876173
DR Cosmic; 917996
DR Cosmic; 946059
DR Cosmic; 1239926
DR Cosmic; 2125281
RX PubMed=3731100;
RX PubMed=4094096;
RX PubMed=11005564;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=19472407;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-14
AC CVCL_1640
SY PC14
DR BTO; BTO:0002877
DR CLO; CLO_0008394
DR EFO; EFO_0002844
DR CLDB; cl3880
DR CCLE; PC14_LUNG
DR CGH-DB; 205-1
DR CGH-DB; 9169-4
DR ChEMBL-Cells; CHEMBL3307306
DR ChEMBL-Targets; CHEMBL614140
DR Cosmic; 753608
DR Cosmic; 801577
DR Cosmic; 876138
DR Cosmic; 897744
DR Cosmic; 932924
DR Cosmic; 946060
DR Cosmic; 1239897
DR Cosmic; 1571737
DR Cosmic; 1656894
DR Cosmic; 1995612
DR Cosmic; 2125282
DR Cosmic-CLP; 753608
DR ECACC; 90071810
DR GDSC; 753608
DR GEO; GSM827410
DR GEO; GSM887505
DR GEO; GSM888587
DR GEO; GSM1670338
DR RCB; RCB0446
RX PubMed=4094096;
RX PubMed=11005564;
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=19472407;
RX PubMed=22313637;
RX PubMed=22460905;
RX PubMed=25120651;
RX PubMed=27397505;
WW http://www.brc.riken.jp/lab/cell/english/rcb0446_announce.shtml
CC Problematic cell line: Contaminated. Shown to be a PC-9 derivative.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB0446; true.
ST Source(s): Cosmic-CLP; ECACC; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 9
ST D18S51: 15
ST D21S11: 29,30
ST D5S818: 11
ST D7S820: 10,11 (Cosmic-CLP)
ST D7S820: 10 (ECACC; PubMed=11416159)
ST D8S1179: 11,15
ST FGA: 23,25
ST TH01: 7
ST TPOX: 11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-14-PM4
AC CVCL_9W69
SY PC-14 PM4
RX PubMed=9563004;
CC Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC Caution: We are not certain that PC-14-PM4 and PC14PE6 are identical.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1640 ! PC-14
SX Male
CA Cancer cell line
//
ID PC-2 [Human pancreatic carcinoma]
AC CVCL_S970
SY PC2
DR Cosmic; 965557
RX PubMed=2118052;
RX PubMed=11169957;
RX PubMed=14640107;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-2 [Rat liver]
AC CVCL_1G62
RX PubMed=4277389;
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1G61 ! RLN-E7
SX Male
CA Transformed cell line
//
ID PC-295
AC CVCL_4876
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=136
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-3
AC CVCL_0035
SY PC3; PC.3
DR BTO; BTO:0001061
DR CLO; CLO_0008395
DR CLO; CLO_0051535
DR EFO; EFO_0002074
DR MCCL; MCC:0000380
DR CLDB; cl3881
DR CLDB; cl3883
DR ATCC; CRL-1435
DR ATCC; CRL-7934
DR BCRC; 60122
DR BCRJ; 0269
DR BioSample; SAMN01821588
DR BioSample; SAMN01821653
DR BioSample; SAMN01821713
DR BioSample; SAMN03472063
DR CCLE; PC3_PROSTATE
DR CCRID; 3111C0001CCC000115
DR CCRID; 3131C0001000700041
DR CCRID; 3131C0001000700158
DR CCRID; 3142C0001000000113
DR ChEMBL-Cells; CHEMBL3307570
DR ChEMBL-Targets; CHEMBL390
DR CLS; 300312/p1699_PC-3
DR Cosmic; 688118
DR Cosmic; 704849
DR Cosmic; 713868
DR Cosmic; 719680
DR Cosmic; 721366
DR Cosmic; 721556
DR Cosmic; 755297
DR Cosmic; 759894
DR Cosmic; 801350
DR Cosmic; 809225
DR Cosmic; 850414
DR Cosmic; 869157
DR Cosmic; 873002
DR Cosmic; 875892
DR Cosmic; 876396
DR Cosmic; 897455
DR Cosmic; 905934
DR Cosmic; 911997
DR Cosmic; 918502
DR Cosmic; 920968
DR Cosmic; 921048
DR Cosmic; 922551
DR Cosmic; 923957
DR Cosmic; 943175
DR Cosmic; 948379
DR Cosmic; 949249
DR Cosmic; 974299
DR Cosmic; 1028650
DR Cosmic; 1028702
DR Cosmic; 1071477
DR Cosmic; 1075273
DR Cosmic; 1092627
DR Cosmic; 1172628
DR Cosmic; 1175888
DR Cosmic; 1188436
DR Cosmic; 1212489
DR Cosmic; 1219448
DR Cosmic; 1305380
DR Cosmic; 1312367
DR Cosmic; 1330910
DR Cosmic; 1436048
DR Cosmic; 1689714
DR Cosmic; 1995613
DR Cosmic; 1998469
DR Cosmic; 2301588
DR Cosmic; 2580130
DR Cosmic; 2585153
DR Cosmic; 2585230
DR Cosmic-CLP; 905934
DR DSMZ; ACC-465
DR ECACC; 90112714
DR ENCODE; ENCBS420VDY
DR ENCODE; ENCBS451OVM
DR ENCODE; ENCBS504WVV
DR ENCODE; ENCBS596CTT
DR ENCODE; ENCBS608AAA
DR ENCODE; ENCBS609AAA
DR GDSC; 905934
DR GEO; GSM50225
DR GEO; GSM50289
DR GEO; GSM91930
DR GEO; GSM142459
DR GEO; GSM142460
DR GEO; GSM482670
DR GEO; GSM525804
DR GEO; GSM595615
DR GEO; GSM648823
DR GEO; GSM750835
DR GEO; GSM784792
DR GEO; GSM799370
DR GEO; GSM799433
DR GEO; GSM847110
DR GEO; GSM844675
DR GEO; GSM844674
DR GEO; GSM887506
DR GEO; GSM888588
DR GEO; GSM1153442
DR GEO; GSM1181274
DR GEO; GSM1181303
DR GEO; GSM1374817
DR GEO; GSM1374818
DR GEO; GSM1670339
DR ICLC; HTL97018
DR IZSLER; BS TCL 175
DR JCRB; JCRB9110
DR KCB; KCB 200725YJ
DR KCLB; 21435
DR LINCS; 50454
DR NCBI_Iran; C427
DR PRIDE; PRD000228
DR PRIDE; PRD000597
DR PRIDE; PXD002107
DR PRIDE; PXD003105
DR RCB; RCB2145
DR SKY/M-FISH/CGH; 2799
DR TKG; TKG 0600
DR TOKU-E; 2868
DR Wikidata; Q7118483
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=447482;
RX PubMed=2041050;
RX PubMed=6244232;
RX PubMed=8687134;
RX PubMed=9018337;
RX PubMed=10702678;
RX PubMed=10754530;
RX PubMed=10972993;
RX PubMed=11135431;
RX PubMed=11172901;
RX PubMed=11414198;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=15486987;
RX PubMed=17088437;
RX PubMed=17254797;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=26256267;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/PC3
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=53
WW http://www.proteinatlas.org/learn/cellines
WW http://capcelllines.ca/details.asp?id=37
WW http://www.addexbio.com/productdetail?pid=61
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-96.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 27.1 hours (DTP); 25 hours (ATCC); ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C427.
CC Discontinued: ATCC; CRL-7934; true.
CC Derived from metastatic site: Bone.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D18S51: 14,15 (CLS; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543; PubMed=25877200)
ST D18S51: 13,14 (PubMed=17254797)
ST D19S433: 14
ST D21S11: 29,31.2 (CLS; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543; PubMed=25877200)
ST D21S11: 29,31 (PubMed=17254797)
ST D2S1338: 18,20
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 8,11 (ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200; RCB)
ST D7S820: 8 (PubMed=17254797; TKG)
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9
ST Penta E: 10,17
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-3 [Human lung carcinoma]
AC CVCL_S982
SY PC-3; PC3; JPC-3
DR BioSample; SAMN03471064
DR Cosmic; 801572
DR Cosmic; 844833
DR Cosmic; 876135
DR Cosmic; 917973
DR Cosmic; 929150
DR Cosmic; 932923
DR Cosmic; 946056
DR Cosmic; 1154599
DR Cosmic; 1239894
DR Cosmic; 1571734
DR Cosmic; 1995465
DR Cosmic; 2125283
DR Cosmic-CLP; 1240202
DR GDSC; 1240202
DR GEO; GSM827580
DR GEO; GSM1670340
DR JCRB; JCRB0077
RX PubMed=9290701;
RX PubMed=11005564;
RX PubMed=19472407;
RX PubMed=27397505;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12,15
ST D13S317: 11,12
ST D16S539: 10
ST D5S818: 12
ST D7S820: 11,13
ST TH01: 9
ST TPOX: 8
ST vWA: 14
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PC-3 [Human pancreatic carcinoma]
AC CVCL_X130
DR Cosmic; 965558
RX PubMed=14640107;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-3 D12
AC CVCL_4Y40
RX PubMed=21982118;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3 D8
AC CVCL_4Y41
RX PubMed=21982118;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3 MC
AC CVCL_6E88
RX PubMed=1773917;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3 MK
AC CVCL_6E89
SY PC-3 Metastasis in Knee bone
RX PubMed=1773917;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3 ML
AC CVCL_6E90
SY PC3-ML; PC-3 Metastasis in Lumbar vertebrae
RX PubMed=1352184;
RX PubMed=1773917;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3 MR
AC CVCL_6E91
SY PC-3 Metastasis in Rib cartilage
RX PubMed=1773917;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3-1A
AC CVCL_4877
RX PubMed=7176035;
WW http://capcelllines.ca/details.asp?id=75
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3-Luc
AC CVCL_J265
DR JCRB; JCRB1406
DR JCRB; NIHS0656
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0656; true.
CC Derived from metastatic site: Bone.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3-luc2
AC CVCL_5J26
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124089.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3-luc2-GFP
AC CVCL_5J29
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Transfected with: UniProtKB; P42212; GFP.
CC Discontinued: PerkinElmer; Catalog number 133416.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3-Red-FLuc
AC CVCL_5J08
SY PC3-Red-FLuc; PC3 Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW128444
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3-Red-FLuc-GFP
AC CVCL_5J09
SY PC3-Red-FLuc-GFP; PC3 Red-FLuc-GFP
WW http://www.perkinelmer.com/Catalog/Product/ID/BW133416
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Transfected with: UniProtKB; P42212; GFP.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3/nKR
AC CVCL_M060
DR KCLB; 60069
CC Derived from metastatic site: Bone.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 8,11
ST FGA: 24
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-310
AC CVCL_4878
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=128
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-324
AC CVCL_4879
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=137
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-329
AC CVCL_4880
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=138
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-339
AC CVCL_4881
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=139
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-346
AC CVCL_4882
SY PC346
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=140
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-346C
AC CVCL_4883
SY PC346C
DR BTO; BTO:0002831
DR GEO; GSM539100
DR GEO; GSM539101
DR GEO; GSM539102
DR GEO; GSM539103
DR GEO; GSM539104
DR GEO; GSM539105
DR GEO; GSM539106
DR GEO; GSM539107
DR GEO; GSM539108
DR GEO; GSM539109
DR GEO; GSM539110
DR GEO; GSM539111
DR GEO; GSM1374819
RX PubMed=14518029;
RX PubMed=15900601;
RX PubMed=20976069;
CC Characteristics: Optimal proliferation of the cell line requires androgens and is inhibited by the antiandrogen hydroxyflutamide.
CC Omics: Transcriptome analysis.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4882 ! PC-346
SX Male
CA Cancer cell line
//
ID PC-374
AC CVCL_4884
RX PubMed=8780407;
WW http://capcelllines.ca/details.asp?id=141
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-3H
AC CVCL_B289
SY PC3H
DR BTO; BTO:0004853
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3M
AC CVCL_9555
SY PC3-M; PC-3/M; PC3M; Pc3M
DR BTO; BTO:0005220
DR Cosmic; 1945877
DR KCLB; 80020
DR TOKU-E; 3851
RX PubMed=447482;
RX PubMed=7471073;
CC Derived from metastatic site: Bone.
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 8,11
ST FGA: 24
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3M-2B4
AC CVCL_G256
SY PC-3M 2B4; PC3M-2B4; 2B4-L
DR CCRID; 3111C0001CCC000200
RX PubMed=18060641;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-IE8
AC CVCL_G257
SY PC-3M IE8; PC3M-IE8; 1E8-H
DR CCRID; 3111C0001CCC000199
RX PubMed=18060641;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-LN1
AC CVCL_L155
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-LN2
AC CVCL_L156
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L155 ! PC-3M-LN1
SX Male
CA Cancer cell line
//
ID PC-3M-LN3
AC CVCL_L157
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L156 ! PC-3M-LN2
SX Male
CA Cancer cell line
//
ID PC-3M-LN4
AC CVCL_D578
SY PC3M-LN4; PC3MLN4
DR BTO; BTO:0005221
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L157 ! PC-3M-LN3
SX Male
CA Cancer cell line
//
ID PC-3M-luc-C6
AC CVCL_D577
RX PubMed=14713107;
RX PubMed=14713108;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: PerkinElmer; Catalog number 119270.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-luc2
AC CVCL_5J25
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 128444.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-Red-FLuc
AC CVCL_5J10
SY PC3M-Red-FLuc; PC3M Red-FLuc
WW http://www.perkinelmer.com/Catalog/Product/ID/BW124089
CC Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-Pro1
AC CVCL_L158
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3M-Pro2
AC CVCL_L159
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L158 ! PC-3M-Pro1
SX Male
CA Cancer cell line
//
ID PC-3M-Pro3
AC CVCL_L301
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L159 ! PC-3M-Pro2
SX Male
CA Cancer cell line
//
ID PC-3M-Pro4
AC CVCL_D579
SY PC-3M-Pro-4; PC3MPro4; PC3MPRO4
DR BTO; BTO:0005222
RX PubMed=9816342;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L301 ! PC-3M-Pro3
SX Male
CA Cancer cell line
//
ID PC-3/MA2
AC CVCL_6E87
SY PC-3 MA2
RX PubMed=447482;
RX PubMed=7459854;
RX PubMed=10754530;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC-3N
AC CVCL_4886
SY PC3N
RX PubMed=10487836;
WW http://capcelllines.ca/details.asp?id=169
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-3U
AC CVCL_0482
DR MCCL; MCC:0000381
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-4
AC CVCL_X128
DR Cosmic; 965559
RX PubMed=14640107;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-44
AC CVCL_B258
SY PC44; PC 44
DR Cosmic; 873001
DR Cosmic; 948378
RX PubMed=11169957;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-5
AC CVCL_M124
RX PubMed=8200854;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-53
AC CVCL_W802
SY PC53
DR Cosmic; 2491090
RX PubMed=2314113;
RX PubMed=9067587;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W803 ! PC-53A
SX Female
CA Cancer cell line
//
ID PC-53A
AC CVCL_W803
SY PC53A
RX PubMed=2314113;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W802 ! PC-53
SX Female
CA Cancer cell line
//
ID PC-6
AC CVCL_C002
SY PC6
DR EFO; EFO_0002845
DR CGH-DB; 105-1
DR CGH-DB; 9051-4
DR ChEMBL-Cells; CHEMBL3307571
DR ChEMBL-Targets; CHEMBL614235
DR Cosmic; 1212199
DR Cosmic; 1571745
RX PubMed=2982333;
RX PubMed=3731100;
RX PubMed=12107105;
RX PubMed=15185009;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-6/SN2-5
AC CVCL_S850
RX PubMed=9259410;
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C002 ! PC-6
CA Cancer cell line
//
ID PC-6/TAX1-1
AC CVCL_S849
SY PC-6/Tax1-1
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C002 ! PC-6
CA Cancer cell line
//
ID PC-7
AC CVCL_A786
SY PC7
DR BTO; BTO:0005440
DR EFO; EFO_0002846
DR Cosmic; 801573
DR Cosmic; 844834
DR Cosmic; 876136
DR Cosmic; 918000
DR Cosmic; 946057
DR Cosmic; 1239895
DR Cosmic; 2125284
RX DOI=10.5795/jjscc.24.451;
RX PubMed=3731100;
RX PubMed=11005564;
RX PubMed=19472407;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-7 [Human pancreatic carcinoma]
AC CVCL_X129
DR Cosmic; 965560
RX PubMed=14640107;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-7/CPT
AC CVCL_A787
RX PubMed=2168285;
CC Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A786 ! PC-7
SX Male
CA Cancer cell line
//
ID PC-8
AC CVCL_4Z01
DR ChEMBL-Cells; CHEMBL3307866
DR ChEMBL-Targets; CHEMBL614101
RX PubMed=1367039;
RX PubMed=3902783;
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-82
AC CVCL_4887
SY PC 82
DR Cosmic; 704851
RX PubMed=7279800;
WW http://capcelllines.ca/details.asp?id=135
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-9
AC CVCL_B260
SY PC9; PC-9/S1; PC-9S1
DR BTO; BTO:0005518
DR CLO; CLO_0050067
DR EFO; EFO_0002847
DR BCRJ; 0331
DR BioSample; SAMN03470946
DR ChEMBL-Cells; CHEMBL3307867
DR ChEMBL-Targets; CHEMBL614102
DR Cosmic; 713867
DR Cosmic; 801574
DR Cosmic; 876137
DR Cosmic; 897746
DR Cosmic; 911753
DR Cosmic; 915329
DR Cosmic; 917985
DR Cosmic; 929156
DR Cosmic; 946058
DR Cosmic; 1001658
DR Cosmic; 1002731
DR Cosmic; 1047092
DR Cosmic; 1128254
DR Cosmic; 1146943
DR Cosmic; 1239896
DR Cosmic; 1336875
DR Cosmic; 1571735
DR Cosmic; 1656893
DR Cosmic; 1731370
DR Cosmic; 1745414
DR Cosmic; 2015224
DR Cosmic; 2125285
DR ENCODE; ENCBS177ANS
DR ENCODE; ENCBS480XRH
DR ENCODE; ENCBS761VSF
DR ENCODE; ENCBS987JQH
DR GEO; GSM434290
DR GEO; GSM481160
DR GEO; GSM784274
DR GEO; GSM794406
DR GEO; GSM827407
DR GEO; GSM1374821
DR IGRhCellID; PC9GEO
DR LINCS; 50038
DR PRIDE; PXD002224
DR RCB; RCB4455
RX DOI=10.5795/jjscc.24.451;
RX PubMed=4094096;
RX PubMed=11005564;
RX PubMed=11078804;
RX PubMed=19472407;
RX PubMed=22313637;
RX PubMed=23733853;
RX PubMed=26202522;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
CC Omics: Deep membrane proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 9
ST D18S51: 15
ST D19S433: 13,15.2
ST D21S11: 30
ST D2S1338: 19,20
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 11,15
ST FGA: 23
ST Penta D: 13
ST Penta E: 11
ST TH01: 7
ST TPOX: 11
ST vWA: 17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC-9-GR-high
AC CVCL_S706
DR Cosmic; 1896429
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9-GR-step
AC CVCL_S707
DR Cosmic; 1896428
RX PubMed=23542356;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/BR
AC CVCL_T015
SY PC-9BR; PC-9/BRc1; PC-9BRc1
DR Cosmic; 2015227
RX PubMed=21734175;
RX PubMed=23733853;
CC Selected for resistance to: ChEBI; CHEBI:61390; Afatinib (BIBW-2992).
CC Omics: Deep RNAseq analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/DR1
AC CVCL_DI33
SY PC-9 DR1
DR GEO; GSM481167
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/DR2
AC CVCL_DI34
SY PC-9 DR2
DR GEO; GSM481168
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/DR3
AC CVCL_DI35
SY PC-9 DR3
DR GEO; GSM481169
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/DR4
AC CVCL_DI36
SY PC-9 DR4
DR GEO; GSM481170
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/DR5
AC CVCL_DI37
SY PC-9 DR5
DR GEO; GSM481171
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/DR6
AC CVCL_DI38
SY PC-9 DR6
DR GEO; GSM481172
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/ER/WR
AC CVCL_DG28
RX PubMed=26980747;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/ER1
AC CVCL_D778
SY PC-9-ER1; PC9-ER1
DR Cosmic; 1731371
RX PubMed=22815900;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/ER3
AC CVCL_D726
SY PC-9-ER3
DR Cosmic; 1745415
RX PubMed=22712764;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/f14
AC CVCL_U149
DR Cosmic; 915331
RX PubMed=11506965;
RX PubMed=17982658;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/f9
AC CVCL_U150
DR Cosmic; 915330
RX PubMed=11078804;
RX PubMed=11506965;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR1
AC CVCL_DI28
SY PC-9 GR1
DR GEO; GSM481161
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR2
AC CVCL_DI29
SY PC-9 GR2
DR GEO; GSM481162
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR3
AC CVCL_DI30
SY PC-9 GR3
DR GEO; GSM481163
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR4
AC CVCL_DH34
SY PC-9 GR4; PC9GR4; GR4
DR GEO; GSM925738
DR GEO; GSM481164
RX PubMed=20118985;
RX PubMed=22961667;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR5
AC CVCL_DI31
SY PC-9 GR5
DR GEO; GSM481165
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR6
AC CVCL_DI32
SY PC-9 GR6
DR GEO; GSM481166
RX PubMed=20118985;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/GR/WR
AC CVCL_DG27
RX PubMed=26980747;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/IR
AC CVCL_DP47
SY PC-9-IR; PC9-IR; PC9/IR; PC9IR; PC9/gef
DR PRIDE; PXD002224
RX PubMed=26202522;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Omics: Deep membrane proteome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/R
AC CVCL_S750
SY PC-9R; PC-9/ER; PC-9ER
DR Cosmic; 1890454
DR Cosmic; 2015225
RX PubMed=21734175;
RX PubMed=22773810;
RX PubMed=23733853;
CC Selected for resistance to: ChEBI; CHEBI:114785; Erlotinib.
CC Omics: Deep RNAseq analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/S2
AC CVCL_T016
SY PC-9S2
DR Cosmic; 2015226
RX PubMed=23733853;
CC Omics: Deep RNAseq analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/WR
AC CVCL_DG29
RX PubMed=26980747;
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-9/WZR09
AC CVCL_DG30
SY WZR09; WZR9
DR GEO; GSM925739
RX PubMed=22961667;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/WZR10
AC CVCL_DG31
SY WZR10
DR GEO; GSM925740
RX PubMed=22961667;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/WZR11
AC CVCL_DG32
SY WZR11
DR GEO; GSM925741
RX PubMed=22961667;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/WZR12
AC CVCL_DG33
SY WZR12
DR GEO; GSM925742
RX PubMed=22961667;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Selected for resistance to: ChEBI; CHEBI:61400; WZ4002.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH34 ! PC-9/GR4
SX Male
CA Cancer cell line
//
ID PC-9/ZD
AC CVCL_V337
SY PC9 ZD
DR GEO; GSM1374824
DR Cosmic; 911754
RX PubMed=15761868;
CC Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).
CC Omics: Transcriptome analysis.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
SX Male
CA Cancer cell line
//
ID PC-93
AC CVCL_4888
DR BioSample; SAMN03151752
RX PubMed=6602397;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=20143388;
WW http://capcelllines.ca/details.asp?id=142
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=14518029, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID PC-EN
AC CVCL_X063
DR Cosmic; 965561
RX PubMed=11869555;
RX PubMed=14640107;
DI NCIt; C45843; Pancreatic carcinoma with mixed differentiation
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PC-J
AC CVCL_X641
DR BTO; BTO:0004191
RX PubMed=18649734;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC-MDS
AC CVCL_1Q81
DR BioSample; SAMN03151810
RX PubMed=17350682;
RX PubMed=17917092;
RX PubMed=19344951;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=19344951).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
SX Female
CA Cancer cell line
//
ID PC/AA
AC CVCL_B261
RX DOI=10.1007/978-1-4612-0411-4_28;
RX PubMed=2369746;
RX PubMed=6746117;
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC/AA/C1
AC CVCL_IQ04
SY AA/C1
RX DOI=10.1007/978-1-4612-0411-4_28;
RX PubMed=2369746;
RX PubMed=16465285;
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B261 ! PC/AA
SX Male
CA Cancer cell line
//
ID PC/AA/C1/SB
AC CVCL_IQ05
SY AA/C1/SB
RX DOI=10.1007/978-1-4612-0411-4_28;
RX PubMed=2369746;
CC Selected for resistance to: ChEBI; CHEBI:64103; Sodium butyrate.
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IQ04 ! PC/AA/C1
SX Male
CA Cancer cell line
//
ID PC/AA/C1/SB10
AC CVCL_IQ06
SY PC/AA/C1/SB/10; AA/C1/SB10
RX DOI=10.1007/978-1-4612-0411-4_28;
RX PubMed=2369746;
RX PubMed=16465285;
CC Selected for resistance to: ChEBI; CHEBI:64103; Sodium butyrate.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IQ05 ! PC/AA/C1/SB
SX Male
CA Cancer cell line
//
ID PC/BH
AC CVCL_IQ07
RX PubMed=6746117;
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PC/BH/C1
AC CVCL_IQ08
RX PubMed=16465285;
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_IQ07 ! PC/BH
SX Female
CA Cancer cell line
//
ID PC/FF
AC CVCL_IQ09
RX PubMed=6746117;
DI NCIt; C5673; Colorectal adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PC/JW
AC CVCL_B262
SY PCJW
DR Cosmic; 948837
DR Cosmic; 1043823
DR Cosmic; 1312308
DR GEO; GSM1374825
RX PubMed=6746117;
RX PubMed=20606684;
CC Omics: Transcriptome analysis.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC/JW/FI
AC CVCL_IQ10
SY PC/JW/Feeder Independent
RX PubMed=16465285;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B262 ! PC/JW
SX Male
CA Cancer cell line
//
ID PC1
AC CVCL_6B05
SY Proximal Caput 1
RX PubMed=12399533;
RX PubMed=17233813;
WW https://www.abmgood.com/Immortalized-Mouse-Proximal-Caput-Epididymal-Epithelial-Cell-Line-(PC1)--T0598.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Conditionally immortalized cell line
//
ID PC12
AC CVCL_0481
SY PC-12; PC 12
DR BTO; BTO:0001009
DR CLO; CLO_0008392
DR CLO; CLO_0050821
DR EFO; EFO_0001225
DR MCCL; MCC:0000379
DR CLDB; cl3876
DR CLDB; cl3877
DR CLDB; cl3878
DR CLDB; cl4922
DR CLDB; cl5245
DR ATCC; CRL-1721
DR BCRC; 60048
DR BCRJ; 0203
DR CCRID; 3111C0001CCC000024
DR CCRID; 3131C0001001000003
DR CCRID; 3142C0001000000006
DR CCRID; 3153C0001000000030
DR ChEMBL-Cells; CHEMBL3307976
DR ChEMBL-Targets; CHEMBL612556
DR CLS; 500311/p701_PC-12
DR DSMZ; ACC-159
DR ECACC; 88022401
DR ICLC; ATL98004
DR IFO; IFO50278
DR IZSLER; BS TCL 91
DR JCRB; JCRB0733
DR KCB; KCB 93033YJ
DR KCB; KCB 200735YJ
DR KCB; KCB 200736YJ
DR KCLB; 21721
DR MeSH; D016716
DR NCBI_Iran; C153
DR RCB; RCB0009
DR TOKU-E; 2867
DR TOKU-E; 3554
DR Wikidata; Q7118481
RX PubMed=682602;
RX PubMed=1065897;
RX PubMed=2493070;
RX PubMed=15541571;
RX PubMed=16223334;
RX PubMed=18005394;
RX PubMed=22538498;
WW https://en.wikipedia.org/wiki/PC12_cell
WW http://www.atcc.org/support/faqs/2ef3f/PC12%20Cells%20%20ATCC%20CRL1721%20vs%20ATCC%20CRL17211-783.aspx
WW http://www.cells-talk.com/index.php/page/copelibrary?key=PC12
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-11.html
WW http://php.med.unsw.edu.au/cellbiology/index.php?title=Cells_-_PC12
CC Characteristics: Responds reversibly to NGF by induction of a neuronal phenotype.
CC Doubling time: ~50-60 hours (DSMZ); 92 hours (ECACC).
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID PC12 HTT-SW2-Q145 clone 14
AC CVCL_DN60
SY CHDI-90000424; CH00288
DR Coriell; CH00288
CC Transfected with: HGNC; 4851; HTT (with 145-Q run).
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 HTT-SW2-Q145-TagRFP clone 5
AC CVCL_DN61
SY CHDI-90000425; CH00289
DR Coriell; CH00289
CC Transfected with: HGNC; 4851; HTT (with 145-Q run).
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 HTT-SW2-Q23 clone 28
AC CVCL_DN62
SY CHDI-90000415; CH00284
DR Coriell; CH00284
CC Transfected with: HGNC; 4851; HTT (with 23-Q run).
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 HTT-SW2-Q23-TagRFP clone 34
AC CVCL_DN63
SY CHDI-90000417; CH00285
DR Coriell; CH00285
CC Transfected with: HGNC; 4851; HTT (with 23-Q run).
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 HTT-SW2-Q73 clone 29
AC CVCL_DN64
SY CHDI-90000419; CH00286
DR Coriell; CH00286
CC Transfected with: HGNC; 4851; HTT (with 73-Q run).
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 HTT-SW2-Q73-TagRFP clone 17
AC CVCL_DN65
SY CHDI-90000422; CH00287
DR Coriell; CH00287
CC Transfected with: HGNC; 4851; HTT (with 73-Q run).
CC Transfected with: UniProtKB; Q9U6Y8; RFP.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 Tet-Off
AC CVCL_V361
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12 Tet-On
AC CVCL_V333
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_Cell_Lines
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12-615
AC CVCL_C130
SY PC12(615); PC-12 615; PC12 (615); 615
RX PubMed=1384575;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12-AC
AC CVCL_J442
DR BTO; BTO:0003060
RX PubMed=15456758;
WW http://137.122.232.177/Protocols/PC12CultureDifferentiation.pdf
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12-F7
AC CVCL_T752
DR CLO; CLO_0050822
DR RCB; RCB2800
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12-G11
AC CVCL_T753
DR CLO; CLO_0050823
DR RCB; RCB2801
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12.P3
AC CVCL_5573
SY PC-12.P3
DR JCRB; JCRB0130
DR JCRB; JCRB0130.1
DR JCRB; NIHS0197
DR JCRB; NIHS0373
CC Discontinued: JCRB; NIHS0197; true.
CC Discontinued: JCRB; NIHS0373; true.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12D
AC CVCL_4681
SY PC-12D
DR BTO; BTO:0001676
RX PubMed=2493070;
RX PubMed=3033256;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12HS
AC CVCL_J438
SY PC12 clone HS
DR JCRB; JCRB0266
DR JCRB; NIHS0375
RX PubMed=1493541;
CC Discontinued: JCRB; NIHS0375; true.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12HS.P3
AC CVCL_J439
SY PC12 clone HS.P3
DR JCRB; JCRB0263.1
DR JCRB; NIHS0374
CC Discontinued: JCRB; NIHS0374; true.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_J438 ! PC12HS
SX Male
CA Cancer cell line
//
ID PC12IS
AC CVCL_J440
SY PC12 clone IS
DR JCRB; JCRB0268
DR JCRB; NIHS0377
RX PubMed=1493541;
CC Discontinued: JCRB; NIHS0377; true.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12K
AC CVCL_4925
SY PC-12K
DR BTO; BTO:0005061
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12MS
AC CVCL_J441
SY PC12 clone MS
DR JCRB; JCRB0267
DR JCRB; NIHS0376
RX PubMed=1493541;
CC Discontinued: JCRB; NIHS0376; true.
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12nnr14
AC CVCL_C126
SY PC12 not nerve growth factor responsive clone 14
RX PubMed=3005338;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12nnr3
AC CVCL_C127
SY PC12 not nerve growth factor responsive clone 3
RX PubMed=3005338;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12nnr5
AC CVCL_C128
SY PC12 not nerve growth factor responsive clone 5
RX PubMed=3005338;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC12nnr6
AC CVCL_C129
SY PC12 not nerve growth factor responsive clone 6
RX PubMed=3005338;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC14Br
AC CVCL_9W71
RX PubMed=10987313;
CC Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1640 ! PC-14
SX Male
CA Cancer cell line
//
ID PC14HM
AC CVCL_J032
RX PubMed=22922681;
CC Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1640 ! PC-14
SX Male
CA Cancer cell line
//
ID PC14PE6
AC CVCL_9W70
SY PC14-PE6; PC14/PE6
RX PubMed=10741721;
RX PubMed=10987313;
RX PubMed=19771249;
CC Problematic cell line: Contaminated. Parent cell line (PC-14) has been shown to be a PC-9 derivative.
CC Caution: We are not certain that PC-14-PM4 and PC14PE6 are identical.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1640 ! PC-14
SX Male
CA Cancer cell line
//
ID PC14PE6/AS2
AC CVCL_9W72
RX PubMed=16518408;
CC Problematic cell line: Contaminated. Grand-parent cell line (PC-14) has been shown to be a PC-9 derivative.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9W70 ! PC14PE6
SX Male
CA Cancer cell line
//
ID PC1CpTr
AC CVCL_1G93
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=35
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC035.
OX NCBI_TaxID=586851; ! Pomacentrus caeruleus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PC1F1Ex
AC CVCL_1G94
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=36
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC036.
OX NCBI_TaxID=586851; ! Pomacentrus caeruleus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PC1L1Tr
AC CVCL_1G95
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=37
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC037.
OX NCBI_TaxID=586851; ! Pomacentrus caeruleus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PC2
AC CVCL_0483
AS CVCL_7089
SY PC12/PC2
DR MCCL; MCC:0000382
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC21A1
AC CVCL_1Q49
RX PubMed=6641706;
RX PubMed=6686281;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C522 ! 2102EP
HI CVCL_1Q47 ! PCC4AO
CA Hybrid cell line
//
ID PC23
AC CVCL_W864
RX PubMed=3499854;
DI NCIt; C7729; Squamous cell carcinoma of the penis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PC3-MM2
AC CVCL_4885
SY PC3MM2; PC-3MM2; PC-3 MM2; PC-3M-MM2
DR BTO; BTO:0005071
DR KCLB; 80021
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9555 ! PC-3M
SX Male
CA Cancer cell line
//
ID PC3.1
AC CVCL_U140
DR CLO; CLO_0050388
DR RCB; RCB2306
RX PubMed=1409580;
CC Monoclonal antibody target: UniProtKB; Q64361; Rat Lxn.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID PC346DCC
AC CVCL_IP21
DR GEO; GSM539100
DR GEO; GSM539101
DR GEO; GSM539102
DR GEO; GSM539103
RX PubMed=15900601;
RX PubMed=20976069;
CC Characteristics: Proliferation of this cell line is androgen independent.
CC Omics: Transcriptome analysis.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4883 ! PC-346C
SX Male
CA Cancer cell line
//
ID PC346Flu1
AC CVCL_IP22
SY PC346FLU1
DR GEO; GSM539104
DR GEO; GSM539105
DR GEO; GSM539106
DR GEO; GSM539107
DR GEO; GSM1374820
RX PubMed=15900601;
RX PubMed=20976069;
CC Characteristics: Proliferation of this cell line is androgen independent.
CC Omics: Transcriptome analysis.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4883 ! PC-346C
SX Male
CA Cancer cell line
//
ID PC346Flu2
AC CVCL_IP23
DR GEO; GSM539108
DR GEO; GSM539109
DR GEO; GSM539110
DR GEO; GSM539111
RX PubMed=15900601;
RX PubMed=20976069;
CC Characteristics: Proliferation of this cell line is androgen independent.
CC Characteristics: Has a AR p.Thr878Ala mutation in the single copy of the AR gene of this cell line.
CC Omics: Transcriptome analysis.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4883 ! PC-346C
SX Male
CA Cancer cell line
//
ID PC3B1
AC CVCL_D689
SY PC3-B1
DR BTO; BTO:0005121
RX PubMed=19491258;
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PC4
AC CVCL_7090
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC6
AC CVCL_7091
SY PC-6; PC 6
DR BTO; BTO:0002752
RX PubMed=8396168;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-94.html
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0481 ! PC12
SX Male
CA Cancer cell line
//
ID PC6-1
AC CVCL_7092
DR BTO; BTO:0002753
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-10
AC CVCL_7093
DR BTO; BTO:0002762
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-11
AC CVCL_7094
DR BTO; BTO:0002763
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-12
AC CVCL_7095
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-13
AC CVCL_7096
DR BTO; BTO:0002764
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-14
AC CVCL_7097
DR BTO; BTO:0002765
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-15
AC CVCL_7098
DR BTO; BTO:0002766
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-16
AC CVCL_7099
DR BTO; BTO:0002755
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-2
AC CVCL_7100
DR BTO; BTO:0002754
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-3
AC CVCL_7101
DR BTO; BTO:0002751
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-4
AC CVCL_7102
DR BTO; BTO:0002756
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-5
AC CVCL_7103
DR BTO; BTO:0002757
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-6
AC CVCL_7104
DR BTO; BTO:0002758
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-7
AC CVCL_7105
DR BTO; BTO:0002759
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-8
AC CVCL_7106
DR BTO; BTO:0002760
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC6-9
AC CVCL_7107
DR BTO; BTO:0002761
RX PubMed=8396168;
DI NCIt; C121568; Rat adrenal gland pheochromocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_7091 ! PC6
SX Male
CA Cancer cell line
//
ID PC880
AC CVCL_U147
RX PubMed=12694655;
DI NCIt; C40022; Primary peritoneal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PC9-DPE2
AC CVCL_S977
RX PubMed=9052401;
CC Transfected with: HGNC; 3148; TYMP.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B260 ! PC-9
CA Cancer cell line
//
ID PCA 31.1
AC CVCL_G246
DR CLO; CLO_0008397
DR ATCC; HB-12314
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PCA 33.28
AC CVCL_G247
DR CLO; CLO_0008398
DR ATCC; HB-12315
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PCBC16iPS
AC CVCL_0H60
DR SKIP; SKIP000584
RX PubMed=23326500;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PCC1
AC CVCL_5T86
RX PubMed=61803;
RX PubMed=4599372;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID PCC2
AC CVCL_5T87
RX PubMed=4599372;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID PCC3
AC CVCL_5T85
RX PubMed=61803;
RX PubMed=4599372;
RX PubMed=6479493;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID PCC3/A/1
AC CVCL_E064
SY PCC3-A/1
DR CLO; CLO_0050538
DR RCB; RCB1791
RX PubMed=61803;
RX PubMed=78963;
RX PubMed=650144;
RX PubMed=886245;
RX PubMed=1893874;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5T85 ! PCC3
SX Male
CA Cancer cell line
//
ID PCC4
AC CVCL_5854
DR JCRB; JCRB0205
RX PubMed=61803;
RX PubMed=4599372;
CC Discontinued: JCRB; JCRB0205; true.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID PCC4 [Mouse lung papillary tumor]
AC CVCL_5U82
SY Peter's Clara Cell 4
RX PubMed=2548715;
RX PubMed=9149863;
RX PubMed=9347924;
CC Breed/subspecies: BALB/cJ.
DI NCIt; C21763; Papillary adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID PCC4 AG
AC CVCL_5855
SY PCC4 AG-r
DR JCRB; JCRB0206
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5854 ! PCC4
SX Male
CA Cancer cell line
//
ID PCC4 AG Cap
AC CVCL_5856
SY PCC4 AG-r Cap-r
DR JCRB; JCRB0216
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:17698; Chloramphenicol.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5855 ! PCC4 AG
SX Male
CA Cancer cell line
//
ID PCC4 Type I
AC CVCL_U221
SY PCC4 TypeI
DR JCRB; JCRB0204
CC Discontinued: JCRB; JCRB0204; true.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_C566 ! L6TG Cap
HI CVCL_5854 ! PCC4
CA Hybrid cell line
//
ID PCC4 Type III
AC CVCL_U222
SY PCC4 TypeIII
DR JCRB; JCRB0203
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_C566 ! L6TG Cap
HI CVCL_5854 ! PCC4
CA Hybrid cell line
//
ID PCC4-azal
AC CVCL_5857
SY PCC4-Azal; PCC-4-azal; PCC4Azal; PCC4 aza1; PCC4.aza 1
DR CLO; CLO_0008400
DR CLDB; cl3887
DR CLS; 400313/p562_PCC4-aza1
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5854 ! PCC4
SX Male
CA Cancer cell line
//
ID PCC4-Azal-ECA2
AC CVCL_G076
SY PCC4-Aza1-ECA2; ECA2
RX PubMed=2479740;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5857 ! PCC4-azal
SX Male
CA Cancer cell line
//
ID PCC4-AzaR
AC CVCL_5912
SY PCC4/AzaR; PCC-4 AzaR; PCC4.azaR; PCC4 azaR; PCC4 AzaR; PCC4-azaR 1; PCC4/AzaR1; PCC4/AzaRl; PCC4 azaR1
RX PubMed=4599372;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5854 ! PCC4
SX Male
CA Cancer cell line
//
ID PCC4-F
AC CVCL_5911
SY PCC4/F; PCC4F
RX PubMed=558822;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5854 ! PCC4
SX Male
CA Cancer cell line
//
ID PCC4AO
AC CVCL_1Q47
SY PCC4 8azaR OuR
RX PubMed=6686281;
RX PubMed=6951167;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5854 ! PCC4
SX Male
CA Cancer cell line
//
ID PCC7-Mz1
AC CVCL_J426
SY PCC7-MZ1; Mz1
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: 129 x C57BL/6.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J430 ! PCC7-S-AzaRt clone 1009
SX Male
CA Cancer cell line
//
ID PCC7-S
AC CVCL_J429
RX PubMed=78963;
CC Breed/subspecies: 129 x C57BL/6.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID PCC7-S-AzaRt clone 1009
AC CVCL_J430
SY Clone 1009
RX PubMed=78963;
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: 129 x C57BL/6.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J429 ! PCC7-S
SX Male
CA Cancer cell line
//
ID PCCL3
AC CVCL_6712
SY PC Cl 3; PCCl3; PCCL-3; PCCL 3
DR BTO; BTO:0003800
DR BCRJ; 0204
RX PubMed=3670314;
CC Discontinued: BCRJ; 0204; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID PCE
AC CVCL_1G96
SY Puntius Chelynoides Eye
RX PubMed=22465535;
CC Group: Fish cell line.
OX NCBI_TaxID=547593; ! Puntius chelynoides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PCF
AC CVCL_W975
SY Puntius Chelynoides Fin
RX PubMed=24852132;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=1
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC001.
OX NCBI_TaxID=547593; ! Puntius chelynoides
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PCG.G6
AC CVCL_1Q50
RX PubMed=6641706;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_1Q46 ! G3.32.2
HI CVCL_1Q47 ! PCC4AO
CA Hybrid cell line
//
ID PCH41-43
AC CVCL_K257
DR CLO; CLO_0050299
DR RCB; RCB0673
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PCH41-44
AC CVCL_K258
DR CLO; CLO_0050353
DR RCB; RCB0674
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PCH42-58
AC CVCL_K259
DR CLO; CLO_0050354
DR RCB; RCB0676
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PCH42-63
AC CVCL_K260
DR CLO; CLO_0050302
DR RCB; RCB0669
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PCH54-37
AC CVCL_K261
DR CLO; CLO_0050300
DR RCB; RCB0678
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PCI-01
AC CVCL_C167
SY PCI-1
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-02
AC CVCL_C168
SY PCI-2
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-03
AC CVCL_C169
SY PCI-3
DR BioSample; SAMN03151894
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=21868764). Originally thought to originate from a oropharyngeal squamous cell carcinoma.
CC Derived from metastatic site: Bone.
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PCI-04A
AC CVCL_C170
SY PCI-4A; PCI-4T
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=14996750;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C171 ! PCI-04B
SX Male
CA Cancer cell line
//
ID PCI-04B
AC CVCL_C171
SY PCI-4B; PCI-4M
DR Cosmic-CLP; 1298531
DR GDSC; 1298531
DR GEO; GSM827146
DR GEO; GSM1670344
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=14996750;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 12,13
ST TH01: 6,7
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C170 ! PCI-04A
SX Male
CA Cancer cell line
//
ID PCI-05
AC CVCL_C172
SY PCI-5
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-06A
AC CVCL_C173
SY PCI-6A; PCI-6T
DR Cosmic-CLP; 1240206
DR GDSC; 1240206
DR GEO; GSM1670345
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=14996750;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,13,14
ST D16S539: 11,14
ST D5S818: 11
ST D7S820: 7,10
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C174 ! PCI-06B
SX Male
CA Cancer cell line
//
ID PCI-06B
AC CVCL_C174
SY PCI-6B; PCI-6M
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=14996750;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C173 ! PCI-06A
SX Male
CA Cancer cell line
//
ID PCI-07
AC CVCL_C175
SY PCI-7
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-08
AC CVCL_C176
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4943; Pyriform fossa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-09A
AC CVCL_C177
SY PCI-9A; PCI9
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C178 ! PCI-09B
SX Male
CA Cancer cell line
//
ID PCI-09B
AC CVCL_C178
SY PCI-9B
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C177 ! PCI-09A
SX Male
CA Cancer cell line
//
ID PCI-10 [Human HNSCC]
AC CVCL_C179
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-10 [Human pancreatic carcinoma]
AC CVCL_5193
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-11
AC CVCL_C180
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4943; Pyriform fossa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-12
AC CVCL_C181
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-13
AC CVCL_C182
SY PCI13
DR Cosmic; 2131852
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-522.html
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 12,13
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 16,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-14
AC CVCL_C183
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-15A
AC CVCL_C184
SY PCI15A; PCI-15; PCI-15T
DR Cosmic; 2131853
DR Cosmic-CLP; 1240204
DR GDSC; 1240204
DR GEO; GSM1670341
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
RX PubMed=8084624;
RX PubMed=14996750;
RX PubMed=21868764;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): Cosmic-CLP; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11
ST D7S820: 11
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C4943; Pyriform fossa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C756 ! PCI-15B
SX Male
CA Cancer cell line
//
ID PCI-15B
AC CVCL_C756
SY PCI-15b; PCI15B; PCI-15; PCI-15M; 15b
DR Cosmic; 2131854
RX PubMed=2766286;
RX PubMed=8084624;
RX PubMed=14996750;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11
ST D7S820: 11
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C4943; Pyriform fossa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C184 ! PCI-15A
SX Male
CA Cancer cell line
//
ID PCI-16
AC CVCL_C185
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
CC Derived from metastatic site: Lymph node.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-17
AC CVCL_C186
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PCI-18
AC CVCL_C187
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=2766286;
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-19
AC CVCL_5194
DR Cosmic; 1066195
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-22A
AC CVCL_1T56
DR BioSample; SAMN03152034
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Probably contaminated. Supposed to be isogenic with PCI-22B (CVCL_1T57) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 8,9
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-22B
AC CVCL_1T57
DR BioSample; SAMN03152035
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Probably contaminated. Supposed to be isogenic with PCI-22A (CVCL_1T56) but does not have the same STR profile and are therefore not originating from the same individual (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-24 [Human OCSCC]
AC CVCL_AT94
SY PCI24
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-24 [Human pancreatic adenocarcinoma]
AC CVCL_5195
DR Cosmic; 1066196
DR Cosmic; 1644308
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-30
AC CVCL_C757
DR Cosmic-CLP; 1298529
DR GDSC; 1298529
DR GEO; GSM1670342
RX PubMed=8084624;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 13
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 10,11
ST vWA: 14,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-35
AC CVCL_5191
SY PCI35
DR BTO; BTO:0003286
DR Cosmic; 707259
DR Cosmic; 1066197
DR Cosmic; 1644309
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-37A
AC CVCL_C758
SY PCI-37a; UPCI-37A; PCI-37T
RX PubMed=14996750;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C759 ! PCI-37B
SX Male
CA Cancer cell line
//
ID PCI-37B
AC CVCL_C759
SY UPCI-37B; PCI-37M
RX PubMed=14996750;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C758 ! PCI-37A
SX Male
CA Cancer cell line
//
ID PCI-38
AC CVCL_M471
DR Cosmic-CLP; 1240205
DR GDSC; 1240205
DR GEO; GSM1670343
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-43
AC CVCL_5139
SY PCI43
DR BTO; BTO:0003285
DR Cosmic; 1066198
DR Cosmic; 1644310
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-50
AC CVCL_M470
RX PubMed=7873144;
RX PubMed=8001029;
RX PubMed=8443824;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-55
AC CVCL_5196
DR Cosmic; 707260
DR Cosmic; 1066199
DR Cosmic; 1644311
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-6
AC CVCL_5197
DR Cosmic; 1066194
DR Cosmic; 1644307
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCI-64
AC CVCL_5198
DR Cosmic; 1066200
DR Cosmic; 1644312
RX PubMed=7804431;
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-66
AC CVCL_5199
DR Cosmic; 707261
DR Cosmic; 1066201
RX PubMed=8797870;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PCI-68
AC CVCL_5200
RX PubMed=11173548;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCI-72
AC CVCL_5201
RX PubMed=11173548;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PCI-79
AC CVCL_5422
RX PubMed=11173548;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PCL12
AC CVCL_2H32
SY PCL-12
DR DSMZ; ACC-794
RX PubMed=26110819;
RX PubMed=26222697;
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PCL1643
AC CVCL_F002
DR Cosmic; 922666
RX PubMed=8665486;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCL1691
AC CVCL_F003
DR Cosmic; 922667
RX PubMed=8665486;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCL1771
AC CVCL_F004
DR Cosmic; 922668
RX PubMed=8665486;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCL3014
AC CVCL_F005
DR Cosmic; 922669
RX PubMed=8665486;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCL3091
AC CVCL_F006
DR Cosmic; 922670
RX PubMed=8665486;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCL4199
AC CVCL_M496
RX PubMed=8665486;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PCM6
AC CVCL_4666
DR CLO; CLO_0051009
DR BioSample; SAMN03472144
DR CCLE; PCM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR GEO; GSM887507
DR GEO; GSM888589
DR RCB; RCB1460
RX PubMed=8112425;
RX PubMed=10936422;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: IL6 dependent.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 10
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 10,11
ST vWA: 16,18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PD PaCa
AC CVCL_8401
SY PDPaCa; Poorly Differentiated Pancreatic adenoCarcinoma; PD
RX PubMed=3971476;
RX PubMed=6435863;
RX PubMed=6805945;
RX PubMed=8863680;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Cancer cell line
//
ID PD(H39)
AC CVCL_Y454
DR ATCC; CRL-6491
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6491; true.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Sex undetermined
CA Undefined cell line type
//
ID PD-1.3
AC CVCL_DF55
SY PD1.3
RX Patent=US8741295;
RX PubMed=20587542;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4122.
CC Monoclonal antibody target: UniProtKB; Q15116; Human PDCD1/PD1/CD279.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PD-iPS1 [Human iPSC China]
AC CVCL_L664
DR ISCR; 1988
RX PubMed=22673189;
CC From: Guangzhou Medical College; China.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L665 ! PD-iPS2
SX Male
CA Induced pluripotent stem cell
//
ID PD-iPS1 [Human iPSC USA]
AC CVCL_C952
SY PD-IPS1
DR ISCR; 5
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L781 ! AG20446
SX Male
CA Induced pluripotent stem cell
//
ID PD-iPS11
AC CVCL_C953
SY PD-IPS11
DR ISCR; 2057
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L781 ! AG20446
SX Male
CA Induced pluripotent stem cell
//
ID PD-iPS2
AC CVCL_L665
DR ISCR; 1989
RX PubMed=22673189;
CC From: Guangzhou Medical College; China.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L664 ! PD-iPS1 [Human iPSC China]
SX Male
CA Induced pluripotent stem cell
//
ID PD-iPS5
AC CVCL_C954
SY PD-IPS5
DR ISCR; 4
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L781 ! AG20446
SX Male
CA Induced pluripotent stem cell
//
ID PD-L1.1
AC CVCL_DF56
SY PDL1.1
RX Patent=US8741295;
RX PubMed=20587542;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4080.
CC Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PD-L1.2
AC CVCL_DF57
SY PDL1.2
RX Patent=US8741295;
RX PubMed=20587542;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4081.
CC Monoclonal antibody target: UniProtKB; Q9NZQ7; Human CD274.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PD-Mel
AC CVCL_M743
CC From: Guadagni F.; Istituto Regina Elena; Roma; Italy.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PD20 RV:D2
AC CVCL_AK49
SY PD.20hygro:RV
RX PubMed=12361951;
WW http://www.ohsu.edu/research/fanconi-anemia/celllines.cfm
CC Transfected with: HGNC; 3585; FANCD2.
CC Transfected with: UniProtKB; P00557; E.coli hygromycin-B 4-O-kinase (hph).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C125706; Fanconi anemia, complementation group D2
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G042 ! GM16633
SX Male
CA Transformed cell line
//
ID PD352.F
AC CVCL_AK48
SY PD352-F; PD.352.F; PD352
RX PubMed=12361951;
DI NCIt; C125708; Fanconi anemia, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID PD5
AC CVCL_4270
SY PD 5
DR CLO; CLO_0008402
DR CLO; CLO_0008403
DR CLDB; cl3889
DR CLDB; cl3890
DR ECACC; 93120830
DR IZSLER; BS CL 99
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID PDA3F-1
AC CVCL_0G96
DR SKIP; SKIP000542
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N797 ! AG20443
SX Male
CA Induced pluripotent stem cell
//
ID PDA3F-5
AC CVCL_0G97
DR SKIP; SKIP000589
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N797 ! AG20443
SX Male
CA Induced pluripotent stem cell
//
ID PDB3F-1
AC CVCL_0G98
DR SKIP; SKIP000590
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB3F-5
AC CVCL_0G99
DR SKIP; SKIP000591
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB3F-8
AC CVCL_0H00
DR SKIP; SKIP000592
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB3F-9
AC CVCL_0H01
DR SKIP; SKIP000593
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB3F-d12
AC CVCL_0H02
DR SKIP; SKIP000594
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB4F-1
AC CVCL_0H03
DR SKIP; SKIP000595
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB4F-2
AC CVCL_0H04
DR SKIP; SKIP000596
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB4F-3
AC CVCL_0H05
DR SKIP; SKIP000597
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB4F-4
AC CVCL_0H06
DR SKIP; SKIP000598
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDB4F-5
AC CVCL_0H07
DR SKIP; SKIP000599
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X806 ! AG20442
SX Male
CA Induced pluripotent stem cell
//
ID PDC3F-1
AC CVCL_0H08
DR SKIP; SKIP000600
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L781 ! AG20446
SX Male
CA Induced pluripotent stem cell
//
ID PDD3F-1
AC CVCL_0H09
DR SKIP; SKIP000601
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD3F-4
AC CVCL_0H10
DR SKIP; SKIP000602
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD3F-7
AC CVCL_0H11
DR SKIP; SKIP000603
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD4F-1
AC CVCL_0H12
DR SKIP; SKIP000604
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD4F-4
AC CVCL_0H13
DR SKIP; SKIP000605
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD4F-5
AC CVCL_0H14
DR SKIP; SKIP000606
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD4F-8
AC CVCL_0H15
DR SKIP; SKIP000607
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDD4F-9
AC CVCL_0H16
DR SKIP; SKIP000608
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X807 ! AG20445
SX Male
CA Induced pluripotent stem cell
//
ID PDE3F-3
AC CVCL_0H17
DR SKIP; SKIP000609
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N795 ! AG08395
SX Female
CA Induced pluripotent stem cell
//
ID PDE3F-4
AC CVCL_0H18
DR SKIP; SKIP000610
RX PubMed=19269371;
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_N795 ! AG08395
SX Female
CA Induced pluripotent stem cell
//
ID PDF
AC CVCL_1G97
SY Puntius Denisonii Fin
RX PubMed=21136193;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=9
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC009.
OX NCBI_TaxID=1606683; ! Sahyadria denisonii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PDFS
AC CVCL_M435
RX PubMed=10720059;
RX PubMed=15541569;
DI NCIt; C3329; Pituitary gland adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PDH
AC CVCL_1G98
SY Puntius Denisonii Heart
RX PubMed=21136193;
CC Group: Fish cell line.
OX NCBI_TaxID=1606683; ! Sahyadria denisonii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PDL-1
AC CVCL_G248
DR CLO; CLO_0008407
DR ATCC; CRL-1882
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6971 ! FOX-NY
CA Hybridoma
//
ID PDL-L2
AC CVCL_6B13
SY PDL-L 2
RX PubMed=12356921;
RX PubMed=17233813;
RX PubMed=24949082;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Omics: Transcriptome analysis.
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID PDSS-26
AC CVCL_B458
DR Cosmic; 1212218
RX PubMed=14553945;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PDV
AC CVCL_5858
DR CLS; 400314/p792_PDV
RX PubMed=102384;
RX PubMed=1855225;
RX PubMed=1934268;
RX PubMed=2185890;
RX PubMed=2414007;
RX PubMed=6190961;
CC Breed/subspecies: C57BL/10 LP.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID PDVC 57B
AC CVCL_4271
SY PDVC57b; PDVC57; PDV.C57; PDV C57
DR ECACC; 01022129
DR Ximbio; 151630
RX PubMed=1855225;
RX PubMed=1934268;
RX PubMed=2185890;
RX PubMed=2414007;
CC Breed/subspecies: C57BL/10 LP.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5858 ! PDV
CA Cancer cell line
//
ID PE
AC CVCL_1D86
DR ChEMBL-Cells; CHEMBL3308676
DR ChEMBL-Targets; CHEMBL614846
RX PubMed=2871947;
WW http://www.ott.nih.gov/erma/mouse-keratinocyte-tumor-cell-line-pe
WW http://www.ctsaip.org/details.cfm?id=24518054
CC Breed/subspecies: SENCAR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Pe Hay
AC CVCL_U670
SY PeHay; XP13BE
DR ATCC; CRL-1258
RX PubMed=225015;
CC Discontinued: ATCC; CRL-1258; true.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID PE-1
AC CVCL_6G49
SY Porcine Endometrial cells-1
RX PubMed=1280756;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Transformed cell line
//
ID Pe-LCL
AC CVCL_6D81
RX PubMed=8127151;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PE/CA-PJ15
AC CVCL_2678
SY PE-CA-PJ15; PE/CA PJ15; PE/CA-PJ-15; PE_CA-PJ15; PE CA PJ15; PECAPJ15
DR EFO; EFO_0006733
DR BioSample; SAMN03473150
DR CCLE; PECAPJ15_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 1339923
DR Cosmic; 1995614
DR Cosmic-CLP; 1240207
DR ECACC; 96121230
DR GDSC; 1240207
DR GEO; GSM827436
DR GEO; GSM887508
DR GEO; GSM888590
DR GEO; GSM1374826
DR GEO; GSM1374827
DR GEO; GSM1670346
DR LINCS; 50039
RX PubMed=9876219;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8,10
ST D16S539: 9,13
ST D18S51: 17
ST D21S11: 29
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 8,12
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 13
ST Penta E: 10
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PE/CA-PJ34 (clone C12)
AC CVCL_2679
SY PE/CA-PJ34; PE/CA-PJ-34; PE CA PJ34; PJ34; Plaepi 34
DR CLO; CLO_0008408
DR CCLE; PECAPJ34CLONEC12_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 1339919
DR ECACC; 97062513
DR GEO; GSM887509
DR GEO; GSM888591
DR GEO; GSM1374828
DR GEO; GSM1374829
RX PubMed=9876219;
RX PubMed=21868764;
RX PubMed=22460905;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9,13
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 18
DI NCIt; C54244; Basaloid squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PE/CA-PJ41 (clone D2)
AC CVCL_2680
SY PE/CA-PJ-41; PE CA PJ41; Plaepi 41
DR CLO; CLO_0008409
DR CCLE; PECAPJ41CLONED2_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 1339922
DR ECACC; 98020207
DR GEO; GSM887510
DR GEO; GSM888592
DR GEO; GSM1374830
DR GEO; GSM1374831
RX PubMed=9876219;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'PECAPJ34CLONED2' in GEO GSM1374830.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 7
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PE/CA-PJ49
AC CVCL_2681
SY PE CA PJ49; PECAPJ49
DR CCLE; PECAPJ49_UPPER_AERODIGESTIVE_TRACT
DR Cosmic; 1339918
DR ECACC; 00060606
DR GEO; GSM887511
DR GEO; GSM888593
DR GEO; GSM1374832
DR GEO; GSM1374833
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 8,12
ST D7S820: 8,9
ST TH01: 6,10
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PE030810
AC CVCL_W916
DR Cosmic; 2054115
RX PubMed=23833040;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PE117
AC CVCL_E802
DR dbMHC; 48997
DR ECACC; 88052028
DR IHW; IHW9028
DR IMGT/HLA; 11643
WW http://bioinformatics.hsanmartino.it/ecbr/cl28.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PE121410
AC CVCL_W917
DR Cosmic; 2054097
RX PubMed=23833040;
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PEA-10
AC CVCL_2684
SY PEA 10; Primary Embryonic Fibroblasts-10
DR CLO; CLO_0008412
DR CLDB; cl5105
DR ATCC; CRL-2215
DR ECACC; 97040310
RX PubMed=8006085;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID PEA-13
AC CVCL_2685
SY PEA 13; Primary Embryonic Fibroblasts-13
DR BTO; BTO:0002832
DR CLO; CLO_0008413
DR ATCC; CRL-2216
DR ECACC; 97040311
RX PubMed=8006085;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID PEA1
AC CVCL_2682
DR Cosmic; 1305317
DR ECACC; 10032306
DR GEO; GSM459742
DR GEO; GSM459851
DR Ximbio; 151678
RX PubMed=3167863;
RX PubMed=20581869;
RX PubMed=23415752;
RX PubMed=25230021;
CC Part of: OCCP ovarian cancer cell line panel.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 14
ST D13S317: 8
ST D16S539: 12,13
ST D18S51: 14,17
ST D19S433: 12,13
ST D21S11: 30
ST D2S1338: 19,25
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 14
ST FGA: 22,25
ST Penta D: 13,15
ST Penta E: 7,13
ST TH01: 9
ST TPOX: 8,12
ST vWA: 18
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2683 ! PEA2
SX Female
CA Cancer cell line
//
ID PEA2
AC CVCL_2683
DR ECACC; 10032307
DR GEO; GSM459852
DR GEO; GSM659401
DR Ximbio; 151679
RX PubMed=3167863;
RX PubMed=20581869;
RX PubMed=23415752;
RX PubMed=25230021;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: ~66 hours (ECACC).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
ST Source(s): ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 8
ST D16S539: 12,13
ST D18S51: 17
ST D19S433: 12,13
ST D21S11: 30
ST D2S1338: 19
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 14
ST FGA: 25
ST Penta D: 13,15
ST Penta E: 7,13
ST TH01: 9
ST TPOX: 8 (ECACC)
ST TPOX: 8,12 (PubMed=25230021)
ST vWA: 17,18
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2682 ! PEA1
SX Female
CA Cancer cell line
//
ID pEAK Rapid
AC CVCL_3772
SY pEAK-Rapid; Peak Rapid; PEAKrapid; PeakRapid; HEK-293 PEAKrapid; PEAK 293; PEAK
DR BTO; BTO:0003615
DR CLO; CLO_0008414
DR ATCC; CRL-2828
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9
ST D5S818: 8,9
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID PEAZ-1
AC CVCL_8437
DR BioSample; SAMN03151782
RX PubMed=11433418;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-1080 derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID PEC.1
AC CVCL_A037
RX PubMed=7514905;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID PECA
AC CVCL_5859
DR CLS; 400189/p569_PECA
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID PECA-4197
AC CVCL_5860
SY PECA 4197; PECA4197
RX PubMed=1961926;
RX PubMed=7908310;
RX PubMed=11966317;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PECA-4451
AC CVCL_5861
SY PECA 4451; PECA4451
RX PubMed=1961926;
RX PubMed=7908310;
RX PubMed=11966317;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PeCa-UkHb-01
AC CVCL_2H31
RX PubMed=26193922;
CC Doubling time: 34.7 +- 3.8 hours (PubMed=26193922).
ST Source(s): PubMed=26193922
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 11
ST D18S51: 13
ST D21S11: 27,29,30
ST D3S1358: 14
ST D5S818: 13
ST D7S820: 8
ST D8S1179: 13,14
ST FGA: 22,23
ST Penta D: 10,13
ST Penta E: 10,15
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4549; Conjunctival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Peccary.K
AC CVCL_6431
SY Peccary K
DR CLO; CLO_0008415
DR ATCC; CRL-6488
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9829; ! Pecari tajacu
SX Female
CA Finite cell line
//
ID PEE
AC CVCL_IJ29
SY Porcine Endometrial Endothelial
RX PubMed=23220338;
CC Doubling time: 40 hours (at 5th passage), 41.1 hours (at 15th passage), 36.6 hours (at 30th passage), 37 hours (at 50th passage) (PubMed=23220338).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Jiangquhai.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Transformed cell line
//
ID Peer
AC CVCL_1913
SY PEER
DR BTO; BTO:0001959
DR CLO; CLO_0008416
DR CLO; CLO_0050081
DR CLDB; cl4115
DR BioSample; SAMN01821654
DR BioSample; SAMN03472523
DR BioSample; SAMN03473496
DR CCLE; PEER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 721704
DR Cosmic; 801731
DR Cosmic; 933548
DR Cosmic; 998727
DR Cosmic; 1037685
DR Cosmic; 1115597
DR Cosmic; 1118460
DR Cosmic; 1130238
DR Cosmic; 1281382
DR Cosmic; 1330494
DR Cosmic; 1375591
DR Cosmic; 1524813
DR Cosmic; 1641383
DR Cosmic; 1760530
DR Cosmic; 2165707
DR Cosmic; 2361369
DR DSMZ; ACC-6
DR GEO; GSM887512
DR GEO; GSM888594
DR JCRB; JCRB0830
DR NCBI_Iran; C511
DR RCB; RCB1879
DR TKG; TKG 0377
DR Wikidata; Q2067085
RX PubMed=1373528;
RX PubMed=6582512;
RX PubMed=8547074;
RX PubMed=9290701;
RX PubMed=9933131;
RX PubMed=10071127;
RX PubMed=22460905;
RX PubMed=22675565;
WW https://de.wikipedia.org/wiki/Peer_(Zelllinie)
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-60 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,14 (DSMZ; RCB; TKG)
ST D13S317: 14 (JCRB)
ST D16S539: 8,13
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7,8
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PEL-5
AC CVCL_9583
DR EFO; EFO_0002075
DR BioSamples; SAMEA365903
DR BioSamples; SAMEA365997
DR GEO; GSM38806
DR GEO; GSM38807
RX PubMed=15613351;
CC Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC Omics: Transcriptome analysis.
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PEL16
AC CVCL_1Q41
SY PEL 16; GM11938
DR CLO; CLO_0020217
DR Coriell; GM11938
RX PubMed=2722195;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybrid cell line
//
ID PEL40
AC CVCL_1Q42
SY PEL 40
RX PubMed=2722195;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybrid cell line
//
ID Pen-3
AC CVCL_IQ93
RX Patent=US7915004;
CC Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 04004.
CC Monoclonal antibody target: UniProtKB; P26022; Human PTX3.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PENN001i-87-2
AC CVCL_EK01
SY iPS-87-098-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN001i-87-2.cmsx
WW http://shared.eagle-i.net/i/00000155-9d79-71a4-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN002i-442-1
AC CVCL_EK02
SY iPS-442-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN002i-442-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a741-c91d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN003i-661-4
AC CVCL_EK03
SY 661-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN003i-661-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bc0a-8c72-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN004i-277-1
AC CVCL_EK04
SY iPS-277-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN004i-277-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9d18-60de-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN005i-35-3
AC CVCL_EK05
SY iPS-35-1360-010-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN005i-35-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a31b-0319-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN006i-149-1
AC CVCL_EK06
SY iPS-149-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN006i-149-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9d5f-b796-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN007i-765-3
AC CVCL_EK07
SY 765-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN007i-765-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bbef-a9d4-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN008i-77-5
AC CVCL_EK08
SY iPS-77-1638-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN008i-77-5.cmsx
WW http://shared.eagle-i.net/i/00000155-9d56-483b-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN009i-57-52
AC CVCL_EK09
SY iPS-57-1673-SeV52
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN009i-57-52.cmsx
WW http://shared.eagle-i.net/i/00000155-a760-3b17-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN010i-486-2
AC CVCL_EK10
SY iPS-486-1610-080-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN010i-486-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a74e-813b-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN011i-719-2
AC CVCL_EK11
SY iPS-719-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN011i-719-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bbf3-e328-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN012i-93-2
AC CVCL_EK12
SY iPS-93-1385-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN012i-93-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bc60-4042-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN013i-72-1
AC CVCL_EK13
SY iPS-72-1677-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN013i-72-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a764-699e-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN014i-37-3
AC CVCL_EK14
SY iPS-37-1189-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN014i-37-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a74b-c87f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN015i-668-5
AC CVCL_EK15
SY iPS-668-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN015i-668-5.cmsx
WW http://shared.eagle-i.net/i/00000155-a216-ea8e-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN016i-821-1
AC CVCL_EK16
SY iPS-821-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN016i-821-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2c4-4b05-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK61 ! PENN061i-821-2
SX Female
CA Induced pluripotent stem cell
//
ID PENN017i-638-2
AC CVCL_EK17
SY iPS-638-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN017i-638-2.cmsx
WW http://shared.eagle-i.net/i/00000155-9d6d-0cde-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN018i-487-4
AC CVCL_EK18
SY iPS-487-1410-005-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN018i-487-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a753-2e45-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN019i-136-2
AC CVCL_EK19
SY iPS-136-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN019i-136-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a2f2-3149-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN020i-588-6
AC CVCL_EK20
SY iPS-588-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN020i-588-6.cmsx
WW http://shared.eagle-i.net/i/00000155-a2c1-20c2-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK91 ! PENN091i-588-2
SX Female
CA Induced pluripotent stem cell
//
ID PENN021i-749-4
AC CVCL_EK21
SY 749-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN021i-749-4.cmsx
WW http://shared.eagle-i.net/i/00000155-9d6f-d6d0-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN022i-89-1
AC CVCL_EK22
SY iPS-89-1342-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN022i-89-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bc5e-53c9-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN023i-82-1
AC CVCL_EK23
SY iPS-82-1572-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN023i-82-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bb91-3d49-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN024i-370-3
AC CVCL_EK24
SY iPS-370-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN024i-370-3 .cmsx
WW http://shared.eagle-i.net/i/00000155-bbf9-b44f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN025i-71-58
AC CVCL_EK25
SY iPS-71-044-SeV58
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN025i-71-58.cmsx
WW http://shared.eagle-i.net/i/00000155-bc63-50da-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN026i-124-1
AC CVCL_EK26
SY iPS-124-1125-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN026i-124-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9d2f-1371-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN027i-40-2
AC CVCL_EK27
SY iPS-40-139-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN027i-40-2.cmsx
WW http://shared.eagle-i.net/i/00000155-9d53-4d2d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN028i-637-2
AC CVCL_EK28
SY iPS-637-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN028i-637-2.cmsx
WW http://shared.eagle-i.net/i/00000155-9d6b-2e6e-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN029i-752-3
AC CVCL_EK29
SY iPS-752-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN029i-752-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a219-0c57-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN030i-384-4
AC CVCL_EK30
SY iPS-384-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN030i-384-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bbf7-a8e0-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN031i-56-1
AC CVCL_EK31
SY iPS-56-061-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN031i-56-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a75c-acf2-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN032i-15-5
AC CVCL_EK32
SY iPS-15-1203-024-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN032i-15-5.cmsx
WW http://shared.eagle-i.net/i/00000155-a312-33fd-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN033i-182-2
AC CVCL_EK33
SY iPS-182-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN033i-182-2.cmsx
WW http://shared.eagle-i.net/i/00000155-9cd0-2196-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN034i-322-1
AC CVCL_EK34
SY iPS-322-1725-058-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN034i-322-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a318-9d80-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN035i-746-3
AC CVCL_EK35
SY iPS-746-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN035i-746-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a23b-30cf-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN036i-286-3
AC CVCL_EK36
SY iPS-286-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN036i-286-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bbfd-af0f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN037i-90-3
AC CVCL_EK37
SY iPS-90-1481-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN037i-90-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bb98-092c-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN038i-366-6
AC CVCL_EK38
SY iPS-366-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN038i-366-6.cmsx
WW http://shared.eagle-i.net/i/00000155-a302-6c95-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN039i-63-1
AC CVCL_EK39
SY iPS-63-1622-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN039i-63-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bba0-dc7d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN040i-134-2
AC CVCL_EK40
SY iPS-134-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN040i-134-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a328-59d3-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN041i-177-46
AC CVCL_EK41
SY iPS-177-SeV46
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN041i-177-46.cmsx
WW http://shared.eagle-i.net/i/00000155-a214-0c19-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN042i-258-12
AC CVCL_EK42
SY iPS-258-SeV12
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN042i-258-12.cmsx
WW http://shared.eagle-i.net/i/00000155-a2f5-d063-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN043i-633-3
AC CVCL_EK43
SY iPS-633-1310-003-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN043i-633-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a322-1bdc-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN044i-51-1
AC CVCL_EK44
SY iPS-51-031-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN044i-51-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a755-7702-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN045i-25-12
AC CVCL_EK45
SY iPS-25-1371-101-SeV12
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN045i-25-12.cmsx
WW http://shared.eagle-i.net/i/00000155-9d77-379d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN046i-271-1
AC CVCL_EK46
SY iPS-271-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN046i-271-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2fe-dbf0-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN047i-254-60
AC CVCL_EK47
SY iPS-254-SeV60
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN047i-254-60.cmsx
WW http://shared.eagle-i.net/i/00000155-a32f-c9ad-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN048i-41-6
AC CVCL_EK48
SY iPS-41-1282-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN048i-41-6.cmsx
WW http://shared.eagle-i.net/i/00000155-bc57-fffc-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN049i-334-8
AC CVCL_EK49
SY iPS-334-SeV8
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN049i-334-8.cmsx
WW http://shared.eagle-i.net/i/00000155-a740-07ef-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN050i-245-10
AC CVCL_EK50
SY iPS-245-clone10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN050i-245-10.cmsx
WW http://shared.eagle-i.net/i/00000155-a32e-2509-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN051i-108-1
AC CVCL_EK51
SY iPS-108-1665-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN051i-108-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bbb0-ff4b-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN052i-444-2
AC CVCL_EK52
SY iPS-444-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN052i-444-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a2b0-9262-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL20 ! PENN120i-444-1
SX Female
CA Induced pluripotent stem cell
//
ID PENN053i-292-3
AC CVCL_EK53
SY iPS-292-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN053i-292-3.cmsx
WW http://shared.eagle-i.net/i/00000155-9d68-8557-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN054i-225-33
AC CVCL_EK54
SY iPS-225-SeV33
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN054i-225-33.cmsx
WW http://shared.eagle-i.net/i/00000155-bc00-24fe-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN055i-106-2
AC CVCL_EK55
SY iPS-106-1231-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN055i-106-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bbe8-43fe-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN056i-1-1
AC CVCL_EK56
SY iPS-1-030-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN056i-1-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9307-ce41-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN057i-427-3
AC CVCL_EK57
SY iPS-427-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN057i-427-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a2a1-e9b5-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK66 ! PENN066i-427-6
SX Female
CA Induced pluripotent stem cell
//
ID PENN058i-285-3
AC CVCL_EK58
SY iPS-285-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN058i-285-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a300-8734-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN059i-555-1
AC CVCL_EK59
SY iPS-555-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN059i-555-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2b8-36dd-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK84 ! PENN084i-555-2
SX Female
CA Induced pluripotent stem cell
//
ID PENN060i-23-1
AC CVCL_EK60
SY iPS-23-1346-028-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN060i-23-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bba6-b11f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN061i-821-2
AC CVCL_EK61
SY iPS-821-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN061i-821-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a2c5-9b91-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK16 ! PENN016i-821-1
SX Female
CA Induced pluripotent stem cell
//
ID PENN062i-278-2
AC CVCL_EK62
SY iPS-278-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN062i-278-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a2dc-b9f1-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK86 ! PENN086i-278-1
SX Male
CA Induced pluripotent stem cell
//
ID PENN063i-114-1
AC CVCL_EK63
SY iPS-114-1160-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN063i-114-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bc10-4955-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN064i-22-2
AC CVCL_EK64
SY iPS-22-1158-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN064i-22-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bba8-9356-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN065i-553-2
AC CVCL_EK65
SY iPS-553-1631-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN065i-553-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a759-fc57-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN066i-427-6
AC CVCL_EK66
SY iPS-427-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN066i-427-6.cmsx
WW http://shared.eagle-i.net/i/00000155-a2a0-79bc-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK57 ! PENN057i-427-3
SX Female
CA Induced pluripotent stem cell
//
ID PENN067i-312-1
AC CVCL_EK67
SY iPS-312-clone1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN067i-312-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a73d-be06-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN068i-697-3
AC CVCL_EK68
SY 697-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN068i-697-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a310-7a3a-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN069i-60-1
AC CVCL_EK69
SY iPS-60-099-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN069i-60-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a762-5056-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN070i-408-1
AC CVCL_EK70
SY iPS-408-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN070i-408-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a30a-24a3-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN071i-216-13
AC CVCL_EK71
SY iPS-216-SeV13
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN071i-216-13.cmsx
WW http://shared.eagle-i.net/i/00000155-a229-f6e8-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN072i-187-3
AC CVCL_EK72
SY iPS-187-1563-146-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN072i-187-3.cmsx
WW http://shared.eagle-i.net/i/00000155-9d4e-1c30-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN073i-133-8
AC CVCL_EK73
SY iPS-133-SeV8
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN073i-133-8.cmsx
WW http://shared.eagle-i.net/i/00000155-9cbe-fe5d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN074i-415-3
AC CVCL_EK74
SY iPS-415-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN074i-415-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a289-8a62-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL27 ! PENN127i-415-1
SX Female
CA Induced pluripotent stem cell
//
ID PENN075i-309-1
AC CVCL_EK75
SY iPS-309-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN075i-309-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9d85-2de9-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN076i-361-2
AC CVCL_EK76
SY iPS-361-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN076i-361-2.cmsx
WW http://shared.eagle-i.net/i/00000155-9d23-49b7-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN077i-521-1
AC CVCL_EK77
SY iPS-521-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN077i-521-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a30b-d2a7-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN078i-SV10
AC CVCL_EK78
SY iPS-SV10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN078i-SV10.cmsx
WW http://shared.eagle-i.net/i/00000155-a2ea-8f18-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN079i-33-1
AC CVCL_EK79
SY iPS-33-016-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN079i-33-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a247-6ed9-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN080i-603-1
AC CVCL_EK80
SY iPS-603-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN080i-603-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bc06-8a68-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN081i-352-4
AC CVCL_EK81
SY iPS-352-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN081i-352-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a238-7c8f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN082i-562-6
AC CVCL_EK82
SY iPS-562-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN082i-562-6.cmsx
WW http://shared.eagle-i.net/i/00000155-9d27-b3f0-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN083i-679-4
AC CVCL_EK83
SY 679-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN083i-679-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a30e-efce-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN084i-555-2
AC CVCL_EK84
SY iPS-555-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN084i-555-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a2b6-dd85-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK59 ! PENN059i-555-1
SX Female
CA Induced pluripotent stem cell
//
ID PENN085i-76-5
AC CVCL_EK85
SY iPS-76-1544-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN085i-76-5.cmsx
WW http://shared.eagle-i.net/i/00000155-bb8a-f66d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN086i-278-1
AC CVCL_EK86
SY iPS-278-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN086i-278-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2df-4dc5-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK62 ! PENN062i-278-2
SX Male
CA Induced pluripotent stem cell
//
ID PENN087i-38-1
AC CVCL_EK87
SY iPS-38-1298-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN087i-38-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a31d-22aa-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN088i-854-7
AC CVCL_EK88
SY iPS-854-SeV7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN088i-854-7.cmsx
WW http://shared.eagle-i.net/i/00000155-bc0d-794c-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN089i-758-4
AC CVCL_EK89
SY 758-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN089i-758-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bbf2-1d7a-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN090i-111-4
AC CVCL_EK90
SY iPS-111-1008-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN090i-111-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bbae-f314-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN091i-588-2
AC CVCL_EK91
SY iPS-588 SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN091i-588-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a2bf-8ff9-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK20 ! PENN020i-588-6
SX Female
CA Induced pluripotent stem cell
//
ID PENN092i-560-3
AC CVCL_EK92
SY 560-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN092i-560-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bbf5-de5c-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN093i-16-7
AC CVCL_EK93
SY iPS-16-1174-SeV7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN093i-16-7.cmsx
WW http://shared.eagle-i.net/i/00000155-a313-e8dc-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN094i-161-1
AC CVCL_EK94
SY iPS-161-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN094i-161-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a32b-78fb-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN095i-123-7
AC CVCL_EK95
SY iPS-123-1031-SeV7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN095i-123-7.cmsx
WW http://shared.eagle-i.net/i/00000155-9d72-3e43-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN096i-44-4
AC CVCL_EK96
SY iPS-44-1336-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN096i-44-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bba3-8f32-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN097i-17-1
AC CVCL_EK97
SY iPS-17-1446-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN097i-17-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9d48-a659-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN098i-50-18
AC CVCL_EK98
SY iPS-50-1394-SeV18
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN098i-50-18.cmsx
WW http://shared.eagle-i.net/i/00000155-a31e-d9d6-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN099i-218-1
AC CVCL_EK99
SY iPS-218-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN099i-218-1.cmsx
WW http://shared.eagle-i.net/i/00000155-9d63-52b1-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN100i-623-3
AC CVCL_EL00
SY iPS-623-085-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN100i-623-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a227-95eb-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN101i-263-39
AC CVCL_EL01
SY iPS-263-SeV39
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN101i-263-39.cmsx
WW http://shared.eagle-i.net/i/00000155-9d15-5ad4-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN102i-96-1
AC CVCL_EL02
SY iPS-96-11592-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN102i-96-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bb9a-229f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN103i-330-4
AC CVCL_EL03
SY iPS-330-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN103i-330-4.cmsx
WW http://shared.eagle-i.net/i/00000155-9d1d-22a8-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN104i-321-6
AC CVCL_EL04
SY iPS-321-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN104i-321-6.cmsx
WW http://shared.eagle-i.net/i/00000155-bc04-7bce-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN105i-342-5
AC CVCL_EL05
SY iPS-342-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN105i-342-5.cmsx
WW http://shared.eagle-i.net/i/00000155-9d20-dd59-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN106i-75-39
AC CVCL_EL06
SY iPS-75-1681-SeV39
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN106i-75-39.cmsx
WW http://shared.eagle-i.net/i/00000155-bb88-6777-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN107i-145-1
AC CVCL_EL07
SY iPS-145-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN107i-145-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a329-d9e3-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN108i-781-3
AC CVCL_EL08
SY 781-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN108i-781-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bbeb-677b-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN109i-802-2
AC CVCL_EL09
SY iPS-802-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN109i-802-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bbe9-b3fe-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN110i-389-6
AC CVCL_EL10
SY iPS-389-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN110i-389-6.cmsx
WW http://shared.eagle-i.net/i/00000155-9d25-e7f9-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN111i-222-5
AC CVCL_EL11
SY iPS-222-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN111i-222-5.cmsx
WW http://shared.eagle-i.net/i/00000155-9d11-da19-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN112i-304-6
AC CVCL_EL12
SY iPS-304-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN112i-304-6.cmsx
WW http://shared.eagle-i.net/i/00000155-9d1a-4c05-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN113i-126-66
AC CVCL_EL13
SY iPS-126-1650-SeV66
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN113i-126-66.cmsx
WW http://shared.eagle-i.net/i/00000155-bbad-0326-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN114i-127-2
AC CVCL_EL14
SY iPS-127-1188-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN114i-127-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bbab-024e-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN115i-316-1
AC CVCL_EL15
SY iPS-316-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN115i-316-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bbfb-b0f1-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN116i-125-16
AC CVCL_EL16
SY iPS-125-1006-SeV16
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN116i-125-16.cmsx
WW http://shared.eagle-i.net/i/00000155-9d74-472d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN117i-88-32
AC CVCL_EL17
SY iPS-88-1451-SeV32
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN117i-88-32.cmsx
WW http://shared.eagle-i.net/i/00000155-bb9f-1014-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN118i-113-2
AC CVCL_EL18
SY iPS-113-1138-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN118i-113-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a745-1a38-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN119i-197-25
AC CVCL_EL19
SY iPS-197-SeV25
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN119i-197-25.cmsx
WW http://shared.eagle-i.net/i/00000155-9d61-a888-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN120i-444-1
AC CVCL_EL20
SY iPS-444 SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN120i-444-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2b3-3ff2-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK52 ! PENN052i-444-2
SX Female
CA Induced pluripotent stem cell
//
ID PENN121i-69-1
AC CVCL_EL21
SY iPS-69-1313-008-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN121i-69-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a23d-16cd-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN122i-627-5
AC CVCL_EL22
SY iPS-627-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN122i-627-5.cmsx
WW http://shared.eagle-i.net/i/00000155-9d2a-6a0c-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN123i-SV20
AC CVCL_EL23
SY iPS-SV20
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN123i-SV20.cmsx
WW http://shared.eagle-i.net/i/00000155-a2ec-b128-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN124i-28-3
AC CVCL_EL24
SY iPS-28-1619-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN124i-28-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a749-ee2e-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN125i-233-4
AC CVCL_EL25
SY iPS-233-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN125i-233-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a2f4-3bde-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN126i-120-1
AC CVCL_EL26
SY iPS-120-1042-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN126i-120-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a748-0543-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN127i-415-1
AC CVCL_EL27
SY iPS-415 SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN127i-415-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a298-e32b-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EK74 ! PENN074i-415-3
SX Female
CA Induced pluripotent stem cell
//
ID PENN128i-8-4
AC CVCL_EL28
SY iPS-8-1433-023-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN128i-8-4.cmsx
WW http://shared.eagle-i.net/i/00000155-9d5b-2833-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN129i-20-14
AC CVCL_EL29
SY iPS-20-138-SeV14
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN129i-20-14.cmsx
WW http://shared.eagle-i.net/i/00000155-bc66-3825-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN130i-78-3
AC CVCL_EL30
SY iPS-78-045-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN130i-78-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a324-7f5f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN131i-86-3
AC CVCL_EL31
SY iPS-86-1380-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN131i-86-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bb93-c521-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN132i-131-5
AC CVCL_EL32
SY iPS-131-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN132i-131-5.cmsx
WW http://shared.eagle-i.net/i/00000155-a326-6ddf-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PENN133i-252-23
AC CVCL_EL33
SY iPS-252-SeV23
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN133i-252-23.cmsx
WW http://shared.eagle-i.net/i/00000155-9d82-f650-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN134i-61-26
AC CVCL_EL34
SY iPS-61-1559-060-SeV26
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN134i-61-26.cmsx
WW http://shared.eagle-i.net/i/00000155-bc59-ec0a-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN135i-30-8
AC CVCL_EL35
SY iPS-30-135-SeV8
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN135i-30-8.cmsx
WW http://shared.eagle-i.net/i/00000155-bc55-36cc-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN136i-262-1
AC CVCL_EL36
SY iPS-262-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN136i-262-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2f9-2b62-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN137i-18-11
AC CVCL_EL37
SY iPS-18-1418-025-SeV11
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN137i-18-11.cmsx
WW http://shared.eagle-i.net/i/00000155-9d4a-8ba9-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN138i-24-4
AC CVCL_EL38
SY iPS-24-1311-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN138i-24-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bc4a-af33-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PENN139i-M5-4
AC CVCL_EL39
SY iPS-M5-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN139i-M5-4.cmsx
WW http://shared.eagle-i.net/i/00000155-c60e-2ec3-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL67 ! PENN167i-M5-3
SX Female
CA Induced pluripotent stem cell
//
ID PENN140i-M12-7
AC CVCL_EL40
SY M12-7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN140i-M12-7.cmsx
WW http://shared.eagle-i.net/i/00000155-a20f-c291-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL58 ! PENN158i-M12-4
SX Male
CA Induced pluripotent stem cell
//
ID PENN141i-M6-2
AC CVCL_EL41
SY iPS-M6-PB-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN141i-M6-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a276-fa9f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL60 ! PENN160i-M6-6
SX Female
CA Induced pluripotent stem cell
//
ID PENN142i-M3-19
AC CVCL_EL42
SY iPS-M3-SeV19
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN142i-M3-19.cmsx
WW http://shared.eagle-i.net/i/00000155-c175-2d55-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL55 ! PENN155i-M3-21
SX Male
CA Induced pluripotent stem cell
//
ID PENN143i-M10-11
AC CVCL_EL43
SY iPS-M10-SeV11
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN143i-M10-11.cmsx
WW http://shared.eagle-i.net/i/00000155-c693-1b40-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C85182; Tangier disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL61 ! PENN161i-M10-5
SX Male
CA Induced pluripotent stem cell
//
ID PENN144i-M7-16
AC CVCL_EL44
SY iPS-M7-SeV16
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN144i-M7-16.cmsx
WW http://shared.eagle-i.net/i/00000155-9394-68d8-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C84525; Abetalipoproteinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL50 ! PENN150i-M7-9
SX Male
CA Induced pluripotent stem cell
//
ID PENN145i-M16-2
AC CVCL_EL45
SY M16-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN145i-M16-2.cmsx
WW http://shared.eagle-i.net/i/00000155-bce1-251b-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL68 ! PENN168i-M16-1
SX Female
CA Induced pluripotent stem cell
//
ID PENN146i-M11-5
AC CVCL_EL46
SY iPS-M11-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN146i-M11-5.cmsx
WW http://shared.eagle-i.net/i/00000155-a2d3-3c97-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL64 ! PENN164i-M11-1
SX Male
CA Induced pluripotent stem cell
//
ID PENN147i-M9-7
AC CVCL_EL47
SY M9-7
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN147i-M9-7.cmsx
WW http://shared.eagle-i.net/i/00000155-c664-49d7-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL71 ! PENN171i-M9-9
SX Male
CA Induced pluripotent stem cell
//
ID PENN148i-M8-3
AC CVCL_EL48
SY iPS-M8-PB-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN148i-M8-3.cmsx
WW http://shared.eagle-i.net/i/00000155-a27e-6019-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL56 ! PENN156i-M8-2
SX Male
CA Induced pluripotent stem cell
//
ID PENN149i-M1-6
AC CVCL_EL49
SY iPS-M1-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN149i-M1-6.cmsx
WW http://shared.eagle-i.net/i/00000155-9d7f-1268-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL51 ! PENN151i-M1-5
SX Female
CA Induced pluripotent stem cell
//
ID PENN150i-M7-9
AC CVCL_EL50
SY iPS-M7-PB-SeV9
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN150i-M7-9.cmsx
WW http://shared.eagle-i.net/i/00000155-93bb-9149-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C84525; Abetalipoproteinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL44 ! PENN144i-M7-16
SX Male
CA Induced pluripotent stem cell
//
ID PENN151i-M1-5
AC CVCL_EL51
SY iPS-M1-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN151i-M1-5.cmsx
WW http://shared.eagle-i.net/i/00000155-9d7c-06a2-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL49 ! PENN149i-M1-6
SX Female
CA Induced pluripotent stem cell
//
ID PENN152i-M18-1
AC CVCL_EL52
SY M18-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN152i-M18-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a21b-17a8-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL54 ! PENN154i-M18-2
SX Male
CA Induced pluripotent stem cell
//
ID PENN153i-M4-10
AC CVCL_EL53
SY iPS-M4-SeV10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN153i-M4-10.cmsx
WW http://shared.eagle-i.net/i/00000155-a250-d02f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL63 ! PENN163i-M4-4
SX Male
CA Induced pluripotent stem cell
//
ID PENN154i-M18-2
AC CVCL_EL54
SY M18-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN154i-M18-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a21c-772c-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL52 ! PENN152i-M18-1
SX Male
CA Induced pluripotent stem cell
//
ID PENN155i-M3-21
AC CVCL_EL55
SY iPS-M3-SeV21
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN155i-M3-21.cmsx
WW http://shared.eagle-i.net/i/00000155-c18a-ed0e-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL42 ! PENN142i-M3-19
SX Male
CA Induced pluripotent stem cell
//
ID PENN156i-M8-2
AC CVCL_EL56
SY iPS-M8-SeV2
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN156i-M8-2.cmsx
WW http://shared.eagle-i.net/i/00000155-a27f-ddd7-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL48 ! PENN148i-M8-3
SX Male
CA Induced pluripotent stem cell
//
ID PENN157i-M2-6
AC CVCL_EL57
SY iPS-M2-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN157i-M2-6.cmsx
WW http://shared.eagle-i.net/i/00000155-c167-fe5f-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C85182; Tangier disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL65 ! PENN165i-M2-21
SX Male
CA Induced pluripotent stem cell
//
ID PENN158i-M12-4
AC CVCL_EL58
SY M12-4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN158i-M12-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a20e-4065-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL40 ! PENN140i-M12-7
SX Male
CA Induced pluripotent stem cell
//
ID PENN159i-M14-4
AC CVCL_EL59
SY M14-4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN159i-M14-4.cmsx
WW http://shared.eagle-i.net/i/00000155-c681-22f5-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C128806; Hyperalphalipoproteinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL62 ! PENN162i-M14-11
SX Female
CA Induced pluripotent stem cell
//
ID PENN160i-M6-6
AC CVCL_EL60
SY iPS-M6-SeV6
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN160i-M6-6.cmsx
WW http://shared.eagle-i.net/i/00000155-a278-e550-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL41 ! PENN141i-M6-2
SX Female
CA Induced pluripotent stem cell
//
ID PENN161i-M10-5
AC CVCL_EL61
SY iPS-M10-PB-SeV5
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN161i-M10-5.cmsx
WW http://shared.eagle-i.net/i/00000155-c68f-e43c-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C85182; Tangier disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL43 ! PENN143i-M10-11
SX Male
CA Induced pluripotent stem cell
//
ID PENN162i-M14-11
AC CVCL_EL62
SY M14-11
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN162i-M14-11.cmsx
WW http://shared.eagle-i.net/i/00000155-c67e-796a-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C128806; Hyperalphalipoproteinemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL59 ! PENN159i-M14-4
SX Female
CA Induced pluripotent stem cell
//
ID PENN163i-M4-4
AC CVCL_EL63
SY iPs-M4-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN163i-M4-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a273-92a3-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL53 ! PENN153i-M4-10
SX Male
CA Induced pluripotent stem cell
//
ID PENN164i-M11-1
AC CVCL_EL64
SY iPS-M11-PB-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN164i-M11-1.cmsx
WW http://shared.eagle-i.net/i/00000155-a2cb-5b29-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL46 ! PENN146i-M11-5
SX Male
CA Induced pluripotent stem cell
//
ID PENN165i-M2-21
AC CVCL_EL65
SY iPS-M2-SeV21
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN165i-M2-21.cmsx
WW http://shared.eagle-i.net/i/00000155-c163-5212-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C85182; Tangier disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL57 ! PENN157i-M2-6
SX Male
CA Induced pluripotent stem cell
//
ID PENN166i-M15-4
AC CVCL_EL66
SY M15-4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN166i-M15-4.cmsx
WW http://shared.eagle-i.net/i/00000155-a24c-3793-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL72 ! PENN172i-M15-10
SX Female
CA Induced pluripotent stem cell
//
ID PENN167i-M5-3
AC CVCL_EL67
SY iPS-M5-PB-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN167i-M5-3.cmsx
WW http://shared.eagle-i.net/i/00000155-c5da-e6ae-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL39 ! PENN139i-M5-4
SX Female
CA Induced pluripotent stem cell
//
ID PENN168i-M16-1
AC CVCL_EL68
SY M16-SeV1
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN168i-M16-1.cmsx
WW http://shared.eagle-i.net/i/00000155-bcdf-1728-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL45 ! PENN145i-M16-2
SX Female
CA Induced pluripotent stem cell
//
ID PENN169i-M17-3
AC CVCL_EL69
SY iPS-M17-SeV3
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN169i-M17-3.cmsx
WW http://shared.eagle-i.net/i/00000155-bce7-41ae-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C85182; Tangier disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL70 ! PENN170i-M17-4
SX Male
CA Induced pluripotent stem cell
//
ID PENN170i-M17-4
AC CVCL_EL70
SY iPS-M17-SeV4
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN170i-M17-4.cmsx
WW http://shared.eagle-i.net/i/00000155-bcea-4ea5-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C85182; Tangier disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL69 ! PENN169i-M17-3
SX Male
CA Induced pluripotent stem cell
//
ID PENN171i-M9-9
AC CVCL_EL71
SY M9-9
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN171i-M9-9.cmsx
WW http://shared.eagle-i.net/i/00000155-c66e-740d-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
DI NCIt; C123416; Familial hypercholesterolemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL47 ! PENN147i-M9-7
SX Male
CA Induced pluripotent stem cell
//
ID PENN172i-M15-10
AC CVCL_EL72
SY M15-10
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/PENN172i-M15-10.cmsx
WW http://shared.eagle-i.net/i/00000155-a24a-8995-dc2e-0c4980000000
CC Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC From: Rader D.; University of Pennsylvania; Philadelphia; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EL66 ! PENN166i-M15-4
SX Female
CA Induced pluripotent stem cell
//
ID PEO1
AC CVCL_2686
SY PE01; PEO-1
DR BTO; BTO:0005796
DR EFO; EFO_0005445
DR BioSample; SAMN03473296
DR Cosmic; 991317
DR Cosmic; 1102826
DR Cosmic; 1305316
DR Cosmic; 1524353
DR Cosmic; 1709263
DR Cosmic-CLP; 1480372
DR ECACC; 10032308
DR GDSC; 1480372
DR GEO; GSM185145
DR GEO; GSM185146
DR GEO; GSM459703
DR GEO; GSM459853
DR GEO; GSM723253
DR GEO; GSM851938
DR GEO; GSM1670347
DR Ximbio; 151672
RX PubMed=3167863;
RX PubMed=8824553;
RX PubMed=9041185;
RX PubMed=20581869;
RX PubMed=22328975;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=27235858;
RX PubMed=27397505;
RX PubMed=27561551;
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: ~37 hours (ECACC).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9
ST D18S51: 16,17
ST D19S433: 13,15
ST D21S11: 32.2
ST D2S1338: 20,21
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13,14 (PubMed=25230021)
ST D8S1179: 13 (PubMed=25877200)
ST FGA: 20
ST Penta D: 14
ST Penta E: 11,12
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 15,16
DI NCIt; C36100; BRCA1 syndrome
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2690 ! PEO4
OI CVCL_2691 ! PEO6
SX Female
CA Cancer cell line
//
ID PEO1-CDDP
AC CVCL_Y032
SY PEO1CDDP; PEO1 cDDPr
DR Ximbio; 151784
RX PubMed=8824553;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Ascites.
DI NCIt; C36100; BRCA1 syndrome
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2686 ! PEO1
SX Female
CA Cancer cell line
//
ID PEO14
AC CVCL_2687
SY PE014; PEO-14
DR EFO; EFO_0005446
DR Cosmic; 1305318
DR ECACC; 10032311
DR GEO; GSM313700
DR GEO; GSM459856
DR GEO; GSM659402
DR Ximbio; 151675
RX PubMed=3167863;
RX PubMed=8824553;
RX PubMed=20581869;
RX PubMed=23415752;
RX PubMed=25230021;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: ~108 hours (ECACC).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
ST Source(s): ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 15
ST D19S433: 14,15
ST D21S11: 27,30
ST D2S1338: 19
ST D3S1358: 16,18
ST D5S818: 11,12 (ECACC)
ST D5S818: 12 (PubMed=25230021)
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9,13
ST Penta E: 10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2689 ! PEO23
OI CVCL_2734 ! TO14
SX Female
CA Cancer cell line
//
ID PEO16
AC CVCL_2688
SY PE016
DR ECACC; 10032312
DR Ximbio; 151676
RX PubMed=3167863;
RX PubMed=25230021;
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: ~120 hours (ECACC).
ST Source(s): ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 13
ST D16S539: 12
ST D18S51: 12,19
ST D19S433: 13,14.2
ST D21S11: 30
ST D2S1338: 20,23
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8
ST D8S1179: 14,15
ST FGA: 19,22
ST Penta D: 13
ST Penta E: 7
ST TH01: 7
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PEO23
AC CVCL_2689
SY PE023
DR EFO; EFO_0005447
DR ECACC; 10032313
DR GEO; GSM459857
DR Ximbio; 151677
RX PubMed=3167863;
RX PubMed=20581869;
RX PubMed=23415752;
RX PubMed=25230021;
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: ~120 hours (ECACC).
CC Derived from metastatic site: Ascites.
ST Source(s): ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11
ST D18S51: 15
ST D19S433: 14,15
ST D21S11: 27,30
ST D2S1338: 24
ST D3S1358: 16
ST D5S818: 11,12 (ECACC)
ST D5S818: 12 (PubMed=25230021)
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9,13
ST Penta E: 10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2687 ! PEO14
OI CVCL_2734 ! TO14
SX Female
CA Cancer cell line
//
ID PEO4
AC CVCL_2690
SY PE04; PEO-4
DR BTO; BTO:0005797
DR EFO; EFO_0005448
DR Cosmic; 1709261
DR ECACC; 10032309
DR GEO; GSM185147
DR GEO; GSM185148
DR GEO; GSM459657
DR GEO; GSM459854
DR GEO; GSM851939
DR Ximbio; 151673
RX PubMed=3167863;
RX PubMed=8824553;
RX PubMed=9041185;
RX PubMed=20581869;
RX PubMed=22328975;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=25230021;
RX PubMed=27235858;
RX PubMed=27561551;
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: ~36 hours (ECACC).
CC Omics: Deep proteome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ECACC; PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9
ST D18S51: 16,17
ST D19S433: 13,15
ST D21S11: 30,32.2
ST D2S1338: 20,21
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9,14
ST Penta E: 11,12
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 15,16
DI NCIt; C36100; BRCA1 syndrome
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2686 ! PEO1
OI CVCL_2691 ! PEO6
SX Female
CA Cancer cell line
//
ID PEO6
AC CVCL_2691
SY PE06; PEO-6
DR BTO; BTO:0005798
DR EFO; EFO_0005449
DR ECACC; 10032310
DR GEO; GSM459855
DR GEO; GSM659400
DR Ximbio; 151674
RX PubMed=3167863;
RX PubMed=20581869;
RX PubMed=22710073;
RX PubMed=23415752;
CC Doubling time: ~77 hours (ECACC).
CC Derived from metastatic site: Ascites.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 15,16
DI NCIt; C36100; BRCA1 syndrome
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2686 ! PEO1
OI CVCL_2690 ! PEO4
SX Female
CA Cancer cell line
//
ID Per Sel
AC CVCL_3327
DR CLO; CLO_0008419
DR ATCC; CRL-1107
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID PER-106
AC CVCL_8904
SY PER 106
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=1581878;
CC Doubling time: 10.5 days for non-adherent, >30 days for adherent (PubMed=1581878).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8905 ! PER-107
OI CVCL_8906 ! PER-108
SX Male
CA Cancer cell line
//
ID PER-107
AC CVCL_8905
SY PER 107
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=1581878;
CC Doubling time: 5.75 days (PubMed=1581878).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8904 ! PER-106
OI CVCL_8906 ! PER-108
SX Male
CA Cancer cell line
//
ID PER-108
AC CVCL_8906
SY PER 108
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=1581878;
CC Doubling time: 3.25 days (PubMed=1581878).
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8904 ! PER-106
OI CVCL_8905 ! PER-107
SX Male
CA Cancer cell line
//
ID PER-117
AC CVCL_W979
SY PER 117
RX PubMed=3472019;
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-145
AC CVCL_W976
RX PubMed=2720661;
RX PubMed=3472651;
RX PubMed=7540895;
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W977 ! PER-163
OI CVCL_W978 ! PER-164
SX Male
CA Cancer cell line
//
ID PER-163
AC CVCL_W977
RX PubMed=2720661;
RX PubMed=3472651;
RX PubMed=7540895;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W976 ! PER-145
OI CVCL_W978 ! PER-164
SX Male
CA Cancer cell line
//
ID PER-164
AC CVCL_W978
RX PubMed=2720661;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W976 ! PER-145
OI CVCL_W977 ! PER-163
SX Male
CA Cancer cell line
//
ID PER-255
AC CVCL_W980
SY PER 255
RX PubMed=2546623;
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-278
AC CVCL_W981
RX PubMed=2340491;
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-365
AC CVCL_A474
DR Cosmic; 1130241
RX PubMed=7536459;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A475 ! PER-377
SX Male
CA Cancer cell line
//
ID PER-371
AC CVCL_W982
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-377
AC CVCL_A475
SY PER377
DR Cosmic; 1130242
RX PubMed=7536459;
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A474 ! PER-365
SX Male
CA Cancer cell line
//
ID PER-423
AC CVCL_K242
SY PER 423
RX PubMed=8429680;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-427
AC CVCL_W983
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PER-485
AC CVCL_W984
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PER-487
AC CVCL_W985
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-490
AC CVCL_W986
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PER-495
AC CVCL_W987
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-537
AC CVCL_W988
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-550
AC CVCL_W989
RX PubMed=12883040;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-604
AC CVCL_W990
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-606
AC CVCL_W991
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-607
AC CVCL_W992
RX PubMed=17117183;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PER-608
AC CVCL_W993
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PER-VAS
AC CVCL_DI60
RX PubMed=26345430;
CC Doubling time: 16.5 hours (PubMed=26345430).
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID PER.C6
AC CVCL_G704
SY PER C6; PER cell clone 6
RX PubMed=9741429;
RX PubMed=11257414;
RX PubMed=25903999;
WW http://web.archive.org/web/20140721200546/http://www.crucell.com/page/downloads/Factsheet_PER.C6_Technology.pdf
WW http://web.archive.org/web/20121219090924/http://www.dsm.com/en_US/downloads/dpp/PER.C6_Brochure.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-452.html
CC Group: Vaccine production cell line.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1A/E1B].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1K15 ! 911
CA Transformed cell line
//
ID Peri.4U
AC CVCL_1E62
WW http://axiogenesis.com/products/neuronal-cells/peri-4u-hipsc-peripheral-neurons.html
WW http://axiogenesis.com/images/pdf/flyers/140919_Flyer_Peri4U_v1.pdf
CC From: Axiogenesis AG; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID PERK-KO-DR
AC CVCL_B067
DR ATCC; CRL-2976
CC Knockout cell: Method=KO mouse; MGI; MGI:1341830; Eif2ak3.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID pES[12]
AC CVCL_C101
SY pES(12); pES12; PES12; ESe027-A
DR hPSCreg; ESe027-A
DR ISCR; 2274
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Documento_Deposito_Lineas_pES12.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID PET
AC CVCL_N816
DR Cosmic; 1656048
RX PubMed=15274292;
RX PubMed=22426987;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PETCH
AC CVCL_E803
DR dbMHC; 48998
DR ECACC; 94092801
DR IHW; IHW9205
DR IMGT/HLA; 11246
WW http://bioinformatics.hsanmartino.it/ecbr/cl205.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID PF
AC CVCL_R981
SY Poecilia Fry
RX CelloPub=CLPUB00098;
CC Group: Fish cell line.
CC Doubling time: ~1.5 days (CelloPub=CLPUB00098).
OX NCBI_TaxID=48698; ! Poecilia formosa
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PF-382
AC CVCL_1641
SY PF382
DR CLO; CLO_0008421
DR CLDB; cl3895
DR CLDB; cl4993
DR BioSample; SAMN03473327
DR CCLE; PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308246
DR ChEMBL-Targets; CHEMBL2366235
DR Cosmic; 909260
DR Cosmic; 913414
DR Cosmic; 1012113
DR Cosmic; 1115593
DR Cosmic; 1151790
DR Cosmic; 1224370
DR Cosmic; 1524814
DR Cosmic; 1641384
DR Cosmic; 2165708
DR Cosmic-CLP; 909260
DR DSMZ; ACC-38
DR GDSC; 909260
DR GEO; GSM887513
DR GEO; GSM888595
DR GEO; GSM1670348
DR ICLC; HTL00006
RX PubMed=2410652;
RX PubMed=3499548;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 9,10
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PF-R
AC CVCL_0I61
SY PF
DR CCLV; CCLV-RIE 0200
RX PubMed=19941903;
CC Group: Bird cell line.
OX NCBI_TaxID=9103; ! Meleagris gallopavo
CA Finite cell line
//
ID PF04015
AC CVCL_E804
DR dbMHC; 48999
DR ECACC; 95052212
DR IHW; IHW9088
DR IMGT/HLA; 11645
DR PRIDE; PXD001205
RX PubMed=25502872;
WW http://bioinformatics.hsanmartino.it/ecbr/cl88.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PF1038
AC CVCL_M196
RX PubMed=23516439;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PF97387
AC CVCL_E805
DR CLDB; cl7226
DR dbMHC; 49000
DR ECACC; 95042722
DR ICLC; HTL14004
DR IHW; IHW9027
DR IMGT/HLA; 11644
WW http://bioinformatics.hsanmartino.it/ecbr/cl27.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PFC
AC CVCL_6F45
RX PubMed=26341227;
CC Transfected with: UniProtKB; F1S027; Pig TERT.
CC Breed/subspecies: Jangquhaid.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Telomerase immortalized cell line
//
ID PFC6
AC CVCL_S883
RX PubMed=6184607;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID Pfeiffer
AC CVCL_3326
SY PFEIFFER
DR CLO; CLO_0008423
DR EFO; EFO_0006472
DR ATCC; CRL-2632
DR BioSample; SAMN03471758
DR CCLE; PFEIFFER_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1670184
DR Cosmic; 1714155
DR Cosmic; 1945187
DR Cosmic; 2276336
DR Cosmic; 2437318
DR GEO; GSM380141
DR GEO; GSM552461
DR GEO; GSM887514
DR GEO; GSM888596
DR IGRhCellID; Pfeiffer
RX PubMed=10485273;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=23292937;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Misspelling: 'Pfieffer' in Cosmic 1945187 and PubMed=23292937.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 10,13
ST D7S820: 8,12
ST TH01: 9,9.3
ST TPOX: 9
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PFF
AC CVCL_R806
SY Puntius Fasciatus Fin
RX PubMed=23933168;
CC Group: Fish cell line.
OX NCBI_TaxID=1503185; ! Haludaria fasciata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PFHR-9
AC CVCL_3566
SY PFHR 9; PFHR9; PF HR-9
DR CLO; CLO_0008424
DR ATCC; CRL-2423
RX PubMed=558822;
RX PubMed=1917782;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5911 ! PCC4-F
SX Male
CA Cancer cell line
//
ID PFI-285
AC CVCL_A664
DR Cosmic; 1086320
RX PubMed=2307225;
DI NCIt; C3466; T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PFIZi001-A
AC CVCL_9S31
SY EM1-3F
DR hPSCreg; PFIZi001-A
CC From: Pfizer, Inc.
DI NCIt; C34593; Erythromelalgia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PFIZi002-A
AC CVCL_9S32
SY EM1-7M
DR hPSCreg; PFIZi002-A
CC From: Pfizer, Inc.
DI NCIt; C34593; Erythromelalgia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PFIZi003-A
AC CVCL_9S33
SY EM2-7M
DR hPSCreg; PFIZi003-A
CC From: Pfizer, Inc.
DI NCIt; C34593; Erythromelalgia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PFIZi004-A
AC CVCL_9S34
SY EM2-7F
DR hPSCreg; PFIZi004-A
CC From: Pfizer, Inc.
DI NCIt; C34593; Erythromelalgia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PFIZi013-A
AC CVCL_IJ00
SY RCFB59 C9; RCi215
DR BioSamples; SAMEA4343623
DR EBiSC; PFIZi013-A
DR ECACC; 66540322
DR hPSCreg; PFIZi013-A
CC From: Pfizer, Inc.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PFIZi014-A
AC CVCL_IJ01
SY OD002-s7
DR BioSamples; SAMEA4454946
DR hPSCreg; PFIZi014-A
CC From: Pfizer, Inc.
DI NCIt; C116573; Dravet syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PFIZi015-A
AC CVCL_IJ02
SY OD003-s5
DR BioSamples; SAMEA4454948
DR hPSCreg; PFIZi015-A
CC From: Pfizer, Inc.
DI NCIt; C116573; Dravet syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PFIZi016-A
AC CVCL_IJ03
SY OD005-s9
DR BioSamples; SAMEA4454950
DR hPSCreg; PFIZi016-A
CC From: Pfizer, Inc.
DI NCIt; C116573; Dravet syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PFSK-1
AC CVCL_1642
SY PFSK
DR CLO; CLO_0008425
DR EFO; EFO_0005234
DR ATCC; CRL-2060
DR BioSample; SAMN03471425
DR ChEMBL-Cells; CHEMBL3308802
DR ChEMBL-Targets; CHEMBL1075560
DR Cosmic; 683667
DR Cosmic; 923655
DR Cosmic; 973260
DR Cosmic; 1728490
DR Cosmic; 1995615
DR Cosmic-CLP; 683667
DR ENCODE; ENCBS054ENC
DR GDSC; 683667
DR GEO; GSM923430
DR GEO; GSM1670349
DR IZSLER; BS TCL 202
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1316433;
RX PubMed=23325432;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/PFSK-1_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,14
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PFV
AC CVCL_DR64
SY Pig Flip-in Visualize
RX PubMed=20336379;
CC Characteristics: Transfected with a construct that contains a Sleeping Beauty (SB) DNA transposon, a puromycin resistance gene, an EGFP reporter gene and an Flp recombinase site for locus-directed gene insertion.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: Gottingen minipig.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Spontaneously immortalized cell line
//
ID PG [Esox lucius]
AC CVCL_4272
DR CLO; CLO_0008426
DR ECACC; 95070629
RX DOI=10.1007/BF02618036;
CC Group: Fish cell line.
OX NCBI_TaxID=8010; ! Esox lucius
SX Female
CA Spontaneously immortalized cell line
//
ID PG [Human lung carcinoma]
AC CVCL_4389
DR BTO; BTO:0002412
RX PubMed=10374431;
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PG-4 (S+L-)
AC CVCL_3413
SY PG-4(S+L-); PG-4 S+L-; PG-4
DR CLO; CLO_0008429
DR CLO; CLO_0008430
DR CLDB; cl3898
DR CLDB; cl3899
DR ATCC; CRL-2032
DR BCRC; 60470
DR CCRID; 3111C0002000000080
DR ECACC; 94102703
DR ICLC; ATL97002
DR JCRB; JCRB9125
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
OX NCBI_TaxID=9685; ! Felis catus
HI CVCL_GR56 ! G355
CA Transformed cell line
//
ID PG-49
AC CVCL_D539
DR ChEMBL-Cells; CHEMBL3308677
DR ChEMBL-Targets; CHEMBL614847
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PG-BE1
AC CVCL_4390
SY PGBE1
DR BTO; BTO:0002413
DR CCRID; 3111C0001CCC000201
RX PubMed=7656376;
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4389 ! PG [Human lung carcinoma]
CA Cancer cell line
//
ID PG-CL3
AC CVCL_4391
SY PGCL3
DR BTO; BTO:0002414
RX PubMed=7656376;
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4389 ! PG [Human lung carcinoma]
CA Cancer cell line
//
ID PG-LH7
AC CVCL_4392
SY PGLH7
DR BTO; BTO:0002415
DR CCRID; 3111C0001CCC000202
RX PubMed=7656376;
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4389 ! PG [Human lung carcinoma]
CA Cancer cell line
//
ID PG/B95-8
AC CVCL_Y555
SY PG-EBV
DR DSMZ; ACC-776
RX PubMed=2836321;
RX PubMed=23297799;
CC Doubling time: ~35 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y545 ! PGA-1
SX Male
CA Transformed cell line
//
ID PG1-iPS-1
AC CVCL_L666
SY PG1-IPS-1
DR ISCR; 1990
RX PubMed=21185252;
CC From: A*STAR Institute of Medical Biology; Singapore; Singapore.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H766 ! AG11498
SX Male
CA Induced pluripotent stem cell
//
ID PG1-iPS-2
AC CVCL_L667
SY PG1-IPS-2
DR ISCR; 1991
RX PubMed=21185252;
CC From: A*STAR Institute of Medical Biology; Singapore; Singapore.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H766 ! AG11498
SX Male
CA Induced pluripotent stem cell
//
ID PG100
AC CVCL_Z278
SY PG-100
RX DOI=10.3748/wjg.v22.i43.9506;
RX PubMed=20658094;
CC Omics: Array-based CGH.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PG13
AC CVCL_4273
DR CLO; CLO_0008427
DR CLDB; cl3900
DR ATCC; CRL-10686
DR ECACC; 95110215
DR TOKU-E; 2880
RX PubMed=1850008;
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9116 ! NIH 3T3-TK-
SX Male
CA Transformed cell line
//
ID PG13/LN c8
AC CVCL_8933
DR CLO; CLO_0008428
DR ATCC; CRL-10685
RX PubMed=1850008;
CC Group: Retrovirus packaging cell line.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4273 ! PG13
SX Male
CA Transformed cell line
//
ID PG19
AC CVCL_S409
SY C57Bl melanoma clone PG 19; PG 19
RX PubMed=893544;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: C57BL/6J.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0192 ! C57/B1
SX Female
CA Cancer cell line
//
ID PG19T3
AC CVCL_S407
RX PubMed=510081;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: C57BL/6J.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S409 ! PG19
SX Female
CA Cancer cell line
//
ID PG19T3:MTXR10-4M
AC CVCL_4Y71
SY PG19T3:MTXR.10-4 M
RX PubMed=510081;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: C57BL/6J.
DI NCIt; C21790; Mouse melanoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S407 ! PG19T3
SX Female
CA Cancer cell line
//
ID PG2-iPS-1
AC CVCL_L668
SY PG2-IPS-1
DR ISCR; 1992
RX PubMed=21185252;
CC From: A*STAR Institute of Medical Biology; Singapore; Singapore.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H765 ! AG06297
SX Male
CA Induced pluripotent stem cell
//
ID PG2-iPS-2
AC CVCL_L669
SY PG2-IPS-2
DR ISCR; 1993
RX PubMed=21185252;
CC From: A*STAR Institute of Medical Biology; Singapore; Singapore.
DI NCIt; C34951; Progeria
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H765 ! AG06297
SX Male
CA Induced pluripotent stem cell
//
ID PG64SV.2
AC CVCL_DQ62
RX PubMed=27345795;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID PGA-1
AC CVCL_Y545
SY PGA1; PG A1; CLL-PGA
DR DSMZ; ACC-766
DR NCBI_Iran; C583
RX PubMed=2836321;
RX PubMed=23297799;
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y555 ! PG/B95-8
SX Male
CA Cancer cell line
//
ID PGC-2
AC CVCL_6713
RX PubMed=8916040;
RX PubMed=15541573;
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Spontaneously immortalized cell line
//
ID PGF
AC CVCL_E806
SY GM03107
DR CLO; CLO_0013567
DR Coriell; GM03107
DR dbMHC; 49001
DR ECACC; 94050342
DR IHW; IHW9318
DR IMGT/HLA; 11248
RX PubMed=16702430;
WW http://bioinformatics.hsanmartino.it/ecbr/cl318.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PGK12.1
AC CVCL_AS07
SY Pgk12.1; PGK 12.1
DR BioSample; SAMN00672592
DR GEO; GSM761213
DR GEO; GSM1081335
RX PubMed=8156596;
RX PubMed=8538762;
RX PubMed=12874099;
RX PubMed=16244654;
CC Omics: Deep RNAseq analysis.
CC Breed/subspecies: PGK x 129/Ola/Hsd.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID PGLC-33h
AC CVCL_HA64
SY PGLC-33H
RX PubMed=788925;
RX PubMed=824057;
RX PubMed=5641111;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C34726; Infectious mononucleosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID PGME1
AC CVCL_0F77
SY PGME 1
RX PubMed=2612208;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0F71 ! MB63
CA Hybrid cell line
//
ID pgsA-745
AC CVCL_4589
SY S745; 745; Mutant 745
DR CLO; CLO_0008434
DR ATCC; CRL-2242
DR CCLV; CCLV-RIE 0316
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID pgsB-618
AC CVCL_4590
SY 618; Mutant 618
DR CLO; CLO_0008435
DR ATCC; CRL-2241
RX PubMed=2957376;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID pgsB-650
AC CVCL_4591
SY 650; Mutant 650
DR CLO; CLO_0008436
DR ATCC; CRL-2243
RX PubMed=2957376;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID pgsC-605
AC CVCL_4592
SY 605; Mutant 605
DR CLO; CLO_0008437
DR ATCC; CRL-2245
RX PubMed=3782085;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID pgsD-677
AC CVCL_4593
DR CLO; CLO_0008438
DR ATCC; CRL-2244
RX PubMed=1532254;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID pgsE-606
AC CVCL_4594
DR CLO; CLO_0008439
DR ATCC; CRL-2246
DR BCRC; 60542
DR CCLV; CCLV-RIE 0317
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID PGV
AC CVCL_W866
SY Porcine Granulosa cell-Virus transformed
RX PubMed=15832078;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Transformed cell line
//
ID PH [Human]
AC CVCL_L107
DR ATCC; CRL-9851
DR BioSample; SAMN03471075
RX Patent=US5447861;
CC Problematic cell line: Contaminated. Shown to be a U-937 derivative.
CC Discontinued: ATCC; CRL-9851; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID PH [Pilchard]
AC CVCL_R915
SY Pilchard Heart
RX PubMed=15801155;
CC Group: Fish cell line.
OX NCBI_TaxID=59687; ! Sardinops neopilchardus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Ph 310
AC CVCL_T588
SY Ph-310; SPPC-PH310
RX PubMed=183370;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9054; ! Phasianus colchicus
CA Spontaneously immortalized cell line
//
ID PH-2
AC CVCL_EJ71
SY PH2
RX Patent=US5830638;
CC Group: Non-human primate cell line.
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2165.
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_EJ70 ! Vero M
SX Female
CA Spontaneously immortalized cell line
//
ID PH1-Fib-hiPSC4F
AC CVCL_DQ60
RX PubMed=27345794;
DI NCIt; C123212; Primary hyperoxaluria type I
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ61 ! PH1-PBMCs-hiPSC4F1
SX Male
CA Induced pluripotent stem cell
//
ID PH1-PBMCs-hiPSC4F1
AC CVCL_DQ61
RX PubMed=27345794;
DI NCIt; C123212; Primary hyperoxaluria type I
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DQ60 ! PH1-Fib-hiPSC4F
SX Male
CA Induced pluripotent stem cell
//
ID PH5
AC CVCL_5862
SY PH-5; Porcine Hyalocyte-derived cell line 5
DR BTO; BTO:0004273
RX PubMed=17707370;
CC Doubling time: 56.9 +- 22.6 hours (PubMed=17707370).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9823; ! Sus scrofa
CA Transformed cell line
//
ID PH61-N
AC CVCL_D282
SY PH61N
DR BioSample; SAMN03151845
DR BioSample; SAMN03472485
DR CGH-DB; 181-1
DR JCRB; JCRB1038
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a MIA PaCa-2 derivative (PubMed=20143388).
CC Discontinued: JCRB; JCRB1038; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12,13
ST D16S539: 10,13
ST D5S818: 12,13
ST D7S820: 12,13
ST TH01: 10
ST TPOX: 9
ST vWA: 15
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0428 ! MIA PaCa-2
SX Male
CA Cancer cell line
//
ID PHA00356IN
AC CVCL_E187
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9555; ! Papio anubis
SX Sex undetermined
CA Transformed cell line
//
ID PHA00357IN
AC CVCL_E188
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9555; ! Papio anubis
SX Sex undetermined
CA Transformed cell line
//
ID PHA00358IN
AC CVCL_E189
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9555; ! Papio anubis
SX Sex undetermined
CA Transformed cell line
//
ID PHEC1
AC CVCL_6G48
SY Permanent Human Endothelial Cells 1
RX PubMed=8835314;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Phi-1
AC CVCL_4274
SY Phi 1
DR CLO; CLO_0008440
DR CLDB; cl3903
DR ECACC; 85061101
RX PubMed=6149229;
CC Breed/subspecies: AxC.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5125 ! Fu5-5
SX Male
CA Cancer cell line
//
ID PhIP12-1
AC CVCL_AS17
DR TKG; TKG 0718
RX PubMed=11289141;
CC Transformant: ChEBI; CHEBI:76290; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
CC Breed/subspecies: Fischer 344 x Sprague-Dawley.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID PhIP7-4
AC CVCL_AS18
DR TKG; TKG 0717
RX PubMed=11289141;
CC Transformant: ChEBI; CHEBI:76290; 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
CC Breed/subspecies: Fischer 344 x Sprague-Dawley.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID PHK16-0b
AC CVCL_3123
DR BioSample; SAMN03470808
DR JCRB; JCRB0141
DR JCRB; NIHS0203
CC Discontinued: JCRB; NIHS0203; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 9,11
ST D7S820: 9,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PHL
AC CVCL_5863
SY Pacific Herring Larva
DR CLO; CLO_0008441
DR ATCC; CRL-2750
RX PubMed=10813363;
RX PubMed=19002917;
CC Group: Fish cell line.
OX NCBI_TaxID=30724; ! Clupea pallasii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PHM1-31
AC CVCL_R869
SY Pregnant Human Myometrial 1-31
RX PubMed=16371591;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PHM1-41
AC CVCL_8566
SY Pregnant Human Myometrial 1-41
DR ATCC; CRL-3046
RX PubMed=8828850;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 14
ST D16S539: 10,12
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PHMLEB
AC CVCL_DG84
DR GEO; GSM232917
DR GEO; GSM232918
RX PubMed=11156605;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PHMLER
AC CVCL_DG85
DR GEO; GSM232914
DR GEO; GSM232915
DR GEO; GSM232916
RX PubMed=11156605;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG84 ! PHMLEB
SX Female
CA Transformed cell line
//
ID Phoenix-Ampho
AC CVCL_H716
SY Phoenix-AMPHO; Phoenix-ampho; Phoenix Ampho; Phoenix ampho; AmphoPhoenix; Phoenix-A; Phoenix A; PhoenixA; AmphoPack 293
DR ATCC; CRL-3213
DR ATCC; SD-3443
WW http://web.stanford.edu/group/nolan/_OldWebsite/retroviral_systems/phx.html
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Discontinued: ATCC; SD-3443; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID Phoenix-Eco
AC CVCL_H717
SY Phoenix-ECO; Phoenix Eco; PhoenixEco; Phoenix-E; Phoenix E
DR ATCC; CRL-3214
DR ATCC; SD-3444
WW http://web.stanford.edu/group/nolan/_OldWebsite/retroviral_systems/phx.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-534.html
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
CC Discontinued: ATCC; SD-3444; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12,13
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID Phoenix-gp
AC CVCL_H718
SY Phoenix-GP; Phoenix GP; PhoenixGP
DR ATCC; CRL-3215
WW http://web.stanford.edu/group/nolan/_OldWebsite/tutorials/retpkg_7_phx_sys.html
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8,9
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID PI 153/3
AC CVCL_G250
SY PI153/3; GM04278
DR CLO; CLO_0008442
DR CLO; CLO_0019597
DR ATCC; TIB-198
DR Coriell; GM04278
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID Pi Kar
AC CVCL_0F70
DR ATCC; CRL-1102
CC Discontinued: ATCC; CRL-1102; true.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID PI-11
AC CVCL_G249
DR CLO; CLO_0008445
DR ATCC; CRL-2591
RX PubMed=1426051;
CC Monoclonal antibody target: UniProtKB; P20810; Human CAST.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID PI1
AC CVCL_V129
DR CLO; CLO_0008444
DR CLDB; cl3904
DR IHW; IHW8021
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID PICM-19
AC CVCL_V146
SY ARS-PICM-19; Pig Inner Cell Mass-19
RX PubMed=7534591;
RX PubMed=8354665;
RX PubMed=8635514;
RX PubMed=12097833;
RX PubMed=20333478;
RX PubMed=23148238;
CC Characteristics: Requires feeder cells.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PICM-19B
AC CVCL_5T67
RX PubMed=20669140;
RX PubMed=23148238;
CC Characteristics: Requires feeder cells.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_V146 ! PICM-19
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PICM-19FF
AC CVCL_5T69
SY PICM-19 Feeder Free
RX PubMed=23148238;
RX PubMed=23397443;
CC Characteristics: Does not require feeder cells.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_V146 ! PICM-19
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PICM-19H
AC CVCL_5T68
RX PubMed=20669140;
RX PubMed=23148238;
CC Characteristics: Requires feeder cells.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_V146 ! PICM-19
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PID0102
AC CVCL_T906
DR SKIP; SKIP000146
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID PID0401
AC CVCL_T907
DR SKIP; SKIP000145
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T908 ! PID0402
CA Induced pluripotent stem cell
//
ID PID0402
AC CVCL_T908
DR SKIP; SKIP000144
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T907 ! PID0401
CA Induced pluripotent stem cell
//
ID PIE
AC CVCL_HC68
SY Porcine Intestinal Epithelial cell line
DR GEO; GSE77095
RX PubMed=18082146;
CC Omics: Transcriptome analysis.
CC Breed/subspecies: LWD (Landrace x Large White x Duroc).
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID PIG1
AC CVCL_S410
SY PIGI
DR ATCC; CRL-2208
DR BioSample; SAMN03472565
RX PubMed=9028834;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Discontinued: ATCC; CRL-2208; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 8,11
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PIL
AC CVCL_E807
DR IHW; IHW0204
WW http://bioinformatics.hsanmartino.it/ecbr/cl367.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID PIL-6
AC CVCL_5347
RX PubMed=2785799;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=PIL-6
CC Breed/subspecies: BALB/c.
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4001 ! MOPC-104E
CA Cancer cell line
//
ID PIN,LJ
AC CVCL_E808
SY PIN, LJ
DR dbMHC; 49002
DR ECACC; 94082208
DR IHW; IHW9109
DR IMGT/HLA; 11654
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl109.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PIR-P3
AC CVCL_DD11
SY CHO PIR-P3
DR ATCC; CRL-11378
RX Patent=US5272070;
CC Selected for resistance to: ChEBI; CHEBI:9367; Swainsonine (Sw).
CC Discontinued: ATCC; CRL-11378; probable.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DD10 ! SwR-100
SX Female
CA Spontaneously immortalized cell line
//
ID PIR-P8
AC CVCL_IQ79
SY CHO PIR-P8
RX Patent=US5272070;
CC Selected for resistance to: ChEBI; CHEBI:9367; Swainsonine (Sw).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DD10 ! SwR-100
SX Female
CA Spontaneously immortalized cell line
//
ID Pit1/0
AC CVCL_U367
RX PubMed=20829390;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Pit1/Prl
AC CVCL_U368
RX PubMed=20829390;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Pit1/Triple
AC CVCL_U369
RX PubMed=20829390;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID PITOUT
AC CVCL_E809
DR dbMHC; 49003
DR ECACC; 94070711
DR IHW; IHW9051
DR IMGT/HLA; 11255
DR PRIDE; PXD001205
RX PubMed=8307784;
RX PubMed=25502872;
WW http://bioinformatics.hsanmartino.it/ecbr/cl51.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PJ-2
AC CVCL_D338
SY PJ2
RX PubMed=15372243;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PJS1JTO
AC CVCL_3124
SY PJ1
DR JCRB; JCRB0320
DR JCRB; KURB2083
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3324; Peutz-Jeghers syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID PJS1JTO(SVT)
AC CVCL_4W90
DR JCRB; KURB2084
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3324; Peutz-Jeghers syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3124 ! PJS1JTO
SX Female
CA Transformed cell line
//
ID PJS5JTO
AC CVCL_3125
SY PJ5
DR JCRB; JCRB0321
DR JCRB; KURB2086
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,10
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C3324; Peutz-Jeghers syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID PK
AC CVCL_AZ81
SY Pig Kidney; Porcine Kidney
RX PubMed=13744439;
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Spontaneously immortalized cell line
//
ID PK-1
AC CVCL_4717
SY PK1
DR BTO; BTO:0004854
DR CLO; CLO_0050105
DR BioSample; SAMN03472897
DR CCLE; PK1_PANCREAS
DR Cosmic; 707253
DR Cosmic; 1066176
DR Cosmic; 1644297
DR Cosmic; 2046536
DR GEO; GSM887515
DR GEO; GSM888597
DR GEO; GSM1588614
DR RCB; RCB1972
DR TKG; TKG 0239
RX PubMed=6205469;
RX PubMed=8872523;
RX PubMed=22460905;
RX PubMed=22490663;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,10
ST D16S539: 12
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 10,15
ST FGA: 22,24
ST Penta D: 9
ST Penta E: 9,20
ST TH01: 9,10 (PubMed=25877200; RCB)
ST TH01: 9 (TKG)
ST TPOX: 9,11
ST vWA: 15,19
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PK-12
AC CVCL_D711
DR Cosmic; 1066179
DR Cosmic; 1644300
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PK-13
AC CVCL_6433
SY PK13; Porcine Kidney-13
DR CLO; CLO_0008450
DR ATCC; CRL-6489
RX PubMed=19508353;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_S287 ! PK-2a
SX Male
CA Spontaneously immortalized cell line
//
ID PK-14
AC CVCL_D712
DR Cosmic; 1066180
DR Cosmic; 1644301
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PK-15
AC CVCL_2160
SY PK(15); PK (15); PK 15; PK15; Porcine Kidney-15
DR BTO; BTO:0001865
DR CLO; CLO_0008447
DR CLO; CLO_0008448
DR CLO; CLO_0050908
DR CLDB; cl3906
DR CLDB; cl3907
DR CLDB; cl3908
DR ATCC; CCL-33
DR ATCC; CRL-6593
DR BCRC; 60057
DR BCRJ; 0355
DR CCLV; CCLV-RIE 0005
DR CCRID; 3111C0001CCC000385
DR CCRID; 3142C0001000000060
DR CLS; 607426/p798_PK-15
DR DSMZ; ACC-640
DR IZSLER; BS CL 72
DR JCRB; JCRB9040
DR KCB; KCB 201002YJ
DR KCLB; 10033
DR RCB; RCB0534
RX PubMed=3009166;
RX PubMed=4132403;
RX PubMed=5962858;
RX PubMed=19508353;
RX PubMed=19941903;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=PK15
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: ~25 hours (DSMZ).
CC Discontinued: ATCC; CRL-6593; true.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_S287 ! PK-2a
SX Male
CA Spontaneously immortalized cell line
//
ID PK-16
AC CVCL_D713
DR Cosmic; 1066181
DR Cosmic; 1644302
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PK-2
AC CVCL_5348
RX PubMed=2679911;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=PK-2
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID PK-2a
AC CVCL_S287
SY PK 2 a; PK2a; PK2A
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_AZ81 ! PK
SX Male
CA Spontaneously immortalized cell line
//
ID PK-2a/CL 13
AC CVCL_6434
DR CLO; CLO_0008452
DR ATCC; CRL-6492
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6492; true.
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_S287 ! PK-2a
CA Spontaneously immortalized cell line
//
ID PK-36
AC CVCL_D719
DR Cosmic; 1066182
DR Cosmic; 1644303
RX PubMed=7622937;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PK-45H
AC CVCL_6748
SY PK-45 H
DR CLO; CLO_0050106
DR EFO; EFO_0006734
DR BioSample; SAMN03472048
DR BioSample; SAMN03472949
DR CCLE; PK45H_PANCREAS
DR Cosmic; 1066184
DR GEO; GSM887516
DR GEO; GSM888598
DR GEO; GSM1588610
DR RCB; RCB1973
DR TKG; TKG 0491
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 9
ST D16S539: 11,12
ST D18S51: 17
ST D21S11: 31.2,32.2
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 11
ST D8S1179: 10
ST FGA: 23,24
ST Penta D: 12,13
ST Penta E: 5,15
ST TH01: 6,9
ST TPOX: 11
ST vWA: 18 (PubMed=25877200)
ST vWA: 16,18 (RCB; TKG)
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6749 ! PK-45P
CA Cancer cell line
//
ID PK-45P
AC CVCL_6749
SY PK-45 P
DR CLO; CLO_0050107
DR EFO; EFO_0006735
DR BioSample; SAMN03472015
DR BioSample; SAMN03472900
DR Cosmic; 1066183
DR Cosmic; 1644304
DR RCB; RCB2141
DR TKG; TKG 0493
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 9,11
ST D16S539: 11,12
ST D18S51: 17
ST D21S11: 31.2,32.2
ST D3S1358: 15
ST D5S818: 10,12
ST D7S820: 11
ST D8S1179: 10,13
ST FGA: 23,24
ST Penta D: 12,13
ST Penta E: 5,15
ST TH01: 9
ST TPOX: 8,11 (PubMed=25877200; RCB)
ST TPOX: 11 (TKG)
ST vWA: 18 (PubMed=25877200; TKG)
ST vWA: 16,18 (RCB)
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6748 ! PK-45H
CA Cancer cell line
//
ID PK-47
AC CVCL_D720
DR Cosmic; 1066185
DR Cosmic; 1644305
RX PubMed=7622937;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PK-59
AC CVCL_4897
SY PK59
DR BTO; BTO:0005487
DR CLO; CLO_0050100
DR EFO; EFO_0006736
DR BioSample; SAMN03472950
DR CCLE; PK59_PANCREAS
DR Cosmic; 707257
DR Cosmic; 1066186
DR Cosmic; 1299305
DR Cosmic; 1644306
DR GEO; GSM887517
DR GEO; GSM888599
DR GEO; GSM1588611
DR RCB; RCB1901
DR TKG; TKG 0492
RX PubMed=7622937;
RX PubMed=22460905;
RX PubMed=22490663;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 13
ST D21S11: 30,31
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 8
ST D8S1179: 11
ST FGA: 19
ST Penta D: 8,11
ST Penta E: 16,22
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PK-8
AC CVCL_4718
SY PK8
DR BTO; BTO:0004855
DR CLO; CLO_0050112
DR EFO; EFO_0006737
DR BioSample; SAMN03472951
DR Cosmic; 707254
DR Cosmic; 1066177
DR Cosmic; 1644298
DR RCB; RCB2700
DR TKG; TKG 0383
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 9,10
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 9,12
ST D8S1179: 13,15
ST FGA: 23
ST Penta D: 9
ST Penta E: 13,15
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PK-82
AC CVCL_8402
DR CLO; CLO_0008453
DR CLDB; cl3909
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/apk-82.htm
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Spontaneously immortalized cell line
//
ID PK-87-19
AC CVCL_V285
SY PK87-19; GM10612
DR CLO; CLO_0024540
DR Coriell; GM10612
RX PubMed=2276735;
RX PubMed=2307476;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V283 ! GM07890
HI CVCL_4595 ! UV135
CA Hybrid cell line
//
ID PK-87-9
AC CVCL_V286
SY PK87-9; GM10611
DR CLO; CLO_0024543
DR Coriell; GM10611
RX PubMed=2276735;
RX PubMed=2307476;
RX PubMed=8314568;
RX PubMed=8661047;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V283 ! GM07890
HI CVCL_4595 ! UV135
CA Hybrid cell line
//
ID PK-89-12
AC CVCL_V284
SY PK89-12; GM10868
DR CLO; CLO_0024131
DR Coriell; GM10868
RX PubMed=2276735;
RX PubMed=8314568;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V283 ! GM07890
HI CVCL_4595 ! UV135
CA Hybrid cell line
//
ID PK-89-6A
AC CVCL_V287
SY PK89-6A; GM11580
DR CLO; CLO_0021219
DR Coriell; GM11580
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V283 ! GM07890
HI CVCL_4595 ! UV135
CA Hybrid cell line
//
ID PK-9
AC CVCL_D721
SY PK9
DR BTO; BTO:0005486
DR Cosmic; 707255
DR Cosmic; 1066178
DR Cosmic; 1644299
DR GEO; GSM1588618
DR TKG; TKG 0240
RX PubMed=7622937;
RX PubMed=8872523;
RX PubMed=22490663;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9,10
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9
ST TPOX: 9,11
ST vWA: 15,19
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PK-SV40
AC CVCL_9W55
RX PubMed=6314331;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PK(D1)
AC CVCL_6432
DR CLO; CLO_0008449
DR ATCC; CRL-6490
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6490; true.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Finite cell line
//
ID PK136
AC CVCL_7695
SY PK-136
DR CLO; CLO_0008451
DR ATCC; HB-191
DR CCRID; 3131C0001000600046
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PK15cl28/BS
AC CVCL_W715
SY PK15-28; PK15 clone 28
DR IZSLER; BS CL 179
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_2160 ! PK-15
SX Male
CA Spontaneously immortalized cell line
//
ID PKE20
AC CVCL_IW61
RX PubMed=2845797;
CC Selected for resistance to: PubChem; 1795; Ethylisopropylamiloride (EIPA).
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_IP75 ! LLC-PK1/Cl4
SX Male
CA Spontaneously immortalized cell line
//
ID PKE5
AC CVCL_IW62
SY PKE 5
RX PubMed=2833317;
RX PubMed=3022596;
CC Characteristics: Devoid of sodium-proton antiporter activity.
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC Breed/subspecies: Hampshire.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_IP75 ! LLC-PK1/Cl4
SX Male
CA Transformed cell line
//
ID PKF
AC CVCL_2692
SY Pig Kidney Fibroblastic
DR IFO; IFO50422
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID PKR
AC CVCL_2693
SY Pig Kidney Rough
DR IFO; IFO50423
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID PKS
AC CVCL_2694
SY Pig Kidney Smooth
DR IFO; IFO50421
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID PKSV-PCT
AC CVCL_0484
DR MCCL; MCC:0000383
RX PubMed=7474657;
RX PubMed=8100235;
RX PubMed=17219250;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID PKSV-PR
AC CVCL_W355
RX PubMed=8100235;
RX PubMed=17219250;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID PKU-1
AC CVCL_C065
SY PKU1; BJMUe001-A
DR hPSCreg; BJMUe001-A
DR ISCR; 1590
RX PubMed=16143641;
CC From: Peking University Third Hospital; Beijing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID PKU-2
AC CVCL_C066
SY PKU2; BJMUe002-A
DR hPSCreg; BJMUe002-A
DR ISCR; 1591
RX PubMed=16143641;
CC From: Peking University Third Hospital; Beijing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID PL
AC CVCL_R916
SY Pilchard Liver
RX PubMed=15801155;
CC Group: Fish cell line.
OX NCBI_TaxID=59687; ! Sardinops neopilchardus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PL-14
AC CVCL_L412
RX PubMed=640319;
CC Doubling time: 72 hours (PubMed=640319).
CC Derived from metastatic site: Ascites.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PL-20
AC CVCL_0C86
RX PubMed=20453304;
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID PL-21
AC CVCL_2161
SY PL21
DR BTO; BTO:0005928
DR EFO; EFO_0006473
DR BioSample; SAMN01821655
DR BioSample; SAMN01821714
DR BioSample; SAMN03473265
DR CCLE; PL21_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787419
DR Cosmic; 975297
DR Cosmic; 999725
DR Cosmic; 1524840
DR Cosmic; 2131556
DR Cosmic; 2306237
DR Cosmic-CLP; 1330991
DR DSMZ; ACC-536
DR GDSC; 1330991
DR GEO; GSM236801
DR GEO; GSM236837
DR GEO; GSM887518
DR GEO; GSM888600
DR GEO; GSM1374834
DR GEO; GSM1670351
DR JCRB; JCRB1319
RX PubMed=6362749;
RX PubMed=6576961;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11,13
ST D18S51: 12,13
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 12,13
ST D8S1179: 10
ST FGA: 21,24
ST Penta D: 11,13
ST Penta E: 5,17
ST TH01: 9
ST TPOX: 9,11
ST vWA: 14,18
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PL-29018
AC CVCL_M704
SY PL29018
DR Cosmic; 2297024
DR GEO; GSM115812
RX PubMed=16960149;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Pl 1Ut
AC CVCL_3771
SY Pl 1Ut (NBL-9); Pl 1 Ut (NBL-9); NBL-9; Pl.1 Ut; Pl 1 UT; Pl 1 Ut
DR CLO; CLO_0008287
DR CLO; CLO_0008443
DR CLDB; cl3910
DR ATCC; CCL-74
DR ATCC; CRL-6596
DR ECACC; 90111909
WW http://fluoview.magnet.fsu.edu/gallery/cells/pl1ut/pl1utcells.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Misspelling: Occasionally 'P1 1Ut'.
CC Discontinued: ATCC; CRL-6596; true.
OX NCBI_TaxID=9654; ! Procyon lotor
SX Female
CA Finite cell line
//
ID PL14
AC CVCL_X982
DR Cosmic; 949525
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PL18
AC CVCL_X507
SY PL-18
DR Cosmic-CLP; 1240208
DR GDSC; 1240208
DR GEO; GSM1670350
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PL377
AC CVCL_S875
RX PubMed=12904596;
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PL4
AC CVCL_S976
SY PL-4
DR Cosmic; 1198212
DR Cosmic-CLP; 1298533
DR GDSC; 1298533
DR GEO; GSM621906
DR GEO; GSM1670352
DR LINCS; 50040
RX PubMed=14695172;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 12
ST D5S818: 10,11
ST D7S820: 12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PL45
AC CVCL_3567
SY PL-45; PL 45
DR CLO; CLO_0008454
DR ATCC; CRL-2558
DR BioSample; SAMN03473284
DR CCLE; PL45_PANCREAS
DR Cosmic; 725721
DR Cosmic; 932513
DR Cosmic; 949236
DR Cosmic; 949524
DR Cosmic; 1006372
DR Cosmic; 2046533
DR Cosmic; 2434098
DR GEO; GSM206536
DR GEO; GSM621890
DR GEO; GSM887519
DR GEO; GSM888601
DR GEO; GSM1024413
DR PRIDE; PXD003198
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27259358;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=PL45
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,12
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 14
ST D5S818: 13
ST D7S820: 8,9
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 12
ST Penta E: 11,13
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 16
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1639 ! Panc 10.05
SX Male
CA Cancer cell line
//
ID PL502
AC CVCL_3126
DR JCRB; JCRB1125
DR JCRB; NIHS0421
CC Discontinued: JCRB; NIHS0421; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,10,12
ST D16S539: 9,10
ST D5S818: 9,11,13
ST D7S820: 9,10,11
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16,18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL504
AC CVCL_8305
DR BioSample; SAMN03472382
DR JCRB; JCRB1126
DR JCRB; NIHS0423
CC Discontinued: JCRB; NIHS0423; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 8
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL505
AC CVCL_3127
DR BioSample; SAMN03472461
DR JCRB; JCRB1128
DR JCRB; NIHS0424
CC Discontinued: JCRB; NIHS0424; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12
ST D7S820: 8,10
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL507
AC CVCL_3128
DR BioSample; SAMN03472462
DR JCRB; JCRB1130
DR JCRB; NIHS0426
CC Discontinued: JCRB; NIHS0426; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 9,11
ST D7S820: 8,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL508
AC CVCL_3129
DR BioSample; SAMN03472429
DR JCRB; JCRB1194
DR JCRB; NIHS0429
CC Discontinued: JCRB; NIHS0429; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,12
ST D16S539: 11,13
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL509
AC CVCL_8310
DR BioSample; SAMN03472432
DR JCRB; JCRB1197
DR JCRB; NIHS0430
CC Discontinued: JCRB; NIHS0430; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11,12
ST D5S818: 9,10
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID PL512
AC CVCL_3130
DR BioSample; SAMN03472449
DR JCRB; JCRB1229
DR JCRB; NIHS0565
CC Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC Discontinued: JCRB; NIHS0565; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,10
ST D16S539: 10,11
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL514
AC CVCL_3131
DR BioSample; SAMN03472390
DR JCRB; JCRB1300
DR JCRB; NIHS0566
CC Discontinued: JCRB; NIHS0566; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,13
ST D7S820: 9,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL516
AC CVCL_3132
DR BioSample; SAMN03472392
DR JCRB; JCRB1302
DR JCRB; NIHS0569
CC Discontinued: JCRB; NIHS0569; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 9,13
ST D7S820: 12,13
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL517
AC CVCL_8314
DR BioSample; SAMN03472395
DR JCRB; JCRB1306
DR JCRB; NIHS0570
CC Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC Discontinued: JCRB; NIHS0570; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL518
AC CVCL_3133
DR BioSample; SAMN03472396
DR JCRB; JCRB1307
DR JCRB; NIHS0571
CC Discontinued: JCRB; NIHS0571; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,10
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 9
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID PL519
AC CVCL_8436
DR JCRB; JCRB1360
DR JCRB; NIHS0575
CC Discontinued: JCRB; NIHS0575; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 10
ST D5S818: 9,12
ST D7S820: 12,13
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID PL520
AC CVCL_8322
DR JCRB; JCRB1364
DR JCRB; NIHS0576
CC Discontinued: JCRB; NIHS0576; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 10,13
ST TH01: 6,8
ST TPOX: 11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID PL521
AC CVCL_8530
DR JCRB; JCRB1423
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 10,13
ST TH01: 6
ST TPOX: 11
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID PL523
AC CVCL_8531
DR JCRB; JCRB1420
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,11
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 11,13
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID PL532
AC CVCL_3134
DR BioSample; SAMN03472444
DR JCRB; JCRB1219
DR JCRB; NIHS0516
CC Discontinued: JCRB; NIHS0516; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID PL551SF
AC CVCL_8532
DR JCRB; JCRB1412
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID PLA-801
AC CVCL_7108
SY PLA801
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PLA-801C
AC CVCL_7109
SY PLA801C; PLA801-95C; 95C
DR BTO; BTO:0002183
RX PubMed=2550196;
RX PubMed=12748951;
CC Omics: Deep proteome analysis.
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7108 ! PLA-801
CA Cancer cell line
//
ID PLA-801D
AC CVCL_7110
SY PLA801D; PLA801-95D; 95D; 95-D; 801-D
DR BTO; BTO:0002182
DR CCRID; 3131C0001000700061
DR Cosmic; 911995
DR KCB; KCB 200690YJ
RX PubMed=1839254;
RX PubMed=2550196;
RX PubMed=12748951;
CC Omics: Deep proteome analysis.
DI NCIt; C4452; Lung giant cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7108 ! PLA-801
CA Cancer cell line
//
ID PLA-802
AC CVCL_AX34
SY PLA 802; PLA802
DR Cosmic; 2296988
RX CelloPub=CLPUB00322;
RX PubMed=27008654;
CC Doubling time: 42 hours (CelloPub=CLPUB00322).
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Plat-A
AC CVCL_B489
SY Platinum-A
WW http://www.cellbiolabs.com/platinum-retroviral-packaging-cell-lines
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID Plat-E
AC CVCL_B488
SY Platinum-E
RX PubMed=10871756;
WW http://www.cellbiolabs.com/platinum-retroviral-packaging-cell-lines
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID Plat-GP
AC CVCL_B490
SY Platinum-GP; PlatGP; PLAT-gp
WW http://www.cellbiolabs.com/platinum-retroviral-packaging-cell-lines
CC Group: Retrovirus packaging cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0063 ! HEK293T
SX Female
CA Transformed cell line
//
ID PLB-985
AC CVCL_2162
SY PLB 985; PLB985
DR BTO; BTO:0002908
DR CLO; CLO_0008457
DR EFO; EFO_0002313
DR CLDB; cl3912
DR BioSample; SAMN03151776
DR Cosmic; 787475
DR Cosmic; 1089520
DR DSMZ; ACC-139
DR IGRhCellID; PLB985
RX PubMed=3475136;
RX PubMed=12592342;
RX PubMed=20143388;
RX PubMed=25984343;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/p/cell-lines-detail-65.html
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342, PubMed=20143388).
CC Doubling time: 35 hours (PubMed=25984343); ~24 hours (DSMZ).
CC Omics: shRNA library screening.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID PLC/AN/2
AC CVCL_5A03
RX PubMed=1694812;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PLC/PRF/5
AC CVCL_0485
AS CVCL_6714
SY Alexander cells; PLC-PRF-5; PLC/PRF5; PLCPRF5; PLC8024; PLC-8024; PLC
DR BTO; BTO:0003492
DR BTO; BTO:0004274
DR CLO; CLO_0008458
DR CLO; CLO_0008459
DR EFO; EFO_0006291
DR MCCL; MCC:0000384
DR CLDB; cl3914
DR CLDB; cl3915
DR CLDB; cl3916
DR CLDB; cl5248
DR ATCC; CRL-8024
DR BCRC; 60223
DR BCRJ; 0274
DR BioSample; SAMN03471130
DR BioSample; SAMN03473236
DR CCLE; PLCPRF5_LIVER
DR CCLE; ALEXANDERCELLS_LIVER
DR CCRID; 3111C0002000000071
DR CCRID; 3131C0001000700119
DR CGH-DB; 9070-4
DR ChEMBL-Cells; CHEMBL3308140
DR ChEMBL-Targets; CHEMBL1075561
DR CLS; 300315/p526_PLC-PRF-5
DR Cosmic; 721061
DR Cosmic; 808505
DR Cosmic; 871514
DR Cosmic; 873402
DR Cosmic; 925349
DR Cosmic; 945155
DR Cosmic; 948065
DR Cosmic; 1019318
DR Cosmic; 1351513
DR Cosmic; 1518224
DR Cosmic; 2023861
DR Cosmic; 2162538
DR Cosmic; 2321033
DR ECACC; 85061113
DR GDSC; 925349
DR GEO; GSM207051
DR GEO; GSM565881
DR GEO; GSM827153
DR GEO; GSM886865
DR GEO; GSM887520
DR GEO; GSM887930
DR GEO; GSM888602
DR GEO; GSM936773
DR IFO; IFO50069
DR IZSLER; BS TCL 122
DR JCRB; JCRB0406
DR KCB; KCB 200785YJ
DR KCLB; 28024
DR NCBI_Iran; C145
DR TKG; TKG 0376
DR TOKU-E; 2898
RX PubMed=63998;
RX PubMed=184551;
RX PubMed=187208;
RX PubMed=1661347;
RX PubMed=2992761;
RX PubMed=2992762;
RX PubMed=2439335;
RX PubMed=6268737;
RX PubMed=6555060;
RX PubMed=6225510;
RX PubMed=8050184;
RX PubMed=9290701;
RX PubMed=12029633;
RX PubMed=15767549;
RX PubMed=20069059;
RX PubMed=22460905;
RX PubMed=23505090;
RX PubMed=23887712;
RX PubMed=25485619;
RX PubMed=25574106;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Contains at least 7 copies of integrated HBV genomes.
CC Characteristics: Secretes hepatitis virus B surface antigen (HBsAg).
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 35-40 hours (PubMed=63998).
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Secretome proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Often called PLC8024 in Chinese literature probably because of a concatenation between PLC/PRF/5 and ATCC-8024.
CC Misspelling: 'PCL/PRF/5' in Cosmic 873402.
ST Source(s): ATCC; CLS; ECACC; JCRB; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 17
ST D21S11: 30,33.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,11 (ATCC; ECACC; JCRB; KCLB; PubMed=25877200)
ST D7S820: 9 (CLS)
ST D8S1179: 13,16
ST FGA: 25 (CLS)
ST FGA: 19.2,25 (KCLB; PubMed=25877200)
ST Penta D: 6,10
ST Penta E: 10,16
ST TH01: 8 (ATCC)
ST TH01: 7,8 (CLS; ECACC; JCRB; KCLB; PubMed=25877200)
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PLH
AC CVCL_E810
DR dbMHC; 49004
DR ECACC; 88052047
DR IHW; IHW9047
DR IMGT/HLA; 11258
DR PRIDE; PXD001205
RX PubMed=8307784;
RX PubMed=25502872;
WW http://bioinformatics.hsanmartino.it/ecbr/cl47.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PLHC-1
AC CVCL_3466
SY Poeciliopsis Lucida Hepatocellular Carcinoma-1; PLHC-1/wt; PLHC1
DR BTO; BTO:0002331
DR CLO; CLO_0008460
DR ATCC; CRL-2406
RX PubMed=9734273;
RX PubMed=22281180;
CC Group: Fish cell line.
OX NCBI_TaxID=56613; ! Poeciliopsis lucida
SX Female
CA Cancer cell line
//
ID PLHC-1/dox
AC CVCL_S585
DR BTO; BTO:0005429
RX PubMed=18950875;
CC Group: Fish cell line.
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
OX NCBI_TaxID=56613; ! Poeciliopsis lucida
HI CVCL_3466 ! PLHC-1
SX Female
CA Cancer cell line
//
ID PLJ-4.7
AC CVCL_0486
SY PLJ-47; CFPAC-PLJ-4.7; PLJ-CFTR-4.7
DR MCCL; MCC:0000385
CC Transfected with: HGNC; 1884; CFTR.
CC Derived from metastatic site: Liver.
DI NCIt; C2975; Cystic fibrosis
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1119 ! CFPAC-1
SX Male
CA Cancer cell line
//
ID PLS-1
AC CVCL_4U94
SY PLS1
RX PubMed=20419128;
DI NCIt; C8795; Recurrent undifferentiated pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PLS10
AC CVCL_Z945
SY PLS-10
RX PubMed=9045956;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID PLS20
AC CVCL_Z946
SY PLS-20
RX PubMed=9045956;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID PLS30
AC CVCL_Z947
SY PLS-30
RX PubMed=9045956;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64013; Adenocarcinoma of the rat prostate
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID PLT-2
AC CVCL_L208
RX PubMed=14712486;
DI NCIt; C4664; T-cell large granular lymphocyte leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2127 ! MOTN-1
SX Female
CA Cancer cell line
//
ID PLum-AD
AC CVCL_AV66
SY Prostate Luminal-Androgen Dependent
RX PubMed=27036046;
CC Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID PLum-AI
AC CVCL_AV67
SY Prostate Luminal-Androgen Independent
RX PubMed=27036046;
CC Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID PLum-C
AC CVCL_AV68
SY Prostate Luminal-Clone
RX PubMed=22022528;
CC Breed/subspecies: Rosa26-Cre(ER)Pten(fl/fl)P53(fl/fl).
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID PluriStem 129S6
AC CVCL_C319
SY PluriStem 129/S6; 129S6
DR BTO; BTO:0004750
DR Millipore; SCR012
CC Breed/subspecies: 129S6/SvEv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PluriStem BALB/C
AC CVCL_E924
DR Millipore; SCC052
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PluriStem C3H/HeN
AC CVCL_E925
DR Millipore; SCC055
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PluriStem C57BL/6N
AC CVCL_E926
DR Millipore; SCC050
CC Breed/subspecies: C57BL/6N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PluriStem DBA/2N
AC CVCL_E927
DR Millipore; SCC054
CC Breed/subspecies: DBA/2N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PluriStem FVB/N
AC CVCL_E928
DR Millipore; SCC053
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID PluriStem NOD
AC CVCL_GS43
DR Millipore; SCC051
CC Discontinued: Millipore; SCC051; true.
CC Breed/subspecies: NOD.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID PlyI
AC CVCL_H636
RX PubMed=2917127;
RX PubMed=15356658;
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PM-WK
AC CVCL_A665
SY PMWK
DR ATCC; CRL-2624
DR Cosmic; 1054843
DR Cosmic; 1507621
DR Cosmic; 2233665
RX PubMed=1867326;
RX PubMed=7680081;
RX PubMed=17308088;
CC Discontinued: ATCC; CRL-2624; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 8
ST D16S539: 11
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 7
ST TPOX: 7
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PM0001
AC CVCL_8Y28
DR ECACC; 01020501
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID PM1
AC CVCL_9472
DR NIH-ARP; 3038-439
RX PubMed=7745720;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0337 ! HuT 78
SX Male
CA Cancer cell line
//
ID PMC2
AC CVCL_3773
SY PMC-2
DR CLO; CLO_0008469
DR ATCC; CRL-9852
DR BioSample; SAMN03471077
RX Patent=US5447861;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12,14
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID PMC42
AC CVCL_5215
SY PMC42ET; PMC42-ET
DR GEO; GSM217595
RX PubMed=2228321;
RX PubMed=6381852;
RX PubMed=6572752;
RX PubMed=6606728;
RX PubMed=11044355;
RX PubMed=11161701;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/pmc42.htm
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PMC42-LA
AC CVCL_5216
SY PMC42LA
RX PubMed=12649344;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5215 ! PMC42
SX Female
CA Cancer cell line
//
ID PMD1-15
AC CVCL_Y529
DR SKIP; SKIP000516
RX PubMed=24936452;
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y531 ! PMD1-7
OI CVCL_Y530 ! PMD1-27
SX Male
CA Induced pluripotent stem cell
//
ID PMD1-27
AC CVCL_Y530
DR SKIP; SKIP000517
RX PubMed=24936452;
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y531 ! PMD1-7
OI CVCL_Y529 ! PMD1-15
SX Male
CA Induced pluripotent stem cell
//
ID PMD1-7
AC CVCL_Y531
DR SKIP; SKIP000515
RX PubMed=24936452;
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y529 ! PMD1-15
OI CVCL_Y530 ! PMD1-27
SX Male
CA Induced pluripotent stem cell
//
ID PMD2-10
AC CVCL_Y532
DR SKIP; SKIP000519
RX PubMed=24936452;
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y534 ! PMD2-6
OI CVCL_Y533 ! PMD2-22
SX Male
CA Induced pluripotent stem cell
//
ID PMD2-22
AC CVCL_Y533
DR SKIP; SKIP000520
RX PubMed=24936452;
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y534 ! PMD2-6
OI CVCL_Y532 ! PMD2-10
SX Male
CA Induced pluripotent stem cell
//
ID PMD2-6
AC CVCL_Y534
DR SKIP; SKIP000518
RX PubMed=24936452;
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y532 ! PMD2-10
OI CVCL_Y533 ! PMD2-22
SX Male
CA Induced pluripotent stem cell
//
ID PMD4-11
AC CVCL_T965
SY PMD 4-11
DR RCB; HPS0090
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y935 ! PMD4-14
OI CVCL_Y936 ! PMD4-16
SX Male
CA Induced pluripotent stem cell
//
ID PMD4-14
AC CVCL_Y935
SY PMD 4-14
DR RCB; HPS0091
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T965 ! PMD4-11
OI CVCL_Y936 ! PMD4-16
SX Male
CA Induced pluripotent stem cell
//
ID PMD4-16
AC CVCL_Y936
SY PMD 4-16
DR RCB; HPS0092
DI NCIt; C75487; Pelizaeus-Merzbacher disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T965 ! PMD4-11
OI CVCL_Y935 ! PMD4-14
SX Male
CA Induced pluripotent stem cell
//
ID PMDC05
AC CVCL_5G47
RX PubMed=19443030;
RX PubMed=25075025;
WW http://www.clg.niigata-u.ac.jp/~matak/eng/resmat12.pdf
DI NCIt; C7203; Blastic plasmacytoid dendritic cell neoplasm
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PME1
AC CVCL_IU82
DR Cosmic; 2559135
RX PubMed=25653542;
CC Doubling time: ~22 hours (PubMed=25653542).
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID PMF No.1
AC CVCL_0H64
RX PubMed=24859480;
DI NCIt; C2862; Primary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H65 ! PMF No.2
OI CVCL_0H66 ! PMF No.4
OI CVCL_0H67 ! PMF No.5
OI CVCL_0H68 ! PMF No.7
OI CVCL_0H69 ! PMF No.11
SX Female
CA Induced pluripotent stem cell
//
ID PMF No.11
AC CVCL_0H69
RX PubMed=24859480;
DI NCIt; C2862; Primary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H64 ! PMF No.1
OI CVCL_0H65 ! PMF No.2
OI CVCL_0H66 ! PMF No.4
OI CVCL_0H67 ! PMF No.5
OI CVCL_0H68 ! PMF No.7
SX Female
CA Induced pluripotent stem cell
//
ID PMF No.2
AC CVCL_0H65
DR SKIP; SKIP000563
RX PubMed=24859480;
DI NCIt; C2862; Primary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H64 ! PMF No.1
OI CVCL_0H66 ! PMF No.4
OI CVCL_0H67 ! PMF No.5
OI CVCL_0H68 ! PMF No.7
OI CVCL_0H69 ! PMF No.11
SX Female
CA Induced pluripotent stem cell
//
ID PMF No.4
AC CVCL_0H66
RX PubMed=24859480;
DI NCIt; C2862; Primary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H64 ! PMF No.1
OI CVCL_0H65 ! PMF No.2
OI CVCL_0H67 ! PMF No.5
OI CVCL_0H68 ! PMF No.7
OI CVCL_0H69 ! PMF No.11
SX Female
CA Induced pluripotent stem cell
//
ID PMF No.5
AC CVCL_0H67
RX PubMed=24859480;
DI NCIt; C2862; Primary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H64 ! PMF No.1
OI CVCL_0H65 ! PMF No.2
OI CVCL_0H66 ! PMF No.4
OI CVCL_0H68 ! PMF No.7
OI CVCL_0H69 ! PMF No.11
SX Female
CA Induced pluripotent stem cell
//
ID PMF No.7
AC CVCL_0H68
DR SKIP; SKIP000564
RX PubMed=24859480;
DI NCIt; C2862; Primary myelofibrosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0H64 ! PMF No.1
OI CVCL_0H65 ! PMF No.2
OI CVCL_0H66 ! PMF No.4
OI CVCL_0H67 ! PMF No.5
OI CVCL_0H69 ! PMF No.11
SX Female
CA Induced pluripotent stem cell
//
ID PMF-ko14
AC CVCL_8747
AS CVCL_H196
DR CLO; CLO_0050629
DR BioSample; SAMN03472136
DR BioSample; SAMN03472887
DR Cosmic; 1187313
DR RCB; RCB1426
RX PubMed=10853016;
CC Misspelling: 'RMF-ko14' in Cosmic 1187313.
ST Source(s): PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13,14,15
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 11,14
ST D21S11: 27,34.2
ST D2S1338: 22,23
ST D3S1358: 14,15
ST D5S818: 11,16 (PubMed=25877200)
ST D5S818: 11 (RCB)
ST D7S820: 8,8.3 (PubMed=25877200)
ST D7S820: 8 (RCB)
ST D8S1179: 13
ST FGA: 20,22
ST Penta D: 12
ST Penta E: 14,18,19
ST TH01: 9.3,11 (PubMed=25877200)
ST TH01: 9.3 (RCB)
ST TPOX: 11,12
ST vWA: 17 (PubMed=25877200)
ST vWA: 17,18 (RCB)
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PMG075
AC CVCL_E811
DR dbMHC; 49005
DR ECACC; 88052077
DR IHW; IHW9078
DR IMGT/HLA; 11646
WW http://bioinformatics.hsanmartino.it/ecbr/cl78.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID PMH161
AC CVCL_E812
DR dbMHC; 49006
DR ECACC; 94062301
DR IHW; IHW9351
DR IMGT/HLA; 11261
WW http://bioinformatics.hsanmartino.it/ecbr/cl351.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PMJ2-PC
AC CVCL_5864
DR CLO; CLO_0008470
DR ATCC; CRL-2457
RX PubMed=7683328;
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID PMJ2-R
AC CVCL_5865
DR CLO; CLO_0008471
DR ATCC; CRL-2458
RX PubMed=7683328;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Transformant: Recombinant retrovirus J2.
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID PMK
AC CVCL_4275
SY Primary Macaque Kidney
DR CLO; CLO_0008472
DR ECACC; 98020308
CC Group: Non-human primate cell line.
CC Discontinued: ECACC; 98020308; probable.
OX NCBI_TaxID=9544; ! Macaca mulatta
CA Finite cell line
//
ID PMO
AC CVCL_V647
SY Penaeus Monodon Oka
DR CCRID; 3142C0001000000547
RX DOI=10.1016/0044-8486(95)01048-3;
RX Patent=US6143547;
RX PubMed=15994770;
CC Group: Fish cell line.
CC Problematic cell line: Misidentified. Originally deposited as a shrimp (Penaeus mondodon) cell line, is in fact a Anguilla japonica cell line (PubMed=15994770).
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200004.
OX NCBI_TaxID=7937; ! Anguilla japonica
CA Spontaneously immortalized cell line
//
ID PNEC25
AC CVCL_B068
RX PubMed=15060276;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID PNEC28
AC CVCL_B069
RX PubMed=15060276;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID PNEC30
AC CVCL_B070
DR ATCC; CRL-2930
RX PubMed=15060276;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID PNEC30-3
AC CVCL_B071
RX PubMed=15060276;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B070 ! PNEC30
SX Male
CA Transformed cell line
//
ID PNET
AC CVCL_4431
SY Primary Neural Ectodermal Tumor cell
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1960 but was never distributed.
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PNET-2
AC CVCL_4432
SY PNET2
DR BTO; BTO:0004011
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PNG-1
AC CVCL_4J78
SY Papua New Guinea-1; Hagahai cell line
DR ATCC; CRL-10528
RX CelloPub=CLPUB00264;
RX Patent=US5397696;
WW http://www.wipo.int/wipo_magazine/en/2006/05/article_0008.html
WW http://www.culturalsurvival.org/publications/cultural-survival-quarterly/papua-new-guinea/national-institutes-health-and-papua-new-g
WW http://www.nytimes.com/1995/11/27/business/patents-recent-patent-papua-new-guinea-tribe-s-cell-line-prompts-outrage-charges.html
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Anecdotal: The patent concerning this cell line caused a highly-mediatic controversy. The cell line is derived from a member of the Hagahai people from New Guinea and it was deemed outrageous that a patent be deposited on biological material originating from an indigenous population without an explicit consent.
CC Discontinued: ATCC; CRL-10528; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PNKT-3
AC CVCL_T685
RX PubMed=221384;
RX PubMed=1087310;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8404; ! Lithobates pipiens
OI CVCL_T686 ! PRKT
CA Cancer cell line
//
ID PNKT-4
AC CVCL_T687
SY PNKT4
RX PubMed=221384;
RX PubMed=1087310;
CC Group: Amphibian cell line.
CC Caution: Could be identical to PNKT-4B (CVCL_T688).
OX NCBI_TaxID=8404; ! Lithobates pipiens
OI CVCL_T688 ! PNKT-4B
CA Cancer cell line
//
ID PNKT-4B
AC CVCL_T688
SY PNKT4B
RX PubMed=221384;
RX PubMed=2328547;
CC Group: Amphibian cell line.
CC Caution: Could be identical to PNKT-4 (CVCL_T687).
OX NCBI_TaxID=8404; ! Lithobates pipiens
OI CVCL_T687 ! PNKT-4
CA Cancer cell line
//
ID PNM-Mel
AC CVCL_M744
CC From: Guadagni F.; Istituto Regina Elena; Roma; Italy.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PNMR 120E
AC CVCL_U057
SY 120E
DR ECACC; 01080926
RX PubMed=11461669;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PNMR 160D
AC CVCL_U058
SY 160D
DR ECACC; 01080923
RX PubMed=11461669;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID PNMR OE
AC CVCL_U059
SY OE
DR ECACC; 01080925
RX PubMed=11461669;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Pno
AC CVCL_1K10
RX PubMed=10910922;
RX PubMed=11564178;
RX PubMed=14962098;
DI NCIt; C9265; Mycosis fungoides and Sezary syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PNP-Mel
AC CVCL_G320
SY PNP Mel
DR Cosmic; 1295330
CC From: Guadagni F.; Istituto Regina Elena; Roma; Italy.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PNT1
AC CVCL_4804
RX PubMed=1714974;
RX PubMed=8977636;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PNT1A
AC CVCL_2163
SY PNT1a; PNT-1A; PNT1-a; PNT1/A
DR BTO; BTO:0003068
DR CLO; CLO_0008475
DR CLDB; cl3926
DR ECACC; 07052901
DR ECACC; 95012614
DR GEO; GSM1374835
RX PubMed=7558421;
RX PubMed=11694337;
RX PubMed=21556542;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 16
ST D21S11: 27,28
ST D8S1179: 10,12
ST FGA: 24
ST TH01: 6
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4804 ! PNT1
SX Male
CA Transformed cell line
//
ID PNT1B
AC CVCL_W767
SY PNT1b; PNT-1B
RX PubMed=7558421;
RX PubMed=11135431;
RX PubMed=21556542;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMK16].
ST Source(s): PubMed=11416159
ST Amelogenin: X,Y
ST D18S51: 16
ST D21S11: 27,28
ST D8S1179: 10,12
ST FGA: 24
ST TH01: 6
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4804 ! PNT1
SX Male
CA Transformed cell line
//
ID PNT2
AC CVCL_2164
SY PNT 2; PNT-2
DR BTO; BTO:0002399
DR CLO; CLO_0008476
DR CLDB; cl3927
DR ECACC; 07042701
DR ECACC; 95012613
RX PubMed=11135431;
RX PubMed=21556542;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC; PubMed=11416159
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8,13
ST D16S539: 9
ST D18S51: 16,17
ST D21S11: 29,33.2
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 22,24
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID PNT2-C2
AC CVCL_4889
SY PNT2C2
DR BTO; BTO:0003539
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2164 ! PNT2
SX Male
CA Transformed cell line
//
ID PNT2-LSD
AC CVCL_W768
SY PNT2-Less Serum Dependent
RX PubMed=21556542;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2164 ! PNT2
SX Male
CA Transformed cell line
//
ID PNUH-12
AC CVCL_S889
RX CelloPub=CLPUB00003;
RX PubMed=17923759;
CC Doubling time: 48 hours (CelloPub=CLPUB00003).
DI NCIt; C4043; Hypopharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PNV35B
AC CVCL_U068
DR ECACC; 01080924
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID PO
AC CVCL_N593
DR CCLV; CCLV-RIE 0017
RX PubMed=19941903;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID Po Co
AC CVCL_U690
SY XP11BE
DR ATCC; CRL-1199
CC Discontinued: ATCC; CRL-1199; probable.
DI NCIt; C3966; Xeroderma pigmentosum, complementation group B
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L460 ! GM02252
SX Female
CA Finite cell line
//
ID PO-2
AC CVCL_9498
DR CLO; CLO_0008477
DR CLDB; cl3928
OX NCBI_TaxID=9940; ! Ovis aries
CA Undefined cell line type
//
ID PO714
AC CVCL_9279
DR CCLV; CCLV-RIE 0714
RX PubMed=15381362;
OX NCBI_TaxID=9940; ! Ovis aries
HI CVCL_N593 ! PO
CA Spontaneously immortalized cell line
//
ID POBC
AC CVCL_6E00
SY Paralichthys Olivaceus Brain Cell line
RX PubMed=25974130;
CC Group: Fish cell line.
OX NCBI_TaxID=8255; ! Paralichthys olivaceus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID POC
AC CVCL_0B89
RX PubMed=3034934;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID POE
AC CVCL_EJ01
DR Cosmic; 2250466
RX PubMed=25223734;
CC From: Delattre O.; Institut Curie; Paris; France.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID POE9n
AC CVCL_L237
RX PubMed=10648628;
RX PubMed=22546478;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
DI NCIt; C129863; Oral dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID POE9n/TERT
AC CVCL_L238
SY POE9n Tert; POE9n TERT
DR GEO; GSM1431129
RX PubMed=10648628;
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transfected with: HGNC; 11730; TERT.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C129863; Oral dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L237 ! POE9n
SX Male
CA Telomerase immortalized cell line
//
ID POG-1382.2
AC CVCL_9513
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID POG-1643
AC CVCL_9514
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID POG-1691
AC CVCL_9515
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID POG-1771
AC CVCL_9516
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID POGRS-1
AC CVCL_7111
AS CVCL_6710
SY PO-GRS1; P0-GRS1; POGRS1
DR BTO; BTO:0002287
RX PubMed=2170421;
RX PubMed=2171916;
RX PubMed=8961254;
RX PubMed=15541573;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID POGS-5
AC CVCL_7112
SY PO-GS5; POGS5
DR BTO; BTO:0002286
RX PubMed=2171916;
RX PubMed=8961254;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID POLH KO
AC CVCL_J376
DR JCRB; JCRB1477
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,17
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M249 ! POLZ KO MSH
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLH KO MSH-
AC CVCL_M247
DR JCRB; JCRB1482
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M249 ! POLZ KO MSH
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLK F171A MSH-
AC CVCL_4W71
DR JCRB; JCRB1517
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M249 ! POLZ KO MSH
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLK KO hetero MSH-
AC CVCL_4W72
DR JCRB; JCRB1518
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M249 ! POLZ KO MSH
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLK KO homo MSH-
AC CVCL_4W73
DR JCRB; JCRB1514
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M249 ! POLZ KO MSH
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLZ KO
AC CVCL_M248
DR JCRB; JCRB1488
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M249 ! POLZ KO MSH
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLZ KO MSH
AC CVCL_M249
DR JCRB; JCRB1494
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M250 ! POLZ L2618M
SX Male
CA Cancer cell line
//
ID POLZ L2618M
AC CVCL_M250
DR JCRB; JCRB1490
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J376 ! POLH KO
OI CVCL_M247 ! POLH KO MSH-
OI CVCL_4W71 ! POLK F171A MSH-
OI CVCL_4W72 ! POLK KO hetero MSH-
OI CVCL_4W73 ! POLK KO homo MSH-
OI CVCL_M248 ! POLZ KO
OI CVCL_M249 ! POLZ KO MSH
SX Male
CA Cancer cell line
//
ID Pom2
AC CVCL_6C24
SY PoM2
RX DOI=10.3390/foods1010040;
RX PubMed=20444515;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Finite cell line
//
ID PomD-iPSC A10
AC CVCL_IM67
DR GEO; GSM674579
RX PubMed=21926084;
CC Characteristics: Homozygous for the GAA p.Asp645Glu mutation.
CC Omics: Transcriptome analysis.
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IM68 ! PomD-iPSC A17
OI CVCL_IM69 ! PomD-iPSC A25
CA Induced pluripotent stem cell
//
ID PomD-iPSC A17
AC CVCL_IM68
DR GEO; GSM674580
RX PubMed=21926084;
CC Characteristics: Homozygous for the GAA p.Asp645Glu mutation.
CC Omics: Transcriptome analysis.
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IM67 ! PomD-iPSC A10
OI CVCL_IM69 ! PomD-iPSC A25
CA Induced pluripotent stem cell
//
ID PomD-iPSC A25
AC CVCL_IM69
DR GEO; GSM674582
RX PubMed=21926084;
CC Characteristics: Homozygous for the GAA p.Asp645Glu mutation.
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IM67 ! PomD-iPSC A10
OI CVCL_IM68 ! PomD-iPSC A17
CA Induced pluripotent stem cell
//
ID PomD-iPSC B03
AC CVCL_IM70
DR GEO; GSM674581
RX PubMed=21926084;
CC Omics: Transcriptome analysis.
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID Porco Clawn iPSC
AC CVCL_5G27
RX PubMed=22889279;
RX PubMed=23913699;
CC Breed/subspecies: Clawn miniature.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Induced pluripotent stem cell
//
ID Porco Rosso-4 iPSC
AC CVCL_5G28
RX PubMed=22889279;
RX PubMed=23913699;
CC Breed/subspecies: [(Landrace x Large white) x Duroc] humanized Kusabira-Orange transgenic.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Induced pluripotent stem cell
//
ID Porco Rosso-6 iPSC
AC CVCL_5G29
RX PubMed=22889279;
RX PubMed=23913699;
CC Breed/subspecies: [(Landrace x Large white) x Duroc] humanized Kusabira-Orange transgenic.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Induced pluripotent stem cell
//
ID Porco Rosso-622-14 iPSC
AC CVCL_5G30
RX PubMed=23913699;
CC Breed/subspecies: [(Landrace x Large white) x Duroc] humanized Kusabira-Orange transgenic.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Induced pluripotent stem cell
//
ID Porthos
AC CVCL_2695
SY PORTHOS
DR CLO; CLO_0008478
DR CLDB; cl3929
DR ECACC; 93122323
RX PubMed=1726925;
RX PubMed=8514246;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Finite cell line
//
ID POS [Dog osteosarcoma]
AC CVCL_L413
DR BTO; BTO:0005399
RX PubMed=7696411;
CC Breed/subspecies: Mixed breed.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID POS [Human B-cell]
AC CVCL_F579
SY TER253
DR IMGT/HLA; 11273
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID POS-1
AC CVCL_0J71
RX PubMed=12406567;
CC Breed/subspecies: C3H.
DI NCIt; C24021; Mouse osteosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Potelligent CHOK1SV
AC CVCL_DR96
WW http://www.lonza.com/custom-manufacturing/development-technologies/potelligent-chok1sv-technology.aspx
CC Knockout cell: Method=ZFN; UniProtKB; G3HCE4; Fut8.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_DR95 ! CHOK1SV
SX Female
CA Spontaneously immortalized cell line
//
ID POVD
AC CVCL_Y194
DR Cosmic; 1434970
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PP-9
AC CVCL_Z843
SY PP9
DR PRIDE; PXD002115
RX PubMed=11126533;
RX PubMed=23773405;
RX PubMed=26307495;
CC Group: Insect cell line.
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=29031; ! Phlebotomus papatasi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PP1084
AC CVCL_5J49
RX PubMed=8344493;
CC Characteristics: Has a TP53 p.Arg273Cys mutation.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PP109
AC CVCL_C233
SY pp109
RX PubMed=19002021;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PP117
AC CVCL_C234
SY pp117
RX PubMed=19002021;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PP161
AC CVCL_C235
SY pp161
RX PubMed=19002021;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PP78
AC CVCL_C236
SY pp78
RX PubMed=19002021;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PP984
AC CVCL_F007
DR Cosmic; 931132
RX PubMed=2052620;
RX PubMed=9473234;
CC Characteristics: Has a TP53 p.Arg273Cys mutation.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PPA00322IN
AC CVCL_E185
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Transformed cell line
//
ID PPA00378IN
AC CVCL_E186
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Sex undetermined
CA Transformed cell line
//
ID PPC-1
AC CVCL_4778
SY Primary Prostate Carcinoma-1; Specimen P-3
DR BTO; BTO:0001062
DR ATCC; HTB-190
DR BioSample; SAMN03151895
DR ChEMBL-Cells; CHEMBL3307780
DR ChEMBL-Targets; CHEMBL1626502
DR Cosmic; 948074
DR GEO; GSM91929
RX PubMed=2016798;
RX PubMed=2583869;
RX PubMed=8616865;
RX PubMed=12725112;
RX PubMed=15486987;
RX PubMed=20143388;
WW http://capcelllines.ca/details.asp?id=171
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; HTB-190; true.
CC Derived from metastatic site: Bone.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 13
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID PPIA-/- Jurkat
AC CVCL_1H23
SY Jurkat CypA -/-
DR NIH-ARP; 10095-136
RX PubMed=11250896;
CC Knockout cell: Method=Homologous recombination; HGNC; 9253; PPIA.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID PPM-Mill
AC CVCL_E110
SY PPM Mill; PPMMill; Mill
RX PubMed=22893632;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID PPM-Phi
AC CVCL_V417
SY Phi
RX PubMed=22552293;
RX PubMed=22893632;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID pPS1
AC CVCL_AD95
RX PubMed=21979046;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID PPY00327IN
AC CVCL_E190
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9601; ! Pongo abelii
SX Sex undetermined
CA Transformed cell line
//
ID PPY00328IN
AC CVCL_E191
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9601; ! Pongo abelii
SX Sex undetermined
CA Transformed cell line
//
ID PPY00329IN
AC CVCL_E192
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9601; ! Pongo abelii
SX Female
CA Transformed cell line
//
ID PPY00330IN
AC CVCL_E193
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Sex undetermined
CA Transformed cell line
//
ID PPY00331IN
AC CVCL_E194
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Sex undetermined
CA Transformed cell line
//
ID Pr-111
AC CVCL_Z948
SY Pr111
RX PubMed=11896566;
RX PubMed=12235003;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID Pr-117
AC CVCL_Z949
SY Pr117
RX PubMed=11896566;
RX PubMed=12235003;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID Pr-14
AC CVCL_Z950
SY Pr14
RX PubMed=9428383;
RX PubMed=12235003;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID Pr-14C1
AC CVCL_Z951
SY Pr14C1
RX PubMed=12235003;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Z950 ! Pr-14
SX Male
CA Transformed cell line
//
ID Pr-14C2
AC CVCL_Z952
SY Pr14C2
RX PubMed=12235003;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_Z950 ! Pr-14
SX Male
CA Transformed cell line
//
ID Pr-E-HNU9
AC CVCL_Z573
RX CelloPub=CLPUB00177;
CC Group: Insect cell line.
OX NCBI_TaxID=64459; ! Pieris rapae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID PR-GTL-16
AC CVCL_7696
RX PubMed=21208906;
CC Selected for resistance to: ChEBI; CHEBI:90197; PHA-665752.
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7668 ! GTL-16
SX Female
CA Cancer cell line
//
ID PR-Mel
AC CVCL_7113
SY PRMel
DR BTO; BTO:0003789
DR Cosmic; 1088702
DR Cosmic; 1109801
DR Cosmic; 1295341
DR GEO; GSM276750
RX PubMed=11121133;
RX PubMed=12696065;
RX PubMed=18384130;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID PR00002
AC CVCL_2V04
DR CLO; CLO_0017726
DR Coriell; PR00002
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
OI CVCL_1G38 ! AG05252
SX Male
CA Finite cell line
//
ID PR00003
AC CVCL_2V05
DR CLO; CLO_0017710
DR Coriell; PR00003
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Finite cell line
//
ID PR00011
AC CVCL_2V06
DR CLO; CLO_0017712
DR Coriell; PR00011
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9545; ! Macaca nemestrina
SX Female
CA Finite cell line
//
ID PR00013
AC CVCL_2V07
DR CLO; CLO_0017711
DR Coriell; PR00013
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00013; probable.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Finite cell line
//
ID PR00017
AC CVCL_2V08
DR CLO; CLO_0017714
DR Coriell; PR00017
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=90387; ! Macaca leonina
SX Female
CA Finite cell line
//
ID PR00019
AC CVCL_2V09
DR CLO; CLO_0017713
DR Coriell; PR00019
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00019; probable.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Finite cell line
//
ID PR00020
AC CVCL_2V10
DR CLO; CLO_0017716
DR Coriell; PR00020
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00020; probable.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Male
CA Finite cell line
//
ID PR00024
AC CVCL_2V11
DR CLO; CLO_0017715
DR Coriell; PR00024
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9545; ! Macaca nemestrina
SX Male
CA Finite cell line
//
ID PR00030
AC CVCL_2V12
DR CLO; CLO_0017718
DR Coriell; PR00030
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9545; ! Macaca nemestrina
SX Female
CA Finite cell line
//
ID PR00033
AC CVCL_2V13
DR CLO; CLO_0017717
DR Coriell; PR00033
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9555; ! Papio anubis
SX Male
CA Finite cell line
//
ID PR00036
AC CVCL_2V14
DR CLO; CLO_0017719
DR Coriell; PR00036
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9555; ! Papio anubis
OI CVCL_2V15 ! PR00037
SX Male
CA Finite cell line
//
ID PR00037
AC CVCL_2V15
DR CLO; CLO_0017872
DR Coriell; PR00037
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9555; ! Papio anubis
OI CVCL_2V14 ! PR00036
SX Male
CA Finite cell line
//
ID PR00039
AC CVCL_2V16
DR CLO; CLO_0017874
DR Coriell; PR00039
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9555; ! Papio anubis
SX Male
CA Finite cell line
//
ID PR00041
AC CVCL_DN72
DR Coriell; PR00041
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00041; probable.
OX NCBI_TaxID=9555; ! Papio anubis
SX Male
CA Finite cell line
//
ID PR00042
AC CVCL_2V17
DR CLO; CLO_0017875
DR Coriell; PR00042
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9555; ! Papio anubis
SX Male
CA Finite cell line
//
ID PR00045
AC CVCL_2V18
DR CLO; CLO_0017878
DR Coriell; PR00045
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9555; ! Papio anubis
SX Male
CA Finite cell line
//
ID PR00048
AC CVCL_2V19
DR CLO; CLO_0017868
DR Coriell; PR00048
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30611; ! Otolemur garnettii
SX Female
CA Finite cell line
//
ID PR00049
AC CVCL_2V20
DR CLO; CLO_0017869
DR Coriell; PR00049
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30611; ! Otolemur garnettii
SX Male
CA Finite cell line
//
ID PR00050
AC CVCL_2V21
DR CLO; CLO_0017870
DR Coriell; PR00050
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Male
CA Finite cell line
//
ID PR00051
AC CVCL_2V22
DR CLO; CLO_0017871
DR Coriell; PR00051
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Female
CA Finite cell line
//
ID PR00052
AC CVCL_2V23
DR Coriell; PR00052
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00052; probable.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Finite cell line
//
ID PR00053
AC CVCL_2V24
DR CLO; CLO_0017863
DR Coriell; PR00053
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00054
AC CVCL_2V25
DR CLO; CLO_0017865
DR Coriell; PR00054
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9601; ! Pongo abelii
OI CVCL_DP06 ! PR01003
SX Male
CA Finite cell line
//
ID PR00055
AC CVCL_2V26
DR CLO; CLO_0017848
DR Coriell; PR00055
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00058
AC CVCL_2V27
DR CLO; CLO_0017846
DR Coriell; PR00058
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9545; ! Macaca nemestrina
SX Female
CA Finite cell line
//
ID PR00062
AC CVCL_2V28
DR CLO; CLO_0017847
DR Coriell; PR00062
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9545; ! Macaca nemestrina
SX Female
CA Finite cell line
//
ID PR00075
AC CVCL_2V29
DR CLO; CLO_0017842
DR Coriell; PR00075
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00077
AC CVCL_2V30
DR CLO; CLO_0017845
DR Coriell; PR00077
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9545; ! Macaca nemestrina
SX Female
CA Finite cell line
//
ID PR00092
AC CVCL_2V31
DR CLO; CLO_0017840
DR Coriell; PR00092
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Female
CA Transformed cell line
//
ID PR00095
AC CVCL_2V32
DR CLO; CLO_0017841
DR Coriell; PR00095
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Female
CA Finite cell line
//
ID PR00096
AC CVCL_2V33
DR CLO; CLO_0017838
DR Coriell; PR00096
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Male
CA Finite cell line
//
ID PR00099
AC CVCL_2V34
DR CLO; CLO_0017839
DR Coriell; PR00099
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=336983; ! Colobus angolensis palliatus
SX Male
CA Finite cell line
//
ID PR00100
AC CVCL_2V35
DR CLO; CLO_0017836
DR Coriell; PR00100
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=54135; ! Allenopithecus nigroviridis
SX Male
CA Finite cell line
//
ID PR00101
AC CVCL_2V36
DR CLO; CLO_0017939
DR Coriell; PR00101
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00103
AC CVCL_2V37
DR CLO; CLO_0017938
DR Coriell; PR00103
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00105
AC CVCL_2V38
DR CLO; CLO_0017927
DR Coriell; PR00105
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00107
AC CVCL_2V39
DR CLO; CLO_0017928
DR Coriell; PR00107
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00108
AC CVCL_2V40
DR CLO; CLO_0017929
DR Coriell; PR00108
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=336983; ! Colobus angolensis palliatus
SX Female
CA Finite cell line
//
ID PR00111
AC CVCL_DN73
DR Coriell; PR00111
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00111; probable.
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Finite cell line
//
ID PR00112
AC CVCL_2V41
DR CLO; CLO_0017931
DR Coriell; PR00112
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Finite cell line
//
ID PR00115
AC CVCL_2V42
DR CLO; CLO_0017932
DR Coriell; PR00115
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Finite cell line
//
ID PR00119
AC CVCL_2V43
DR CLO; CLO_0017933
DR Coriell; PR00119
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Male
CA Finite cell line
//
ID PR00120
AC CVCL_2V44
DR CLO; CLO_0017934
DR Coriell; PR00120
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00122
AC CVCL_2V45
DR CLO; CLO_0017935
DR Coriell; PR00122
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9455; ! Varecia variegata
SX Female
CA Finite cell line
//
ID PR00123
AC CVCL_2V46
DR CLO; CLO_0017908
DR Coriell; PR00123
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9455; ! Varecia variegata
SX Male
CA Finite cell line
//
ID PR00124
AC CVCL_2V47
DR CLO; CLO_0017907
DR Coriell; PR00124
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Female
CA Finite cell line
//
ID PR00126
AC CVCL_2V48
DR CLO; CLO_0017905
DR Coriell; PR00126
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Male
CA Finite cell line
//
ID PR00127
AC CVCL_2V49
DR CLO; CLO_0017899
DR Coriell; PR00127
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=87288; ! Eulemur macaco flavifrons
SX Female
CA Finite cell line
//
ID PR00128
AC CVCL_2V50
DR CLO; CLO_0017900
DR Coriell; PR00128
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=87288; ! Eulemur macaco flavifrons
SX Male
CA Finite cell line
//
ID PR00129
AC CVCL_2V51
DR CLO; CLO_0017897
DR Coriell; PR00129
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34829; ! Eulemur rubriventer
SX Female
CA Finite cell line
//
ID PR00130
AC CVCL_2V52
DR CLO; CLO_0017898
DR Coriell; PR00130
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34829; ! Eulemur rubriventer
SX Male
CA Finite cell line
//
ID PR00131
AC CVCL_2V53
DR CLO; CLO_0017902
DR Coriell; PR00131
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00132
AC CVCL_2V54
DR CLO; CLO_0017903
DR Coriell; PR00132
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00133
AC CVCL_2V55
DR CLO; CLO_0017901
DR Coriell; PR00133
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9509; ! Ateles geoffroyi
SX Female
CA Finite cell line
//
ID PR00134
AC CVCL_DN74
DR Coriell; PR00134
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00134; probable.
OX NCBI_TaxID=9509; ! Ateles geoffroyi
SX Female
CA Transformed cell line
//
ID PR00174
AC CVCL_2V56
DR CLO; CLO_0018370
DR Coriell; PR00174
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Male
CA Finite cell line
//
ID PR00175
AC CVCL_2V57
DR CLO; CLO_0018377
DR Coriell; PR00175
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Finite cell line
//
ID PR00198
AC CVCL_2V58
DR CLO; CLO_0018378
DR Coriell; PR00198
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=54135; ! Allenopithecus nigroviridis
SX Female
CA Finite cell line
//
ID PR00219
AC CVCL_2V59
DR CLO; CLO_0018375
DR Coriell; PR00219
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00220
AC CVCL_2V60
DR CLO; CLO_0018376
DR Coriell; PR00220
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00221
AC CVCL_2V61
DR CLO; CLO_0018373
DR Coriell; PR00221
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00222
AC CVCL_2V62
DR CLO; CLO_0018374
DR Coriell; PR00222
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Male
CA Finite cell line
//
ID PR00223
AC CVCL_2V63
DR CLO; CLO_0018371
DR Coriell; PR00223
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00224
AC CVCL_2V64
DR CLO; CLO_0018372
DR Coriell; PR00224
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00226
AC CVCL_2V65
DR CLO; CLO_0018359
DR Coriell; PR00226
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Finite cell line
//
ID PR00227
AC CVCL_2V66
DR CLO; CLO_0018360
DR Coriell; PR00227
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34825; ! Propithecus verreauxi
SX Female
CA Finite cell line
//
ID PR00228
AC CVCL_2V67
DR CLO; CLO_0018361
DR Coriell; PR00228
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=31869; ! Daubentonia madagascariensis
SX Female
CA Finite cell line
//
ID PR00230
AC CVCL_2V68
DR CLO; CLO_0018366
DR Coriell; PR00230
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00232
AC CVCL_2V69
DR CLO; CLO_0018367
DR Coriell; PR00232
RX PubMed=16214744;
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9568; ! Mandrillus leucophaeus
SX Male
CA Finite cell line
//
ID PR00235
AC CVCL_2V70
DR CLO; CLO_0018368
DR Coriell; PR00235
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Female
CA Finite cell line
//
ID PR00236
AC CVCL_2V71
DR CLO; CLO_0018369
DR Coriell; PR00236
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Finite cell line
//
ID PR00237
AC CVCL_2V72
DR CLO; CLO_0018362
DR Coriell; PR00237
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Finite cell line
//
ID PR00238
AC CVCL_2V73
DR CLO; CLO_0018363
DR Coriell; PR00238
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Finite cell line
//
ID PR00239
AC CVCL_2V74
DR CLO; CLO_0018364
DR Coriell; PR00239
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=43777; ! Pithecia pithecia
SX Male
CA Finite cell line
//
ID PR00240
AC CVCL_2V75
DR CLO; CLO_0018365
DR Coriell; PR00240
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Male
CA Finite cell line
//
ID PR00241
AC CVCL_2V76
DR CLO; CLO_0018351
DR Coriell; PR00241
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Female
CA Finite cell line
//
ID PR00242
AC CVCL_2V77
DR CLO; CLO_0018349
DR Coriell; PR00242
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Male
CA Finite cell line
//
ID PR00243
AC CVCL_2V78
DR CLO; CLO_0018350
DR Coriell; PR00243
RX PubMed=21878684;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9589; ! Hylobates pileatus
SX Female
CA Transformed cell line
//
ID PR00244
AC CVCL_2V79
DR CLO; CLO_0018354
DR Coriell; PR00244
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=1215604; ! Eulemur albifrons
SX Male
CA Finite cell line
//
ID PR00245
AC CVCL_2V80
DR CLO; CLO_0018355
DR Coriell; PR00245
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=1215604; ! Eulemur albifrons
SX Male
CA Finite cell line
//
ID PR00247
AC CVCL_2V81
DR CLO; CLO_0018352
DR Coriell; PR00247
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=47178; ! Eulemur fulvus collaris
SX Female
CA Finite cell line
//
ID PR00251
AC CVCL_2V82
DR CLO; CLO_0018353
DR Coriell; PR00251
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Transformed cell line
//
ID PR00253
AC CVCL_2V83
DR CLO; CLO_0018357
DR Coriell; PR00253
RX PubMed=16214744;
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9601; ! Pongo abelii
SX Male
CA Transformed cell line
//
ID PR00254
AC CVCL_2V84
DR CLO; CLO_0018358
DR Coriell; PR00254
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Female
CA Finite cell line
//
ID PR00255
AC CVCL_2V85
DR CLO; CLO_0018356
DR Coriell; PR00255
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=47178; ! Eulemur fulvus collaris
SX Male
CA Finite cell line
//
ID PR00257
AC CVCL_2V86
DR CLO; CLO_0018339
DR Coriell; PR00257
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=13557; ! Hapalemur griseus
SX Male
CA Finite cell line
//
ID PR00258
AC CVCL_2V87
DR CLO; CLO_0018340
DR Coriell; PR00258
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=13557; ! Hapalemur griseus
SX Female
CA Finite cell line
//
ID PR00259
AC CVCL_2V88
DR CLO; CLO_0018341
DR Coriell; PR00259
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Male
CA Finite cell line
//
ID PR00260
AC CVCL_2V89
DR CLO; CLO_0018342
DR Coriell; PR00260
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Male
CA Finite cell line
//
ID PR00261
AC CVCL_2V90
DR CLO; CLO_0018343
DR Coriell; PR00261
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Male
CA Finite cell line
//
ID PR00262
AC CVCL_2V91
DR CLO; CLO_0018344
DR Coriell; PR00262
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=132548; ! Colobus guereza kikuyuensis
SX Male
CA Finite cell line
//
ID PR00265
AC CVCL_DN75
DR Coriell; PR00265
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00265; probable.
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Transformed cell line
//
ID PR00266
AC CVCL_2V92
DR CLO; CLO_0018345
DR Coriell; PR00266
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Male
CA Finite cell line
//
ID PR00267
AC CVCL_2V93
DR CLO; CLO_0018346
DR Coriell; PR00267
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Male
CA Finite cell line
//
ID PR00268
AC CVCL_2V94
DR CLO; CLO_0018347
DR Coriell; PR00268
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Male
CA Finite cell line
//
ID PR00269
AC CVCL_2V95
DR CLO; CLO_0018348
DR Coriell; PR00269
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Male
CA Finite cell line
//
ID PR00270
AC CVCL_2V96
DR CLO; CLO_0018338
DR Coriell; PR00270
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Male
CA Finite cell line
//
ID PR00273
AC CVCL_2V97
DR CLO; CLO_0018337
DR Coriell; PR00273
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34829; ! Eulemur rubriventer
SX Female
CA Finite cell line
//
ID PR00275
AC CVCL_2V98
DR Coriell; PR00275
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30608; ! Microcebus murinus
SX Female
CA Finite cell line
//
ID PR00276
AC CVCL_DN76
DR Coriell; PR00276
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00276; probable.
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Female
CA Transformed cell line
//
ID PR00279
AC CVCL_2V99
DR CLO; CLO_0018336
DR Coriell; PR00279
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00280
AC CVCL_2W00
DR CLO; CLO_0018335
DR Coriell; PR00280
RX PubMed=21878684;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00281
AC CVCL_2W01
DR CLO; CLO_0018334
DR Coriell; PR00281
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34825; ! Propithecus verreauxi
SX Male
CA Finite cell line
//
ID PR00282
AC CVCL_2W02
DR CLO; CLO_0018333
DR Coriell; PR00282
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34825; ! Propithecus verreauxi
SX Female
CA Finite cell line
//
ID PR00283
AC CVCL_DP26
DR Coriell; PR00283
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00283; probable.
OX NCBI_TaxID=100224; ! Cercopithecus lhoesti
SX Male
CA Finite cell line
//
ID PR00285
AC CVCL_2W03
DR CLO; CLO_0018332
DR Coriell; PR00285
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=87288; ! Eulemur macaco flavifrons
SX Female
CA Finite cell line
//
ID PR00288
AC CVCL_2W04
DR CLO; CLO_0018331
DR Coriell; PR00288
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Female
CA Finite cell line
//
ID PR00289
AC CVCL_2W05
DR CLO; CLO_0018330
DR Coriell; PR00289
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Female
CA Finite cell line
//
ID PR00290
AC CVCL_2W06
DR CLO; CLO_0018329
DR Coriell; PR00290
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9455; ! Varecia variegata
SX Female
CA Finite cell line
//
ID PR00291
AC CVCL_2W07
DR CLO; CLO_0018328
DR Coriell; PR00291
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00292
AC CVCL_2W08
DR CLO; CLO_0018327
DR Coriell; PR00292
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00293
AC CVCL_2W09
DR CLO; CLO_0018324
DR Coriell; PR00293
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00294
AC CVCL_2W10
DR CLO; CLO_0018323
DR Coriell; PR00294
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00295
AC CVCL_2W11
DR CLO; CLO_0018326
DR Coriell; PR00295
RX PubMed=16214744;
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9495; ! Callimico goeldii
SX Female
CA Finite cell line
//
ID PR00296
AC CVCL_2W12
DR CLO; CLO_0018325
DR Coriell; PR00296
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=336983; ! Colobus angolensis palliatus
SX Male
CA Finite cell line
//
ID PR00301
AC CVCL_2W13
DR CLO; CLO_0018320
DR Coriell; PR00301
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00302
AC CVCL_2W14
DR CLO; CLO_0018319
DR Coriell; PR00302
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34825; ! Propithecus verreauxi
SX Male
CA Finite cell line
//
ID PR00303
AC CVCL_2W15
DR CLO; CLO_0018322
DR Coriell; PR00303
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Female
CA Finite cell line
//
ID PR00304
AC CVCL_2W16
DR CLO; CLO_0018321
DR Coriell; PR00304
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30603; ! Eulemur macaco macaco
SX Female
CA Finite cell line
//
ID PR00306
AC CVCL_2W17
DR CLO; CLO_0018314
DR Coriell; PR00306
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Female
CA Finite cell line
//
ID PR00307
AC CVCL_DP27
DR Coriell; PR00307
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00307; probable.
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00316
AC CVCL_2W18
DR CLO; CLO_0018312
DR Coriell; PR00316
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=40322; ! Eulemur fulvus fulvus
SX Female
CA Finite cell line
//
ID PR00319
AC CVCL_2W19
DR CLO; CLO_0018311
DR Coriell; PR00319
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=13514; ! Eulemur coronatus
SX Female
CA Finite cell line
//
ID PR00320
AC CVCL_2W20
DR CLO; CLO_0018318
DR Coriell; PR00320
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=13514; ! Eulemur coronatus
SX Female
CA Finite cell line
//
ID PR00322
AC CVCL_2W21
DR CLO; CLO_0018317
DR Coriell; PR00322
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00323
AC CVCL_2W22
DR CLO; CLO_0018316
DR Coriell; PR00323
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Male
CA Finite cell line
//
ID PR00324
AC CVCL_2W23
DR CLO; CLO_0018315
DR Coriell; PR00324
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=554167; ! Varecia variegata rubra
SX Female
CA Finite cell line
//
ID PR00326
AC CVCL_2W24
DR CLO; CLO_0018306
DR Coriell; PR00326
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34825; ! Propithecus verreauxi
SX Male
CA Finite cell line
//
ID PR00330
AC CVCL_2W25
DR CLO; CLO_0018304
DR Coriell; PR00330
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=54180; ! Trachypithecus francoisi
SX Female
CA Finite cell line
//
ID PR00331
AC CVCL_2W26
DR CLO; CLO_0018301
DR Coriell; PR00331
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9447; ! Lemur catta
SX Male
CA Finite cell line
//
ID PR00333
AC CVCL_2W27
DR CLO; CLO_0018292
DR Coriell; PR00333
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Female
CA Finite cell line
//
ID PR00334
AC CVCL_2W28
DR CLO; CLO_0018291
DR Coriell; PR00334
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Male
CA Finite cell line
//
ID PR00335
AC CVCL_2W29
DR CLO; CLO_0018295
DR Coriell; PR00335
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Male
CA Finite cell line
//
ID PR00336
AC CVCL_2W30
DR CLO; CLO_0018294
DR Coriell; PR00336
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=40322; ! Eulemur fulvus fulvus
SX Female
CA Finite cell line
//
ID PR00337
AC CVCL_2W31
DR CLO; CLO_0018297
DR Coriell; PR00337
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=859984; ! Eulemur rufifrons
SX Male
CA Finite cell line
//
ID PR00338
AC CVCL_2W32
DR Coriell; PR00338
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00338; probable.
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Male
CA Finite cell line
//
ID PR00340
AC CVCL_2W33
DR CLO; CLO_0018296
DR Coriell; PR00340
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=13557; ! Hapalemur griseus
SX Female
CA Finite cell line
//
ID PR00341
AC CVCL_2W34
DR CLO; CLO_0018299
DR Coriell; PR00341
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34829; ! Eulemur rubriventer
SX Male
CA Finite cell line
//
ID PR00342
AC CVCL_2W35
DR CLO; CLO_0018298
DR Coriell; PR00342
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=47178; ! Eulemur fulvus collaris
SX Male
CA Finite cell line
//
ID PR00344
AC CVCL_2W36
DR CLO; CLO_0018283
DR Coriell; PR00344
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=87288; ! Eulemur macaco flavifrons
SX Male
CA Finite cell line
//
ID PR00345
AC CVCL_2W37
DR CLO; CLO_0018281
DR Coriell; PR00345
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Male
CA Finite cell line
//
ID PR00357
AC CVCL_2W38
DR CLO; CLO_0018496
DR Coriell; PR00357
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=859984; ! Eulemur rufifrons
SX Male
CA Finite cell line
//
ID PR00366
AC CVCL_2W39
DR CLO; CLO_0018483
DR Coriell; PR00366
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Female
CA Transformed cell line
//
ID PR00367
AC CVCL_DN77
DR Coriell; PR00367
RX PubMed=16214744;
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00367; probable.
OX NCBI_TaxID=9597; ! Pan paniscus
SX Female
CA Transformed cell line
//
ID PR00370
AC CVCL_2W40
DR Coriell; PR00370
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00370; probable.
OX NCBI_TaxID=34828; ! Eulemur mongoz
SX Female
CA Finite cell line
//
ID PR00381
AC CVCL_2W41
DR CLO; CLO_0018484
DR Coriell; PR00381
RX PubMed=16214744;
RX PubMed=21878684;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=61852; ! Nomascus gabriellae
SX Male
CA Transformed cell line
//
ID PR00389
AC CVCL_2W42
DR CLO; CLO_0018485
DR Coriell; PR00389
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=1215604; ! Eulemur albifrons
SX Female
CA Finite cell line
//
ID PR00398
AC CVCL_DN78
DR Coriell; PR00398
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00398; probable.
OX NCBI_TaxID=9561; ! Mandrillus sphinx
SX Male
CA Transformed cell line
//
ID PR00399
AC CVCL_2W43
DR CLO; CLO_0018486
DR Coriell; PR00399
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9561; ! Mandrillus sphinx
SX Male
CA Finite cell line
//
ID PR00400
AC CVCL_2W44
DR CLO; CLO_0018479
DR Coriell; PR00400
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID PR00408
AC CVCL_DN79
DR Coriell; PR00408
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00408; probable.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Transformed cell line
//
ID PR00418
AC CVCL_2W45
DR CLO; CLO_0018480
DR Coriell; PR00418
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Finite cell line
//
ID PR00446
AC CVCL_DN80
DR Coriell; PR00446
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00446; probable.
OX NCBI_TaxID=9597; ! Pan paniscus
SX Female
CA Finite cell line
//
ID PR00474
AC CVCL_2W46
DR CLO; CLO_0018481
DR Coriell; PR00474
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis
SX Male
CA Finite cell line
//
ID PR00485
AC CVCL_2W47
DR CLO; CLO_0018482
DR Coriell; PR00485
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9530; ! Cercocebus torquatus
SX Male
CA Finite cell line
//
ID PR00486
AC CVCL_2W48
DR CLO; CLO_0018487
DR Coriell; PR00486
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=263448; ! Cercopithecus wolfi
SX Female
CA Finite cell line
//
ID PR00488
AC CVCL_DN81
DR Coriell; PR00488
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00488; probable.
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Female
CA Transformed cell line
//
ID PR00494
AC CVCL_2W49
DR CLO; CLO_0018474
DR Coriell; PR00494
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=40322; ! Eulemur fulvus fulvus
SX Female
CA Finite cell line
//
ID PR00495
AC CVCL_2W50
DR Coriell; PR00495
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00495; probable.
OX NCBI_TaxID=9580; ! Hylobates lar
SX Male
CA Finite cell line
//
ID PR00496
AC CVCL_2W51
DR CLO; CLO_0018472
DR Coriell; PR00496
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID PR00503
AC CVCL_2W52
DR CLO; CLO_0018465
DR Coriell; PR00503
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=54600; ! Macaca nigra
SX Female
CA Finite cell line
//
ID PR00512
AC CVCL_DN82
DR Coriell; PR00512
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00512; probable.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Finite cell line
//
ID PR00519
AC CVCL_2W53
DR CLO; CLO_0018466
DR Coriell; PR00519
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30609; ! Galago moholi
SX Female
CA Finite cell line
//
ID PR00522
AC CVCL_2W54
DR Coriell; PR00522
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00522; probable.
OX NCBI_TaxID=9536; ! Cercopithecus hamlyni
SX Male
CA Finite cell line
//
ID PR00524
AC CVCL_2W55
DR CLO; CLO_0018463
DR Coriell; PR00524
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Finite cell line
//
ID PR00525
AC CVCL_2W56
DR CLO; CLO_0018464
DR Coriell; PR00525
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9519; ! Lagothrix lagotricha
SX Female
CA Finite cell line
//
ID PR00527
AC CVCL_2W57
DR CLO; CLO_0018461
DR Coriell; PR00527
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9535; ! Cercopithecus cephus
SX Female
CA Finite cell line
//
ID PR00530
AC CVCL_2W58
DR CLO; CLO_0018462
DR Coriell; PR00530
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=263448; ! Cercopithecus wolfi
SX Female
CA Finite cell line
//
ID PR00531
AC CVCL_2W59
DR CLO; CLO_0018459
DR Coriell; PR00531
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9535; ! Cercopithecus cephus
SX Male
CA Finite cell line
//
ID PR00548
AC CVCL_2W60
DR CLO; CLO_0018460
DR Coriell; PR00548
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Transformed cell line
//
ID PR00550
AC CVCL_2W61
DR CLO; CLO_0020703
DR Coriell; PR00550
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30586; ! Saguinus midas
SX Male
CA Finite cell line
//
ID PR00551
AC CVCL_2W62
DR CLO; CLO_0020704
DR Coriell; PR00551
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30586; ! Saguinus midas
SX Male
CA Finite cell line
//
ID PR00553
AC CVCL_2W63
DR CLO; CLO_0020705
DR Coriell; PR00553
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30601; ! Propithecus tattersalli
SX Male
CA Finite cell line
//
ID PR00554
AC CVCL_2W64
DR CLO; CLO_0020706
DR Coriell; PR00554
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=30586; ! Saguinus midas
SX Male
CA Finite cell line
//
ID PR00559
AC CVCL_2W65
DR CLO; CLO_0020699
DR Coriell; PR00559
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9557; ! Papio hamadryas
SX Female
CA Finite cell line
//
ID PR00566
AC CVCL_2W66
DR CLO; CLO_0020700
DR Coriell; PR00566
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti
SX Male
CA Finite cell line
//
ID PR00573
AC CVCL_DN83
DR Coriell; PR00573
RX PubMed=16214744;
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00573; probable.
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00576
AC CVCL_2W67
DR CLO; CLO_0020701
DR Coriell; PR00576
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Female
CA Finite cell line
//
ID PR00578
AC CVCL_2W68
DR CLO; CLO_0020702
DR Coriell; PR00578
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Female
CA Finite cell line
//
ID PR00582
AC CVCL_2W69
DR CLO; CLO_0020688
DR Coriell; PR00582
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9534; ! Chlorocebus aethiops
SX Female
CA Finite cell line
//
ID PR00586
AC CVCL_2W70
DR CLO; CLO_0020686
DR Coriell; PR00586
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9490; ! Saguinus oedipus
SX Female
CA Finite cell line
//
ID PR00592
AC CVCL_2W71
DR CLO; CLO_0020690
DR Coriell; PR00592
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9590; ! Symphalangus syndactylus
SX Female
CA Transformed cell line
//
ID PR00594
AC CVCL_2W72
DR CLO; CLO_0020697
DR Coriell; PR00594
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9590; ! Symphalangus syndactylus
SX Female
CA Transformed cell line
//
ID PR00597
AC CVCL_2W73
DR CLO; CLO_0020698
DR Coriell; PR00597
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9572; ! Colobus polykomos
SX Male
CA Finite cell line
//
ID PR00598
AC CVCL_2W74
DR CLO; CLO_0020695
DR Coriell; PR00598
RX PubMed=16214744;
RX PubMed=16326750;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9590; ! Symphalangus syndactylus
SX Male
CA Transformed cell line
//
ID PR00603
AC CVCL_2W75
DR CLO; CLO_0020696
DR Coriell; PR00603
RX PubMed=21878684;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00603; probable.
OX NCBI_TaxID=9521; ! Saimiri sciureus
SX Female
CA Finite cell line
//
ID PR00604
AC CVCL_2W76
DR CLO; CLO_0020693
DR Coriell; PR00604
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=54180; ! Trachypithecus francoisi
SX Male
CA Finite cell line
//
ID PR00605
AC CVCL_2W77
DR CLO; CLO_0020694
DR Coriell; PR00605
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID PR00608
AC CVCL_2W78
DR CLO; CLO_0020691
DR Coriell; PR00608
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=255237; ! Cercocebus agilis
SX Female
CA Finite cell line
//
ID PR00609
AC CVCL_2W79
DR CLO; CLO_0020692
DR Coriell; PR00609
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=75566; ! Lophocebus aterrimus
SX Male
CA Finite cell line
//
ID PR00612
AC CVCL_2W80
DR CLO; CLO_0020845
DR Coriell; PR00612
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Discontinued: Coriell; PR00612; probable.
OX NCBI_TaxID=9521; ! Saimiri sciureus
SX Female
CA Finite cell line
//
ID PR00615
AC CVCL_2W81
DR CLO; CLO_0020826
DR Coriell; PR00615
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9460; ! Cheirogaleus medius
SX Female
CA Finite cell line
//
ID PR00616
AC CVCL_2W82
DR CLO; CLO_0020825
DR Coriell; PR00616
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=75566; ! Lophocebus aterrimus
SX Female
CA Finite cell line
//
ID PR00622
AC CVCL_2W83
DR CLO; CLO_0020824
DR Coriell; PR00622
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00623
AC CVCL_2W84
DR CLO; CLO_0020823
DR Coriell; PR00623
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00626
AC CVCL_2W85
DR CLO; CLO_0020822
DR Coriell; PR00626
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti
SX Female
CA Finite cell line
//
ID PR00627
AC CVCL_2W86
DR CLO; CLO_0020821
DR Coriell; PR00627
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=37293; ! Aotus nancymaae
SX Male
CA Finite cell line
//
ID PR00628
AC CVCL_2W87
DR Coriell; PR00628
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=37293; ! Aotus nancymaae
SX Male
CA Transformed cell line
//
ID PR00631
AC CVCL_2W88
DR CLO; CLO_0020820
DR Coriell; PR00631
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9470; ! Nycticebus coucang
SX Male
CA Finite cell line
//
ID PR00632
AC CVCL_2W89
DR CLO; CLO_0020819
DR Coriell; PR00632
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=57176; ! Aotus vociferans
SX Male
CA Finite cell line
//
ID PR00634
AC CVCL_2W90
DR CLO; CLO_0020818
DR Coriell; PR00634
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=192857; ! Cercopithecus ascanius schmidti
SX Female
CA Finite cell line
//
ID PR00636
AC CVCL_2W91
DR CLO; CLO_0020817
DR Coriell; PR00636
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=57176; ! Aotus vociferans
SX Male
CA Finite cell line
//
ID PR00643
AC CVCL_DN84
DR Coriell; PR00643
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00643; probable.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID PR00644
AC CVCL_2W92
DR CLO; CLO_0020855
DR Coriell; PR00644
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9493; ! Callithrix pygmaea
SX Female
CA Finite cell line
//
ID PR00648
AC CVCL_2W93
DR CLO; CLO_0020857
DR Coriell; PR00648
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Female
CA Transformed cell line
//
ID PR00650
AC CVCL_2W94
DR CLO; CLO_0020856
DR Coriell; PR00650
RX PubMed=21878684;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Male
CA Transformed cell line
//
ID PR00652
AC CVCL_2W95
DR CLO; CLO_0020852
DR Coriell; PR00652
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=61852; ! Nomascus gabriellae
SX Female
CA Transformed cell line
//
ID PR00655
AC CVCL_DN85
DR Coriell; PR00655
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00655; probable.
OX NCBI_TaxID=33548; ! Colobus guereza
SX Female
CA Transformed cell line
//
ID PR00657
AC CVCL_2W96
DR CLO; CLO_0020851
DR Coriell; PR00657
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Transformed cell line
//
ID PR00660
AC CVCL_DN86
DR Coriell; PR00660
RX PubMed=16214744;
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: Coriell; PR00660; probable.
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Female
CA Transformed cell line
//
ID PR00661
AC CVCL_2W97
DR CLO; CLO_0020854
DR Coriell; PR00661
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9597; ! Pan paniscus
SX Male
CA Transformed cell line
//
ID PR00663
AC CVCL_2W98
DR CLO; CLO_0020853
DR Coriell; PR00663
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00664
AC CVCL_2W99
DR Coriell; PR00664
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Finite cell line
//
ID PR00669
AC CVCL_2X00
DR CLO; CLO_0020849
DR Coriell; PR00669
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00671
AC CVCL_2X01
DR CLO; CLO_0020848
DR Coriell; PR00671
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
ID PR00674
AC CVCL_2X02
DR CLO; CLO_0020850
DR Coriell; PR00674
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=43780; ! Nasalis larvatus
SX Male
CA Finite cell line
//
ID PR00677
AC CVCL_2X03
DR CLO; CLO_0020889
DR Coriell; PR00677
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=881949; ! Saguinus fuscicollis nigrifrons
SX Male
CA Finite cell line
//
ID PR00678
AC CVCL_2X04
DR CLO; CLO_0020888
DR Coriell; PR00678
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=100224; ! Cercopithecus lhoesti
SX Female
CA Finite cell line
//
ID PR00679
AC CVCL_2X05
DR CLO; CLO_0020887
DR Coriell; PR00679
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=43780; ! Nasalis larvatus
SX Female
CA Finite cell line
//
ID PR00680
AC CVCL_2X06
DR CLO; CLO_0020886
DR Coriell; PR00680
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9519; ! Lagothrix lagotricha
SX Female
CA Finite cell line
//
ID PR00707
AC CVCL_2X07
DR CLO; CLO_0020883
DR Coriell; PR00707
CC Group: Non-human primate cell line.
CC From: Integrated Primate Biomaterials and Information Resource (IPBIR).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Male
CA Finite cell line
//
- 公告/新闻
免费订购电话: 400-800-2947